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Abstract
The aim of this project was to develop new coatings for titanium based implants, most
particularly stents, incorporating heterocyclic functional groups in their structure that
will have the potential to bind to a titanium surface and prevent or reduce metal
corrosion. Many of the current coatings are chemically bound onto metallic surfaces,
but this project looks at electropolymerising the coatings onto the surface of the
Ti6Al4V stents. Hence, polymerising functional groups have been incorporated with
azoles in the structure of the synthesised compounds. Additionally, surface
characterisation and preliminary corrosion studies have been carried out on a series of
coated TI6Al4V stents.
In this study, the compounds synthesised have been divided into three groups.
Compounds from series 1 have been synthesised from the core unit 2-(1H-tetrazol-5yl)pyridine, while compounds from series 2 have been derived from pyrrole or 1,2dimethyltetrahydrofuran. Series 3 compounds were obtained by reacting compounds
1 and 2 together. This in turn created a series of tetrazole/pyrrole based compounds.
A total of 16 compounds are reported in this thesis. The compounds were isolated and
identified by spectroscopic techniques (1H and

13

C NMR, IR) as well as elemental

analysis. A selection of series 3 compounds were subsequently chosen based on their
polymerisation properties and coated onto a Ti6Al4V stent surface. The coatings were
characterised by microscopy (SEM and AFM) and subjected to electrochemical
corrosion testing via Tafel analysis.
The preliminary results indicated that some of the synthesised coatings display a good
coating ability and improved anti-corrosion properties, relative to coatings currently
on the medical device market. Compounds 2-(2,2-diethoxyethane-3amino-pyrrol-1-yl
ethyl-(1-tetrazol-5-yl)

pyridine

and

2-(n-ethylphenylpyrrole-(2H-tetrazol-5-yl)

pyridine demonstrated the best reduction in corrosion, with a 5 fold reduction when
compared to the uncoated Ti6Al4V stent.
New tetrazole/pyrrole based coatings have been synthesised in this project, that have
the capabilities of adhering to metallic surfaces and reduce metal corrosion. It is hoped
that this exploratory work could lead to an introduction of new corrosion reducing
iii

coatings onto the medical stent market. However, further research is needed to bring
the application of this project to the market.
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Abbreviation
AFM

Atomic force microscopy

Ar

Aromatic ring

ßb

Anodic slope

ßc

Cathodic slope

CAD

Coronary artery disease

CH3CN

Acetonitrile

CDCl3

Deuterochloroform

cm-1

Wavenumber

CV

Cyclic voltammetry

DCM

Dichloromethane

DEAD

Diethyl azodicarboxylate

DES

Drug eluting stent

DMF

N, N – Dimethylformamide

DNA

Deoxyribonucleic acid

d

Doublet

dd

Doublet of doublets

d

Chemical shift

e.g.

Example

Ecorr

Corrosion potential

EtOH

Ethanol

eq.

Equation

FDA

Food and drug administration

g

Gram

HOMO

Highest occupied molecular orbital

HPLC

High-performance liquid chromatography

HVSFS

High-Velocity Suspension Flame Spray

icorr

Corrosion current

IMCR’s

Iso-cyanide based multicomponent reaction.

IR

Infrared

ISR

In-stent restenosis

J

Coupling constant

LUMO

Lowest unoccupied molecular orbital
v

m.p

Melting points

M

Molar

m

Multiplet

MeOH

Methanol

min

Minute

mL

Milliliter

NMR

Nuclear magnetic resonance

PBMA

Poly(n-butyl methacrylate)

PC

Phosphorylcholine

PCI

Percutaneous coronary intervention

PEVA

Poly(ethylene-co-vinyl acetate)

Ph

Phenyl group

ppm

Parts per million

PTCA

Percutaneous transluminal coronary angioplasty

r.t

room temperature

Rp

Polarisation resistance

s

Singlet

SBF

Simulated body fluid

SEM

Scanning electron microscopy

SF

Silk fibroin

SIBS

Poly(styrene-b-isobutylene-b-styrene)

SiO2

Silica gel

t

Triplet

TBAF

Tetrabutylammonium fluoride

TBAP

Tetrabutylammonium perchlorate

TMEDA

Tetramethylethylenediamine

TMS

Tetramethylsilane

TMSN3

Trimethylsilyl azide

TSA

Toluenesulfonic acid

µL

microliter

µM

Micromolar

UV/vis

Ultraviolet/visible

VSMC

Vascular smooth muscle cell

Y•

Radical
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Chapter 1
Introduction

1.1

Aim of Research

Over the last 30 years, the use of joint replacements are increasing due to many factors
such as aging population, and higher expectations of quality of life for elderly patients.
In 2018, nearly 100,000 people underwent total hip replacement in the United
Kingdom.1 In 2019, the global market for medical implants topped 85.38 billion
dollars, and is projected to generate 147 billion by 2027.2 This rise is not only because
of the aging population, but due to an increase in sport and car related injuries.3 In the
field of orthopaedics one of the main aims is to improve prosthetic implants in terms
of duration, allowing insertion into younger patients, prevent corrosion of the
prosthetic, and resistance to bacterial contamination. A biomaterial in contact with
bone tissue requires several surface characteristics in order to be effective. The main
objective is to obtain a biocompatible and osseointegrable implant.
The World Health Organisation International Agency for research on cancer released
a monograph listing hexavalent chromium as a proven carcinogen; trivalent chromium
a potential carcinogen; and cobalt ions a probable carcinogen, all of which are used in
alloys found in medical implants.4 Multiple studies and research organisations have
warned of the carcinogenic potential of metal-on-metal hip implants,5 their debris and
their effects on the body, for example, renal toxicity, neuro toxicity, cardiac toxicity
and hepatic toxicity. In spite of this, over the last 30 years orthopaedic surgery has
immeasurably improved the lives of millions of people, restoring their mobility,
bringing pain relief and ultimately giving a better quality of life.6 Titanium and its
alloys have been used as prosthetic material for many years due to their special
properties: non-toxic, corrosion resistance, fatigue durability and biocompatibility.7
Despite the success of these prosthetic operations, it is generally accepted that within
15 – 20 years post-surgery, aseptic loosening of the implants is almost inevitable.6 If
infection is excluded, the most frequent complication associated with joint
replacement is the deterioration of the prosthetic components and this can cause
release of metal ions into the physiological system, resulting in a biological response
by the body.8 The FDA have stated that these metal particles cause damage to bone
and/or tissues surrounding the implant and joint. This response is an “adverse local
tissue reaction” and the systemic and local responses are referred to as “adverse
2

reaction to metal debris”. Soft tissue damage may lead to pain, implant loosening,
device failure and the need for revision surgery.9
The aim of this project is to develop new coatings for titanium based implants in
particular stents, incorporating heterocyclic azole units in their structure that will have
the potential to bind to the titanium surface and prevent or reduce metal corrosion.
Azole functional groups were incorporated within coatings as it has been found, by
previous members of this research group, that they possess metal binding properties.10
Figure 1.1 illustrates the type of compound desired from this research. Traditionally,
coatings are chemically painted onto the surface, but the project aims to
electropolymerise the coatings onto the surface of the medical stent. Hence,
polymerising functional groups have been incorporated with azoles in the structure of
the synthesised compounds.
Ti

T
i
S
T
E
N
T

a - SITE OF POLYMERISATION

Ti
Ti
Ti

N

AZOLE GROUP

SPACER

N

Ti
Ti
Ti

Figure 1.1

1.2

Schematic representation of compounds to be synthesised

Heterocyclic Chemistry Overview

A heterocyclic structure can be characterised as a cyclic compound containing one or
more atoms other than carbon in a ring system.11 The elements most commonly found
in these structures are nitrogen, oxygen and sulphur. Heterocyclic rings can occur in a
range from 3 – 9 membered rings with the largest focus being on 5 and 6 membered
rings. The focus is on 5 and 6 membered rings due to their greater stability, smaller
rings can easily open under mild reaction conditions to relieve steric strain, while
larger rings are more conformationally mobile and can result in different solid and
solution properties. These ring structures can be divided into two groups, namely
saturated and unsaturated. Saturated and unsaturated heterocycles differ in their
electronic structure. Figure 1.2 displays a range of saturated five and six membered
heterocycles containing either nitrogen, oxygen or sulphur atoms. The addition of
3

these atoms to the cyclic structure results in them behaving like their acyclic
derivatives, meaning that tetrahydrofuran and piperidine act as conventional ethers
and amines. Unexpectedly, they do have slightly modified steric profiles.

N
H

O

S

pyrrolidine

tetrahydrofuran

tetrahydrothiophene

N
H

O

S

piperidine

Figure 1.2

tetrahydro-2H-pyran tetrahydro-2H-thiopyran

Saturated five and six membered heterocyclic compounds

Figure 1.3 displays a range of unsaturated five and six membered heterocyclic
structures containing nitrogen, oxygen and sulphur atoms. These molecules are
aromatic and therefore display enhanced stabilisation properties as a cyclic
conjugation system, due to the lone pair of electrons present on the non-carbon atoms,
for example in furan on the oxygen, inhibiting p-orbitals perpendicular to the ring
plane. This stabilises the ring structure by delocalisation of the lone pair within the
conjugated system. A general rule to describe the aromaticity in a complex was
proposed by Hückel in 1931. This states that aromaticity is observed in cyclical
conjugated systems of (4n+2) π-electrons. By far, the majority of monocyclic aromatic
and heteroaromatic systems are those with six electrons.12
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N
H

O

S

1H-pyrrole

furan

thiophene

N

O

S

2H-pyran

2H-thiopyran

pyridine

Figure 1.3

Unsaturated five and six membered heterocyclic compounds

Unsaturated heterocyclic structures can be further sub-divided into two groups. Group
one contains heteroatoms with a lone or unshared pair of electrons while group two
contains heteroatoms that are connected to another atom via a double bond. Pyrrole is
an example of a heterocyclic structure from the first group, as it contains a lone or
unshared pair of electrons. The nitrogen in the pyrrole is covalently bonded to two
carbon atoms and one hydrogen atom. Nitrogen has five electrons in its outermost
shell and therefore three of these electrons have entered into the three covalent bonds
with the two carbon atoms and one hydrogen atoms while an unshared pair of electrons
remains available to partake in cyclic conjugations. The two electrons from each of
the two carbon-carbon double bonds and the delocalised unshared pair of electrons
from the nitrogen are drawn into the aromatic sextet. As the unshared pair of electrons
on the nitrogen atom are drawn into the aromatic sextet a net flow of electron density
from the nitrogen atom to the carbon atoms is experienced giving rise to a stable
resonance hybrid.
An example of a molecule from group two would be pyridine. Pyridine is linked to
two carbon atoms via one single bond and one double bond, however, the π-electron
sextet is completed by a contribution of one electron from each of the five carbon
atoms in the ring and the final electron being donated by the nitrogen atom in the ring.
This means that the unshared pair of electrons on the nitrogen atom are not involved
in the completion of the π-electron sextet. Furthermore, because of the nitrogen’s
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electronegativity there tends to be a net flow of electrons towards the nitrogen unlike
with the pyrrole.
One of the main reasons that five membered ring structures are of great importance to
chemists is that they can be easily manipulated in order to achieve the desired effect.
It is also proven that systems such as furan are considerably more reactive than
benzene for electrophilic substitution reactions with reactions taking place using
milder conditions and in shorter time frames. By varying the non-carbon atoms in
these systems, using nitrogen, oxygen, sulphur or any element from group fourteen or
fifteen of the periodic table, it is possible to change their chemical properties such as
acidity, basicity and polarity.11

1.3

Nitrogen Containing Heterocycles with More Than One Heteroatom

Azoles are a class of five membered heterocyclic ring structure containing nitrogen
and at least one other heteroatom such as a second nitrogen atom or an oxygen or
sulphur atom. Azoles are often found in nature, an example of one being imidazole.13
Imidazole is part of a fused ring system in adenine and guanine, two of the four
building blocks of DNA. Imidazole’s are also structural units of potent antifungals
such as clotrimazole, econazole and ketoconazole.14
N

N

N
N

O

N
H

N
H

oxoazole

1H-imidazole

1H-1,2,4-triazole

N

N
N

Figure 1.4

N

S

N
H

N
H

thiazole

1H-pyrazole

1H-1,2,3-triazole

Azoles containing two and three nitrogen atoms and their two isomeric
structures along with azoles containing sulphur and oxygen atoms
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Figure 1.4 contains examples of five membered ring structures that are usually
derived from the replacement of one or more CH groups by sp2 hybridized nitrogen,
giving the classification as azoles. It is the number and variable placement of the
hetero atoms that gives the structural diversity and unique properties of these rings
systems. The addition of the extra nitrogen has important effects on the properties of
the ring system. The lone pair on the additional nitrogen atoms are not involved in the
π-orbitals and are in the plane of the ring, therefore a favourable point of reaction with
protons and other electrophiles.11 The additional nitrogen also has the effect of
lowering the energy levels of the π-orbitals compared to benzene and pyridine so that
heterocycles containing two of more heteroatoms are less π-electron rich. This results
in the heterocycle being less reactive towards electrophilic attack at the carbon atoms,
that in mono-heteroaromatic compounds such as seen in pyrrole, furan and thiophene.
It can be observed from pKa values that, as the nitrogen number increases, its strength
as a base decreases while its acidity increases. This is due to the lone pair of electrons
on the nitrogen providing a site for protonation. Pyrazole is a weak base due to the
inductive electron-withdrawing effect of the additional nitrogen atoms which also
explains the increasing acidity of triazole and tetrazoles.11 The Broadwell pKa table
establishes the difference in acidity for a range of azoles in DMSO. The pKa ranges
from 19.8 for 1H-pyrazole all the way down to 8.2 for 2H-tetrazole.15 As the number
of nitrogen atoms in the heterocyclic system increases, the basicity of the molecule
decreases and the acidity of the molecule increases. Taking an example of 1,2,3triazole and 1,2,4-triazole, it can be seen that the three nitrogen atoms side by side in
the 1,2,3-triazole lead to a more stable structure than that of the 1,2,4-triazole due to
an increase in aromaticity. Furthermore, the pKa values differ dramatically with 1,2,3triazole being much more acidic than 1,2,4-triazole. As a result the uses of these
molecules also differ. 1,2,3-Triazoles are commonly used in the biological area, due
to its antifungal and antioxidant properties, while 1,2,4-triazoles are utilised in
medicinal and agricultural areas due to its antitumoral, antiviral, and its antifungal
effects.16

7

1.4

Tetrazoles

1.4.1 Introduction
In the late 1800’s, Bladin et al.17 first discovered tetrazoles, as shown in Figure 1.5.
This pioneering work only began to take on significance in the 20th century and has
continued with vigour to the present day. Since then, numerous chemists have
investigated tetrazoles and simplified their synthetic mechanism.18–20
H
N
N
N

Figure 1.5

N

Basic structure of a tetrazole

Common uses of tetrazoles include in the field of material science as speciality
explosives,19,21 in pharmaceuticals as antivirals,22 antibacterial,23 and antifungals,24 in
coordination chemistry as ligands20 and as precursors to a variety of nitrogen
heterocycles by the Huisgen rearrangement.25,26 In medicinal chemistry, they act as a
metabolically stable surrogate for a carboxylic acid group.27
Tetrazoles are doubly unsaturated organic heterocyclic structures that contain four
nitrogen atoms, one carbon and two hydrogen atoms in a five membered ring and have
a molecular formula of C1H2N4. Tetrazoles have a very strong N-H acidity with a pKa
of 4.5 – 4.9 in water, which is comparable to the pKa of carboxylic acids, which have
a pKa of 4.4 – 4.7. This means that tetrazoles can act as bioisosteres. Bioisosteres are
chemical groups that have similar chemical and physical properties and contain similar
biological properties.28 Tetrazoles possess the ability to tolerate a wide range of
chemical conditions such as strong acid or basic, as well as oxidising and reducing
environments.

1.4.2 Tetrazole Tautomerisation
Tetrazoles can exist in one or two tautomeric forms the first of which is 1H-tetrazole
referred to as N-1 and the second is 2H-tetrazole, which is referred to as N-2, these
8

structures can be seen below in Figure 1.6. In solution the 1H-tetrazole dominates
over the 2H-tetrazole.29
1
1

H
N

5

N
N

4

N

NH

2
4

N

N

N
3

3

Figure 1.6

2

Tautomeric structures of tetrazoles

Mono and di-substituted forms of both tautomers are known, and both also exist in
fused ring systems. As seen from the labelled figures, Figure 1.7, there are three
possible mono-substituted tetrazoles entities and these arise from the substitution of
one of the protons in the 1, 2 or 5 position.
R
R

H
N

N
N

N
N
Figure 1.7

N

N

N

N
N

N

R

N

Mono-substituted tetrazoles in the 1, 2 and 5 position

There are two possible di-substituted tetrazole entities that can arise from the
substitution of the protons in the 1, 5 – and the 2, 5 – positions as displayed in Figure
1.8.
R
R'

R'

N

N

N
N
Figure 1.8

N
N

N

N

Di-substituted tetrazoles in the 1, 5 – and 2, 5 – positions
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1.4.3 Tetrazole Synthesis
As previously discussed, the first tetrazole was discovered by Bladin in 188517. This
happened somewhat accidentally while he was investigating dicyanophenyl hydrazine
reactions, the condensation product of cyanogen and phenylhydrazine. Treatment of
dicyanophenyl hydrazine with nitrous acid led to the compound later known as 5cyano-2-phenyltetrazole, as shown in Scheme 1.1.
N

N

H
N

CN2H2 +

N
N
H

H2N

N

HNO2
N
N

N
N

Scheme 1.1

First tetrazole synthesis by Bladin17

Bladin showed the existence of the tetrazole ring moiety by degrading cyano-phenyltetrazole to its simplest form tetrazole. The considerable robust qualities that the
tetrazole unit possessed such as its ability to withstand alkaline and acidic conditions
and oxidizing and reducing agents was intriguing and this spurred on his research in
this new area. The first synthesis of a single tetrazole unit by Bladin is as shown in
Scheme 1.2.
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N
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N
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Scheme 1.2
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N
H

KMnO4
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N
N

C6H4NH2

Degradation of 5-cyano-2-phenyltetrazole to tetrazole by Bladin30

Following on from Bladin’s primary investigative research into tetrazole chemistry,
many other research groups began making tetrazole compounds. The synthesis of 5aminotetrazole by Thiele et al.31, 5-aryl-substituted tetrazoles by Pinner32 and sulphur
derivatives by Freund and Paradies33 over a century ago provided a pivotal platform
for an expanded array of derivatised tetrazole moieties. R. Stolle of Heidelberg
contributed greatly to the study of tetrazoles and other heterocycles over the period of
1914 – 1937.34 The research involved the synthesis and characterisation of numerous
5-substituted tetrazoles using different starting materials, which when combined with
hydrazoic acid gave the corresponding tetrazole unit.
Today, the most common method of synthesising tetrazoles is the reaction of nitriles
with azides. This occurs via the 1,3-dipolar cycloaddition reaction, which is also better
known as the Huisgen cycloaddition. It is a concerted reaction that occurs between a
1,3-dipole and a dipolarophile resulting in the formation of a five membered ring. In
the formations of a tetrazole, sodium azide acts as the 1,3-dipole as it is a three-atom
π-electron system with four π-electrons delocalised over the three atoms, while the
cyano group acts as the dipolarophile. A 1,3-dipolar cycloaddition reaction generally
tends to experience very little solvent interaction which simplifies it even further as
unwanted side reactions and by-product formation are limited. Figure 1.9 displays the
synthesis of a typical 1,3-dipolar cycloaddition.
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N

N

Huisgen cycloaddition synthetic route

1,3-dipolar cycloadditions can be divided into three types. Type one occurs when the
dipole has a highest occupied molecular orbital (HOMO) which overlaps with the
lowest unoccupied molecular orbital (LUMO) of the dipolarophile. Type two occurs
when the HOMO of the dipole can pair with the LUMO of the dipolarophile or the
HOMO of the dipolarophile can pair with the LUMO of the dipole. Type three occurs
when the dipole has a low-lying LUMO that overlaps with the HOMO of the
dipolarophile. 1,3-Dipolar cycloadditions involving azides tend to fall into the type
two category as the energy gaps in both directions are similar. Dipoles such as azides
in type two are commonly referred to as HOMO-LUMO controlled dipoles or
ambiphilic dipoles.35
Throughout the years there has been a wide variety of cycloaddition methods
successfully carried out for the synthesis of tetrazoles that are published in the
literature. The most common similarity between the majority of these methods is the
use of sodium azide, ammonium salts and a dipolar aprotic solvent.36,37 It has been
reported that the reaction of sodium azide, aryl nitriles and an amine hydrochloride
was also successful for the synthesis of tetrazoles.38 Other methods of performing
cycloaddition reaction include the use of Zn(II) salts catalysts39, and Lewis acids.40
Safer methods that didn’t involve the handling of the hazardous inorganic azide salts
were also developed. These utilised substances such as trimethylsilyl,41 trialkyltin,42
organoaluminium azides43 and TBAF catalysts.44 Catalytic systems were also
developed utilizing compounds such as ZnO,45 Zn hydroxyapatite46 and CuO47 along
with countless others.
Another synthetic approach to the synthesis of tetrazoles is the one-pot click synthetic
method that converts aldehydes and hydroxylamines into tetrazoles using 1-butyl-312

methylimidazolium azide ([bmim]N3). In this reaction [bmim]N3 is used instead of the
classic sodium azide. [bmim]N3 is an ionic liquid that contains azide as a counter ion
and it can be used as a substrate in the reaction. Yields of up to 96% have been reported
using this novel synthetic route,48 as in Figure 1.10.
Ar

O

Cu(OAc)2
DMF

+ NH2OH + [bmim]N3
Ar

H

Figure 1.10

H
N
N
N

N

One-pot click synthesis of tetrazoles using 1-butyl-3-methylimidazolium
azide ([bmim]N3)48

1.4.4 Tetrazole Derivatisation
The derivatisation of tetrazoles can occur through the C-5, N-1 or N-2 atoms of the
tetrazole. This can occur due to the tetrazole being comparable in acidity to its
carboxylic acid analogue. This allows deprotonation of the tetrazole ring in the
presence of base to form the tetrazolate anion and subsequent nucleophilic attack on
an electrophilic reagent. Using this methodology many tetrazole derivatives can be
synthesised. Tetrazoles exist as tautomeric 1H – and 2H – tetrazoles, or the
corresponding anions, where alkylation can occur at the N-1 or N-2 position, but
generally a mixture of both derivatives are obtained, as seen from Figure 1.11.49
Derivatisation at C-5 of a tetrazole occurs in advance of the tetrazole formation.
Variations of nitrile or cyano containing compounds are selected based on the
requirements of the group to be situated at the C-5 derivatised tetrazole. The most
common method for tetrazole formation involves the concerted 1,3-dipolar
cycloaddition as discussed in Section 1.4.3.49,50,51
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CH3Cl
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Figure 1.11
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Alkylation of 5-substituted tetrazole to obtain N-1 and N-2 isomers49
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In 1996, Purchase et al.52 published a new alkylation of tetrazoles using the Mitsunobu
reaction. The introduction of the Mitsunobu protocol for the activation and
displacement of alcohols by carboxylic and phosphoric acids, has found great utility
in the derivatisation of tetrazoles.53 The scope of this reaction has been broadened to
include carbon-nitrogen, carbon-sulphur, carbon-halogen and carbon-carbon
formations. Carbon-nitrogen bond formation in the alkylation of nitrogen-based
heterocycles with alcohols has been demonstrated for a number of ring systems
including 1,2,4-triazole,54 piperidine,55 and indole.56 Purchase et al.52 was interested
in using this method to achieve successful alkylation of tetrazoles with both primary
and secondary alcohols, as seen from Figure 1.12. This resulted in higher yields
compared to previous alkylation techniques attempted.
R2
R1

H
N

R1
N

N

+

R2OH

PPh3, DEAD
CH2Cl2

N

+

N
N

N

R1

N

N
N

N

N

Mitsunobu alkylation of tetrazole ring52

Figure 1.12

In 2016, Lisakova et al.57 published a method for the alkylation of 5-substituted N-H
tetrazoles using alcohols with the super-acid CF3SO3H. The research group found that
the structure of the tetrazole and the nature of the alcohol both influenced the
selectivity of the reaction and the reaction yields. They found that tetrazoles bearing
phenyl, electron donating aryl, or benzyl groups at the 5-position afforded 2-alkyl-2Htetazoles in good to excellent yields,57 as shown in Figure 1.13.
R1
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N

R1
N

N

N

+

R2OH

N

CF3SO3H
20 - 60 oC
0.3 - 12 hr

N
N

R2

N

30 - 96%

Figure 1.13

The alkylation of tetrazoles using alcohols in the super-acid CF3SO3H57
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In 2010, Spulak et al.58 published a method for direct C-H arylation of 1-substituted
tetrazoles. This reaction was carried out by the use of palladium catalysis in the
presence of CuI and Cs2CO3 to synthesise the 1-substituted tetrazoles and found that
a phosphine ligand was necessary to prevent the intermediate tetrazolyl-PdII species
from fragmenting,58 as seen from Figure 1.14.
R1
N
N
N

R1

1.0 R2I, CH3CN
5% Pd(OAc)2
10% TFP, 1.0 CuI
1.1 Cs2CO3

R2

N

N
N
N

N

The direct arylation of 1-substituted tetrazoles using Pd catalysis58

Figure 1.14

Later in 2015, Onka et al.59 published a method for the [Cu(OH)(TMEDA)]2Cl2
catalysed regioselective 2-arylation of 5-substituted tetrazoles with boronic acids
under mild reaction conditions, as seen from Figure 1.15. This research demonstrated
that the reaction was highly regioselective with no more than 6% of 1-arylation of 5substituted tetrazoles occurring.59
X

H
N

B(OH)2
N

N

N

Figure 1.15

+

[Cu(OH)(TMEDA)]2Cu(12% mol%)
K2CO3 (1.1 equiv)
CH2Cl2, rt, O2 balloon

R

X

N
N
N

N

Regioselective 2-arylation of 5-substituted tetrazoles synthesis59

More recently, in 2019, Xiong et al.60 published a method for the asymmetric synthesis
of alkyl and aryl three-component tetrazoles with the use on Mg(OTf)2, TMSN3 and
2-naphthyl iso-cyanide under inert atmospheric conditions, Figure 1.16. This research
has led to further exploration into asymmetric iso-cyanide based multicomponent
reactions (IMCRs) and applying this type of catalysis to other type IMCRs.
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Asymmetric synthesis of three-component tetrazoles

1.4.5 Complexation Capabilities
The complexation of tetrazoles dates back to the 1960’s.61 Transition metals used in
complexation reactions with substituted tetrazoles include copper(II), silver(I),
nickel(II), cobalt(II), chromium(III), titanium(II) to name but a few. The position, N1 or N-2, of the substituents as well as their nature can greatly affect the composition
and structure of the resulting complexes. N-1 and N-2 substituted tetrazoles have been
shown to vary in their ability to form complexes.62
Medicinal chemistry is one of the most important fields in chemistry dealing with
compound design, optimisation and development. Medicinal chemistry dates back to
the 16th century with reports of therapeutic effects in the treatment of cancer.63 Since
then the effect of different metal-based compounds has been well documented.64
Tetrazoles have been found to have low toxicity values while possessing high
physiological activity. This makes them and their complexes interesting and
potentially valuable in the pharmaceutical market. For example studies have shown
that when cefazolin, Figure 1.17, is complexed to metals such as Cu(II), Co(II), Ni(II)
and Zn(II) the resulting complexes demonstrate higher antibacterial activities in-vitro
against some bacterial strains.65
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The chemical structure of cefazolin

Early findings from Popova et al. indicate that these types of compounds may also
contribute to the development of a new generation of filtering materials that can be
used in the purification of biological fluids from heavy metal ions, such as blood, and
lymph, through the use of chelators.66
Tetrazoles can act as ligands by forming complexes with metals either via covalent or
ionic bonds. Additionally, the tetrazole can remain in the neutral form or switch to an
anionic or cationic form depending on the coordination modes of the metal.65,67 Many
synthetic pathways have been developed when forming tetrazole complexes. One
route involves the direct reaction of the tetrazoles with a metal salt in a polar solvent,
for example ethanol, methanol or an aqueous medium.65

1.4.5.1 Complexes of N-H Unsubstituted C5-Substituted Tetrazoles
Due to the acidic nature of N-H unsaturated 5R-tetrazoles, the NH acts as an acid
towards various metal bases such as hydroxides and hydrides. This results in the
formation of the corresponding salts known as tetrazolates and can lead to the
deprotonation of the tetrazoles NH forming a salt-like compound that possess an ionic
structure, as seen in Figure 1.18.65,67,68
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The direct reaction of NH-5R-tetrazoles with metal bases68
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When reacting NH-5R-tetrazoles with organometallic bases and oxides a complex
structure with both covalent and coordination bonds between the metal and nitrogen
are formed, as seen from Figure 1.19.65,67,68,69
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• 2 MeOH
• 2 H2O

MeOH
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NH
N

TlPh2

N

N

N
N

N

Figure 1.19

TlPh2

Reaction of NH-5R-tetrazoles with organometallic bases and oxides65,67,68,69

1.4.5.2 N-1 Substituted Tetrazoles
In the reaction of N1-substituted tetrazole with metal salts the ligands no longer
possess the acidic N-H and therefore do not act as an acid and displays properties of
that of a weak base. Therefore, the N1-substituted tetrazoles can only form metal
derivatives in the neutral from.70 Based on this the metal ions can bind through
covalent and coordination bonds but not through ionic bonds. In N1-substituted
tetrazoles, the N4 atom displays the highest basicity and therefore is most commonly
the atom that participates in the formation of coordination bonds with the metal ion.67
It is well known that N1-substituted tetrazoles readily react with metal halides such as
CuBr2 and AgCl, as seen in Figure 1.20. During these reactions the solvent is chosen
based on its electron-donor activity, its dissolution capabilities and ability to aid in the
recrystallization of the final product. Weakly coordinating solvents such as alcohols,
diethyl ether and acetonitrile tend to aid in the complex formation at room temperature
and with the formation of a solid complex compound.65 As the tetrazoles have a strong
affinity for complexation to the metal ion the weakly coordinating solvents are
displaced from the crystal lattice. If the coordinating solvents have a stronger affinity
then complex formation is unlikely to occur.
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Synthesis of N1-substitution tetrazole.66

Coordination compounds have been of great interest, in particular binuclear N1substituted tetrazoles. Yu et al. published findings conveying the reaction of 1,2bis(tetrazole-1-yl)ethane with inorganic salts MX2 (M = Cu(II), Cd(II), Ni(II), Co(II)
and X = Cl, Br, SCN) which afforded new coordination polymers. The group
determined that the copper atoms coordinate with the N4 atom of the tetrazole to form
the complex,71,72 as seen in Figure 1.21.
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Figure 1.21

N

Synthesis of N1-substituted tetrazoles with inorganic salts,71,72 where MX2
(M = Cu(II), Cd(II), Ni(II), Co(II) and X = Cl, Br, SCN)

1.4.5.3 N-2 Substituted Tetrazoles
Complexation of the N-2 substituted tetrazoles can be more difficult that the N1
derivative due to its poor solubility. Reducing the volume of solvent after the reaction
process can aid in the formation of a solid product. As with the N1- substituted
tetrazole, the most basic atom of the N2-substituted tetrazole is the N4 atom. In
addition to this, the basicity of the N2-substituted tetrazole is to some extent lower
than that of the N1-substituted tetrazoles which increases the tendency for the metalligand bond to form at the N4 atom of the tetrazole. It can be seen that a bis-tetrazole
system was formed following the complexation reaction of 2-methyltetrazole and
CuCl2,73, as displayed in Figure 1.22.
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Synthesis of a bis-tetrazole complex from 2-methyltetrazole and CuCl273

1.5 Pyrrole Compounds
The most common five-membered ring system would be that of a nitrogen containing
pyrrole system. Pyrrole is a planar molecule, which indicates that the nitrogen atom is
sp2 hybridised. The three sigma-bonds attached to the nitrogen lie in the plane of the
molecule, and the p-orbital, lies orthogonal to the plane and contains the remaining
lone pair of electrons. The p-orbital on the nitrogen interacts with the four p-orbitals
on the carbon atoms which in turn leads to a cyclic π electron system derived from
five p-orbitals but containing a total of six electrons.74
Pyrrole, also known as azole, was first isolated in 1834 from coal tar by F.F. Runge75
and then again in 1857 from the pyrolysate of bone. Its name comes from the Greek
Pyrrhus – based on the reaction used for its detection.76 Pyrrole itself is not naturally
occurring, but many of its derivatives are found in a variety of cofactors and natural
products.
Pyrrole was first widely looked at due to its presence in both the respiratory pigment
haem, and the green pigment chlorophyll found in photosynthetic organisms, such as
plants, algae and cyanobacteria.77 Both of these pigments are naturally synthesised in
these animal and plant cells from porphobilinogen, Figure 1.23, which is the only
aromatic pyrrole of major importance in fundamental metabolism.78
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Figure 1.23

In addition to heme and chlorophyll, pyrroles can be found in more complex
macrocycles such as vitamin B12, tobacco smoke, bile pigments such as bilirubin and
biliverdin, and the porphyrins of heme, chlorophyll, chlorins, bacteriochlorin’s and
porphyrinogens.77,79,80

1.5.1 Pyrrole Synthesis
Pyrrole is a colourless volatile liquid, unstable in the presence of air, where it darkens
easily, so a preliminary distillation before use is required.81 One of the earliest
synthetic procedures was the pyrolysis of the ammonium salt of the sugar, mucic acid82
and can be seen in Figure 1.24.
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Figure 1.24
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Early stage synthesis of pyrrole

In industry, pyrrole is produced by the treatment of furan with ammonium in the
presence of a solid acid catalyst, such as Al2O3 or SiO2, as shown in Figure 1.25.83
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Industrial production of pyrrole using a solid acid catalyst

The most prominent and applied method for the synthesis of substituted pyrroles and
its derivatives is the well-known Paal-Knorr synthesis. This synthesis is based on
reacting a 1,4-dicarbonyl compound with ammonia or a primary amine to from pyrrole
and substituted pyrroles, respectively, as shown in Figure 1.26.
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Figure 1.26

Paal-Knorr pyrrole synthesis

In 1991, Amarnath et al.84 proposed a mechanism for the cyclisation that involves a
two-step nucleophilic attack by the amine N, initially on a protonated carbonyl,
forming a hemiaminal, with the second attack giving rise to ring closure to from a 5dihydroxytetrahydropyrrole. This then undergoes dehydration to form the
corresponding substituted pyrrole,85 as shown in Figure 1.27. This type of reaction is
generally carried out under protic or Lewis acidic conditions, with a primary amine.
The use of ammonium hydroxide or ammonium acetate produces the N-substituted
pyrrole.85
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Reaction scheme showing the mechanism of Paal-Knorr synthesis85

Recently numerous chemists have modified / optimised the traditional Paal-Knorr
synthesis by changing the initial starting reagents and/or the reaction conditions. A
selection of these are shown in Figure 1.28. Optimisation of the Paal-Knorr process
has been achieved via various routes, for example, the use of bismuth nitrate (A),86
organic-inorganic hybrid (B),87 silica-supported bismuth(III) chloride (G)86 and metal
triflates as a possibility to run the reaction in a solvent free media (E).88 Additionally
a one-pot eco-friendly catalysts has been explored by Rahmatpour et al.89
A Bi(NO3)3,
5H2O
B CH2Cl2
CH3CN, 80oC
[MIMBS]3PW12O40,
C 5 mol%, H2O

O

D 15min, reflux
ionic liquid

R'

+ R-NH2
R''

E Sc(OTF)3

R

R'

R''

F Solvent free
PS/GaCl3 10 mol%
O

G CH3CN, reflux
BiCl3/SiO2 7.5 mol%
H Hexane, RT
CC/U, 80oC

Figure 1.28

Reaction scheme displaying a summary of the modifications in Paal-Knorr
pyrrole synthesis85–88

Many modifications to the Paal-Knorr synthesis have been reported. Wang et al.90
published a synthesis of substituted pyrroles using ionic liquids as the solvent, aiming
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to avoid using toxic catalysts and simplicity in the isolation procedure, (D).90
Similarly, Dilek et al.91 reported the introduction of water as a reaction media with the
aim of eradicating toxic components.
Handy et al.92 published a method comprising of the application of non-toxic,
inexpensive and recyclable deep eutectic solvents, (combination of either urea or
glycerol with choline chloride) as effective solvents/catalysts for the Paal-Knorr
synthesis. These reactions conditions are mild and do not require the addition of a
Bronsted or Lewis acid catalyst, (H).92 A solvent free method was reported by Zhang
et al.93 describing the synthesis of N-substituted pyrroles in good to excellent yields
from the various substituted 1,4-diketones with primary amines catalysed by MgI2
etherate,93 as seen from Figure 1.29.
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Synthesis of N-substituted pyrroles from 1,4-diketones with primary amines
catalysed by MgI2 etherate

1.5.2 Pyrrole Derivatisation
Pyrrole and its derivatives are important heterocyclic compounds as they possess
interesting biological properties. Pyrroles are the backbone of many intermediates in
the synthesis of pharmaceuticals, medicines, agrochemicals, dyes, photographic
chemicals, perfumes and other organic compounds.94 In addition, pyrroles are used as
catalysts for polymerisation, corrosion inhibitors, preservatives and organic synthesis,
to name but a few. It is an important component in many pharmaceutical drugs, as
seen from Figure 1.30, providing a pivotal pharmacological effect for drugs such as:
atorvastatin – antihyperlipidemic, aloracetam for treatment of Alzheimer’s disease,
elopiprazole – antipsychotic, and tolmetin for anti-inflammatory activity.95
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Chemical structure of drugs containing pyrrole heterocycles

Generally pyrroles react with electrophiles at the a-position due to the greater
delocalisation of the positive charge in the intermediate ionic species, as shown in
Figure 1.31. Pyrroles can be easily halogenated, nitrated and sulfonated by
electrophilic aromatic substitution.76 When the pyrrole nitrogen is silylated, a halogen
in the β-position is possible, thus this is considered a useful procedure for
functionalisation of the less active β-position.96

E
N
H

Figure 1.31

-H
N
H

E

E

N
H

N
H

E

N
H

E

Mechanism of the reaction of pyrrole with electrophiles

1.6 Polymerisation
Polymerisation is a chemical reaction in which two or more molecules combines to
from larger molecules that contain repeating structural units, called a polymer. Radical
polymerisation is one of the mostly frequently used polymerisation techniques.97 It
has significant advantages over ionic polymerisation, including being applicable to
nearly all vinyl monomers and requiring relatively simple conditions. By comparison,
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anionic polymerisation requires demanding purification of monomer reagents, low
temperatures, inert atmospheres and in the case of vinyl monomers the presence of
electron withdrawing substituents,98 for example vinyl pyridine and alkyl
methacrylates. The first reported anionic polymerisation involved the polymerisation
of styrene and took place in the 1950’s by Swedish chemist Szwarc et al..99,100 This
technique is rarely used now as the synthesis has been enhanced by the more robust
and versatile radical polymerisation alternatives. Cationic polymerisation occurs with
electron rich monomers, for example p-methylstyrene or vinyl ether, however this also
required demanding purification of reagents and the side reactions such as b-proton
elimination.101 Styrene is one of the few vinyl monomers that can be polymerised by
all three addition polymerisation techniques.102

1.6.1 Radical Polymerisation
Since the 1980’s approximately 50% of the total production of synthetic polymers
worldwide used as plastics were obtained by free radical polymerisation process.103
Due to the increasing importance of metal organic initiation systems for plastics and
synthetic rubber, the participation of radical polymerisation is decreasing slightly in
recent years, but nevertheless it still amounts to nearly 45%, or 100 million tons, of
plastic materials and 40%, or 4.6 million tons, of synthetic rubber being produced
annually.103 Radical polymerisation can be carried out in various media, including
aqueous and organic solutions. This allows radical polymerisation to be carried out in
bulk, emulsion, solution, precipitation, dispersion and suspension. Thus, it is not
surprising that it accounts for approximately 50% of all commercial polymers.104
The conventional radical polymerisation is an example of a chain growth
polymerisation technique where monomer concentration decreases steadily as the
polymerisation evolves and higher molecular weights can be achieved at low
conversions. This mechanism consists of initiation, propagation, chain transfer and
termination, as shown from Figure 1.32 – 1.35.
Initiation is a process where the initiator, generally an azo or peroxide compound,
decomposes thermally to obtain two initiating radicals (R•).
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Initiation in radical polymerisation

The second stage involves addition of these initiating radicals onto the monomer,
forming a propagating radical, as shown from Figure 1.33.
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Propagation in radical polymerisation

Propagation is a bimolecular reaction which involves the addition of monomer units
onto the propagating radical species, producing growth radical chains. The rate of this
chain growth varies from monomer to monomer depending on the relative stability of
the adduct radical. The propagating rate constant is generally considered to be
independent of chain length.
Chain transfer involves the radical chain reacting with a non-radical species to produce
a dead polymer chain and a new radical (Y•) , which adds onto a monomer to initiate
a new propagating radical chain. Chain transfer to small species such as monomer and
solvents can lead to low molecular weight polymers.105,106 To minimise chain transfer
to solvent hydrogen free solvents are used or polymerisation is carried out at lower
temperatures.107
Termination can occur via two synthetic routes in radical polymerisation. The first
synthetic route is recombination. In ionic polymerisations, recombination does not
occur due to the repulsive behaviours of the reacting species. However, in radical
polymerisation it is likely that when the active propagating chains are in close
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proximity to each other they will react to form a new bond and create dead polymer
chains, as shown from Figure 1.34.
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Termination via recombination

The second method of termination is through disproportionation. This involves the
removal of a hydrogen atom from one end of the active species, giving two dead
polymer chains, one of which is unsaturated, as shown in Figure 1.35.
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1.6.2 Electropolymerisation
Electrochemistry is the branch of chemistry that deals with the relationship between
the flow of electrons and chemical reactions. These chemical reactions involve the
transfer of electrons in reduction and oxidation processes. Electrochemical processes
are found in both biological and chemical environments, such as photosynthesis in
plants and metabolism in animals, corrosion of metals and in the production of many
substances including metals and gases. There are a number of methodologies within
electrochemistry, with cyclic voltammetry being the one of interest to this research.108
In recent years great focus has been placed on the development of polymeric products
intended for use as thin films in technological applications, ranging from sensors to
medical devices. Electrochemical polymerisation is an attractive alternative to the
more traditional methods, since it allows for enhanced deposition of the polymer on
materials and fine control over the film thickness. Electrochemistry has always been
an excellent tool for synthesis and material characterisation. Now in the 21st century
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it is being used as a tool for the preparation of new materials, in particular those that
combine metals and organic coatings in a framework or a device.
Cyclic voltammetry (CV), also known as linear sweep voltammetry, is probably the
most widely used of all methods for studying electrode processes, including polymer
formation.108 In CV, the potential of a stationary working electrode is charged linearly
with time starting from a potential where no electrode reaction occurs and moving to
potentials where reduction or oxidation of a solute or adsorbed species occurs.109 The
excitation signal is a linear potential scan with a triangular waveform and scan rates
range from a few mV/s to hundreds of volts per second. The triangular potential
excitation signal sweeps the potential of the working electrode back and forth between
two set values called the switching potentials. The potential typically changes at the
same rate between two points and permits the display of a complete voltammogram
with anodic and cathodic waveforms, one above the other for a reversible system.
The formation of a typical CV is dependent on the species present. Assuming that only
the oxidised form of the species in question is present initially, a negative potential
scan is chosen for the first half cycle, during which a cathodic current is observed.
Since the solution is quiescent, the product generated in the forward scan is now
available at the electrode surface for the reverse scan resulting in an anodic current.
So, during a typical experiment, a complex waveform consisting of two isosceles
triangles is formed. The voltage is first held at an initial potential where no electrolysis
occurs. As the voltage is scanned in the negative direction, the oxidised form is
reduced at the electrode surface. The scan direction is reversed upon reaching a set
potential and the reduced form is now oxidised. Once the initial voltage is reached,
the experiment is complete.108,109
Figure 1.36, displays the basic shape of the current response for a CV experiment. At
the beginning of the experiment, the initial potential applied, point A, is chosen to
avoid any electrolysis of electroactive species in the sample. Here the bulk solution
contains only the reduced form of the redox couple, R, and there is no net conversion
of R to O, the oxidised form. The potential is then scanned in the anodic direction.
When the potential becomes sufficient enough to cause oxidation of the electroactive
species at the electrode surface, the anodic current beings to flow and this increases
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rapidly until the surface concentration of reductant at the electrode surface approaches
zero, signalled by the anodic current peaking at point B. The current then decays with
t-1/2 according to the Cottrell equation, as the solution surrounding the electrode is
depleted of reductant due to its electrochemical conversion to the oxidised state. The
Cottrell equation describes how the current, I, decays as a function of time, t, and is
defined as:
! = #$%&' ()/+,
Where co is the surface concentration, I is the current, D is the diffusion coefficient, A
is the electrode area, F is Faraday’s constant, n is the number of electrons transferred
and t is time.

Figure 1.36

Example of the current response for a CV experiment110

At the switching potential, point C, the potential is switched to scan in the cathodic
direction. As the electrode potential becomes sufficiently negative to bring about the
reduction of the oxidant, which had been accumulating at the electrode surface, a
cathodic current begins to flow and increases rapidly until the surface concentration
of the accumulated oxidant reaches zero, at which point the cathodic current peaks at
point D. The cathodic current then decays as the solution surrounding the electrode is
depleted of oxidant formed during the forward scan, and the potential is finally taken
back to the initial value.
If a redox system remains in equilibrium throughout the potential scan, the
electrochemical reaction is said to be reversible. Equilibrium requires that the surface
concentrations of oxidant and reductant be maintained at the levels required by the
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Nernst equation.109 Also important is the fact that the number of electrons involved in
the redox reaction for a reversible couple is related to the difference of peak potential
by the equation:
- = -/ −

12
ln 6
3$

Where - is the reduction potential, - / is the standard potential, 1 is the universal gas
constant, 2 is the temperature in kelvin, 3 moles of electrons, $ is Faradays constant
and 6 is the reaction quotient.

1.7

Biomaterials

During the industrial revolution of the 19th century, medical implants using
biocompatible metals led to the development of the medical device industry.111 The
growth of metal implants was determined mainly by the demand for attempts to repair
bone, in particular long bone fractures. The first successful implantation was
performed in the 1860’s by Lister, who implanted bone pins and spinal wires made of
gold, silver and iron.112 Since the 1990’s with improvements in surgical procedures
biocompatible metals have played an important role in modern orthopaedic
appliances. Since then appliances such as pins, screws, bone plates, and permanent
implants, have been developed for medical and dental applications.113
Biomaterials are defined as “materials intended to interface with biological systems to
evaluate, treat, augment or replace any tissue, organ or function of the body”.114–117 A
biomaterial must also be biocompatible. It can be artificial or natural, and can be
applied to replace or support some of the tissues or organs while in proximate
connection with them.118 The choice and design of a biomaterial depends on its desired
function in medicine. The design and development of new biomaterials is an
interdisciplinary effort and frequently requires a collaborative effort among material
engineers, scientists, pathologists, biomedical engineers and clinicians. Metallic
implants need to possess significant features to securely and correctly serve for a long
period of time without impacting on the carrier. The important considerations are
biocompatibility

(non-toxicity),

high

corrosion

and

wear

resistance,

and

osseointegration.119,120 The main biocompatible metals used are stainless steel 316,
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cobalt-chromium, titanium and its alloys. The applications of the three major classes
or biocompatible metals are detailed in Table 1.1.
Table 1.1

Major biocompatible metals and their biomedical applications

Alloys/Metals
Stainless Steel

Cobaltchromium
alloys

Application
Orthopaedic
Dentistry
Cardiovascular

Orthopaedic
Dentistry
Cardiovascular

•

•
•
•

•
Titanium
its alloys

and

Orthopaedic
Dentistry
Cardiovascular

•
•

•
•

Implants
Femoral
prosthesis,
orthopaedic
implants,
acetabular cup applications, noble metal ion
implantation, reconstructive surgery, rovascular
implants, monobloc hip stems.
Dental implants, orthodontic wire leads.
Cardiovascular stents, heart valves, coronary stents.
Total hip arthroplasty, reciprocating pin-on-disk
testing, bone in-growth structure, orthopaedic
implants, total hip implant, endothelial cells,
vascular smooth muscle cells, osteoblasts,
reconstructive surgery, rovascular implants, total
knee replacement, medical implants, femoral stems,
bone implant, load-bearing implants.
Dental implants, removable partial dentures,
orthodontic wire.
Vascular stents, heart valve parts.
Reciprocating pin-on-disk testing, joints, hip stems,
orthopaedic prostheses, total hip implant,
endothelial cells, vascular smooth muscle cells,
osteoblasts, acetabular cup, reconstruction of
craniofacial defects, channel implants, hard tissue
substitutions,
bone
substitution
implants,
reconstructive surgery, rovascular implants, human
mesenchymal
stem
cells,
self-assembled
monolayers, skeletal prostheses, load-bearing
implants.
Dental implants, orthodontic wire.
Cardiovascular stents, heart valve parts.

Biocompatible materials are designed to cause minimal disruption to the normal
physiological activity. Unfortunately, this is not always the case. Non-compatible
biomaterials have the potential to cause illness due to the leaching of metals damaging
the surrounding environment and result in implant rejection. Medical implants are
designed to promote biocompatibility, for example, material composition, size, shape,
surface wettability, surface roughness and charge. In addition to these design features,
biomaterials must ensure they do not alter the function of plasma proteins, not result
in the development of thrombus, not effect cellular material within the blood, not
produce toxic responses, not effect electrolyte balances and must be able to withstand
extremities of serialisation.

121

In practice, no synthetic material is completely
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harmonious with the living environment, however, materials do have different levels
of inertness, as discussed in Section 1.7.4.

1.7.1 Medical Stents
Heart disease involves a spectrum of disorders including valves, muscles or coronary
arteries, all of which cause the heart not to function correctly. These problems
normally result in a reduced ability of the heart to circulate the appropriate amount of
blood within vessels and arteries, resulting in crisis within the body. Coronary artery
disease (CAD) is a common heart disease among communities and it arises due to a
build-up of plaque on the inner surface of arteries, causing thinning of the internal
diameter. Over time this thinning and accumulation of plaque can result in a complete
blockage called atherosclerosis.122
In the 1990’s, the use of medical stents was first introduced into clinical practice to
prevent restenosis, a narrowing of arteries or veins, the main limitation associated with
percutaneous transluminal coronary angioplasty (PTCA). PTCA is a minimally
invasive procedure used to dilate narrow arteries using a catheter with a deflated
balloon at its tip. This is inserted into the narrow part of the artery, the balloon is then
inflated, compressing the obstructing plaque build-up and enlarging the inner diameter
of the vessel. This development revolutionised the treatments of CAD and its uses
rapidly progressed in terms of capabilities, efficacy and design. It resulted in the
advancement of new materials, manufacturing processes, biocompatibility and the
overall development and robustness of medical stents.122,123 The idea of cardiovascular
stents has revolutionised the treatment of coronary related diseases. Stents are a wise
replacement for surgery and were first introduced with the balloon angioplasty in 1977
by Grüntzig.124 This trend followed suit with the first implantation of a self-expanding
stent in 1986 by Sigwart125 and further in 1987 by Palmax et al.126
Medical stents are generally constructed from flexible tubular metallic mesh and have
developed in a number of forms and from a range of different materials selected for
their ability to match a number of desirable attributes. An example of these attributes
would be mechanical strength to provide adequate scaffolding with thinner struts for
improved flexibility, deliverability and reduced stent restenosis rates, biocompatibility
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and degree of radiopacity during delivery to the target vessel and through lesions.
Stents are designed either as metallic coils or slotted tubes, as seen from Figure 1.37,
and are made to either self-expand, depending on the high elastic modulus of the
memory-shape alloy material, or balloon expand.

Figure 1.37

Examples of different stents (a) AquaT3 (Cordis), (b) Boston monorail
express (Boston Scientific), (c) Sonic (Cordis), (d) Frontier (Abbott
Vascular)123

Inflation of the balloon causes the stent to expand at a specific site of the
atherosclerotic plaque build-up and results in an increase in the diameter of the vessel,
the sealing of intimal flaps, the limiting of vessels recoil and the reduction of vascular
remodelling. This in turn provides wider smoother lumen than balloon angioplasty
alone, as seen in Figure 1.38.
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Figure 1.38

Schematic displaying how balloon catheter is inserted into an artery (a) and
inflated to expand the stent (b). The balloon is deflated and the catheter
removed leaving the stent in place and a wider diameter of the artery (c)123

Although the use of medical stents revolutionised CAD and its treatments,
disadvantages were prevalent. These included an increased risk of thrombosis and
restenosis. During stent surgery, intravascular injury is a likely occurrence and can
progress into in-stent restenosis (ISR). ISR is the leading cause of artery blockage over
time, and the loss of artery patency subsequently causes stent failure. Numerous events
can lead to the loss of the artery patency for example, dysfunctional vascular
endothelium directly causes ISR, and starts to occur when there is a deficiency of
antithrombic and antiatherogenic properties. The artery dysfunction suppresses the
proliferation of vascular smooth muscle cells (VSMC) making them overgrow inside
the blood vessels. Overtime this results in blockages of the vessel.127
As reported by Fischman et al.128 in 1994, 15 – 20% of all implanted stent patients
require reintervention within 6 -12 months after the first stent implantation due to ISR.
Although, the rate of ISR has been reduced by the advancement of new generations of
stents and in technology, this problem is still prevalent today.129
Despite the advancements in manufacturing and technology, corrosion resistance of
medical implants still remains an issue for both cardio vascular and orthopaedic
devices. Recently, research groups have found corrosion damage in titanium and
cobalt-chromium alloys from medical devices.130–134 Significant corrosion from
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medical implant material may not only adversely affect the structure or function of the
device, it also provokes an adverse biological response resulting in numerous
biological complications. This will be discussed in more depth in Section 1.7.4.

1.7.2 Recent Developments in Stent Coatings
The use of biomaterials in a vast array of surgeries has led to research in the
development of surface treatments and coatings aiming to reduce the host response
towards the metallic implant. A number of different materials can be used to cover a
stent surface using a number of techniques, including dipping, electrochemical,
plasma spraying, plating, sputtering or surface-induced mineralisation.129 These
coatings have been developed for reasons such as antibiofilm135, antibacterial136, drug
delivery129, and corrosion prevention137 to name but a few.
Drug-eluting stents (DES) were introduced onto the European market in 2002 with the
aim to resolve adverse effects of percutaneous coronary intervention (PCI) and
subsequent stent implantation.138 These are vascular stents which allow the delivery
of antiproliferative drugs to inhibit VSMC. Despite high efficacy regarding the
inhibition of in-stent restenosis, first generation DES were based on biostable nondegradable polymeric drug carriers, such as poly(ethylene-co-vinyl acetate) (PEVA),
poly(n-butyl methacrylate) (PBMA), and poly(styrene-b-isobutylene-b-styrene) block
polymers (SIBS). The stents were comprised of three layers of different polymer
mixes. The first, a parylene layer which was applied to the metal surface of the stent
to ease the attachment of further layers by enhancing the adhesion properties. Second,
the mixture of the drug with PEVA and PBMA, two polymers which are miscible with
the drug, are added to allow controlled drug release. The outermost layer of
PEVA/PBMA contained no drug, but was only applied to help drugs to have a
controlled and sustained elution form the second layer. The top layer was selected for
inhibiting any burst release of drugs in order to have a long drug elution to the site of
action.122 The use of long-term non-degradable polymers triggered adverse effects
within the body leading to late stage thrombosis.139
This led to the second generation DES, which were biodegradable polymers. Chen et
al.140 developed coatings designed to offer the pharmacological effect of a DES, the
structural strength and flexibility of the implant, but with the added ability of the
coating polymer to degrade once its function is fulfilled. This coating would be
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excreted from the body. It was also found that a reduction in late and very late stentthrombosis was evident. Biomimetic polymers such as phosphorylcholine (PC),
poly(vinylidene fluoride)-hexafluoropropylene (PVDF-HFP), or the BioLinx polymer
do not interfere with formation of endothelial tissue and are currently used in second
and third generation DES.141 More recently, advancements in DES include antibioticreleasing coatings142 that are housed in biodegradable polymers143, sol-gel
composites144, and nanoparticle systems.142 Antibiotic loaded hydroxyapatite145,
silica146 and chitosan147 have also been developed and are used for a wide range of
DES.
Francolini et al. investigated the antimicrobial and antibiofilm properties of antibiotic
polymer coatings.148 This was conducted by impregnating a polymer matrix with (+)usnic acid using a casting method. 100 µL of acetone solution containing 2% (w/v) of
(+)-usnic acid was casted onto polyurethane PEUADED coated Teflon plates followed
by solvent evaporation under vacuum at 30 oC. Release studies were conducted by
measuring the concentration of (+)-usnic acid in water after immersion for six days by
UV-Vis spectroscopy. However, it was found no leaching of (+)-usnic acid was
detected due to the insoluble attributes of (+)-usnic acid. This indicates that the
antimicrobial activity of the coating occurs on the surface of the polymer and does not
radiate outwards into the surrounding area. The antimicrobial activity of the antibiotic
polymer system was evaluated in-vitro using the microdilution method and showed
good activity against S. aureus but poor activity against P. aeruginosa.
Francolini et al. also investigated the development of polyurethane anionomers
containing metal ions.149 This was conducted by synthesising a carboxylated
polyurethane (PEUA) by a two-step condensation reaction. To prepare the metalcoating polyurethanes, the sodium salt of the carboxylated polyurethane was treated
with equimolar amounts of the metals. Francolini et al. developed metal-containing
polyurethanes with AgNO3, Cu(CH3COO)2, Zn(NO3)2, AlCl3 and Fe(NO3)3 to create
PEUA-Ag, PEUA-Cu, PEUA-Zn, PEUA-Al and PEUA-Fe. Following completion of
these steps, the antibiotic ciprofloxacin (CPF) was adsorbed onto the metal-containing
polyurethanes by dipping the polymer discs into an aqueous antibiotic solution (0.04
M) for 24 hours at room temperature under mild stirring conditions. These disks were
then removed and washed twice with a saline solution for 1 hour each time to remove
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any unabsorbed antibiotic. UV-Vis spectroscopy was used to determine antibiotic
levels. The group used the Kirby Bauer test to evaluate the antimicrobial activity of
the antibiotic-metal-polymer system. As a control, the metal-polymer system were
also evaluated using the same methodology. The results generated show that PEUAAg was the only metal-polymer system to show a zone of bacterial growth inhibition
against S. epidermidis lasting 15 days. The other systems showed no zones of bacterial
inhibition against S. epidermidis. Conversely, all of the antibiotic-metal-polymer
systems showed a zone of bacterial growth inhibition against S. epidermidis indication
antibiotic elution from the polymer surface. In the case of PEUA-Ag-CPF the diameter
of the zone of bacterial inhibition decreased irregularly until day 19 whereas all other
antibiotic-metal-polymer systems showed a rapid reduction in the diameter of the
zones of inhibition in the early days, reaction 0 by day 6. Further studies demonstrated
a synergistic effect between Ag+ and CPF as the antibiotic-metal-polymer system
showed activity for at least 25 days while the metal-polymer system showed activity
up to 16 days.
More recently, in 2020, Xu et al. has published an anti-corrosion polymer coating for
medical stents using silk fibroin (SF).150 The SF was prepared by extraction from silk,
immersed in 0.08 w/v % Na2CO3 solution at reflux temperature for 30 minutes,
removing sericin from the silk. After this time the extract was washed with water and
dried at room temperature overnight. The dried SF fibres were then dissolved in 9 M
LiBr solution and dialysed against water using Spectra / Pro Membrane for 3 days at
4 oC. The aqueous solution was then centrifuged and the supernatant was lyophilised
for 3 days to obtained the SF sponge. This sponge was further treated in
hexafluoroisopropanol to obtain a 1 wt % SF solution for purification. This research
was carried out on Mg alloy stents and coated using the dip-coating method and dried
under vacuum at 70 oC. The mean thickness of the coating on the stents was
approximately 2 µm. Prior to coating the stents were washed in acetone using an
ultrasonic cleaner and dried under vacuum at 30 oC for 30 minutes.
To investigate the effect of the SF coating on anti-corrosion properties, the coated
stents were immersed for 2 minutes in Eagle’s minimal essential medium with 10%
fetal bovine serum and incubated under imitated biological conditions of 37 oC with
5% CO2, for 14 days. Then, 100 µL of supernatant medium was collected at 1, 3, 5, 7,
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and 14 days to evaluate the Mg2+ ion concentration. The Mg2+ ions were quantified
with a Magnesium B-test Wako test kit. After the 14 days period the Mg stent was
removed from the incubation chamber, the SF coating chemically removed and the
surface morphology of the stent was observed using SEM. The same methodology
was carried out on a control sample, a non-coated Mg stent.
The research group found that the SF coating did not affect the corrosion of the Mg
stent, indicating that the SF coating did not result in accelerated corrosion of the
coated-stent that already had high corrosion resistance. Because of the special
structure of the SF, which contained both hydrophobic and hydrophilic blocks, the SF
layer could not completely protect against water invasion through the oxide layer. In
2018, Wang et al. showed similarly that the SF coating did not improve the
anticorrosive quality of Mg-Zn-Y-Nd alloys disks. 151

1.7.3 Corrosion – Basic Concepts
Corrosion is an important factor to consider during the design and selection of the
metals and alloys in-vivo. Allergenic, toxic/cytotoxic or carcinogenic (e.g. Ni, Co, Cr,
V, Al) species may be released within the body during the corrosion processes
mentioned above.152 In addition, corrosion may result in implant loosening and failure.
Corrosion can be defined as a process that involves deterioration or degradation of
metals. The most common corrosion seen on a daily basis, is the accumulation of rust
on steel. Most corrosion phenomena are of electrochemical nature and consist of at
least two reactions taking place on the surface of the corroding metal. One of these is
oxidation, also known as the anodic partial reaction, and an example of this is the
dissolution of iron. The other is a reduction reaction and is commonly referred to as
the cathodic partial reaction, for example the reduction of oxygen. The products
formed from the electrochemical reaction can react with each other nonelectrochemically and form a final product, rust. In the case of the corrosion of iron to
form rust the overall reaction can be seen in Figure 1.39.
2 $8 + 2 :; < + <; → 2 $8(<:);
Figure 1.39

Reaction showing the corrosion of iron
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This reaction includes the dissolution of iron, the reduction of oxygen and the
formation of rust and can be broken into their individual reactions of anodic, cathodic
and chemical, as in Figure 1.40.
$8 → $8 ;@ + 28 A (%#BCD& )
2:; < + <; + 48 A → 4 <:A (FG,ℎBCD&)
$8 ;@ + 2 <: A → $8(<:); (Fℎ8ID&GJ)
Figure 1.40

Reaction scheme showing the anodic, cathodic and chemical reaction for the
generation of rust on iron

Iron is vital for biochemical actives, for example the oxygen transport system. Fe
generally exists in the physiochemical environment in two principle oxidation stare,
Fe2+ and Fe3+, but aerobic conditions oxygen promotes the shift from Fe2+ to the more
stable Fe3+.153
Corrosion can be divided into different forms. Uniform corrosion is the simplest form
of degradation, where the exposed surface of the metal is degraded at a uniform rate.
This type of corrosion results in loss of material until failure. This is the most
widespread form of corrosion that is observed.154,155 Figure 1.41 displays uniform
corrosion over a period of time.

Figure 1.41

SEM images of uniform corrosion regions of Zn medical stent156

In 2013, Bowen et al.157 published work showing the degradation of Zn wire stents
that were implanted into the abdominal aorta of an adult male Sprague-Dawley rats
for up to 6 months. It was found that in the first 3 months on the implantation of the
Zn stent uniform, corrosion was present, while after 4.5 and 6 months in-vivo,
relatively severe, and localised corrosion was observed. In more recent studies, 2017,
it was reported that the Zn wire exhibits relatively steady uniform corrosion, with a
penetration rate of 0.25 ± 0.10 mm/year, without local toxicity for up to at least 20
months post-implantation.158 This steady uniform corrosion could simplify stent
design in terms of their lifetime and corrosion potential.
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The FDA states crevice corrosion, or localised corrosion, can occur with medical
implants where the metallic device is in contact with small volumes of stagnant liquid.
Local chemistry changes within these crevices resulting in the depletion of oxygen
and a drop in pH, making the metal surface more prone to corrosion.159 This type of
corrosion can be seen more commonly in gaskets, washers, insulation material,
fastener heads, surface deposits, disbanded coatings, threads, lap joints and clamps
and can result in crevice corrosion. In addition modular orthopaedic devices may
facilitate local fluid stagnation increasing the potential for corrosion, even in metals
that normally have good corrosion resistance.159
Pitting corrosion is a localised form of corrosion by which pits or ‘pin holes’ are
produced in the metal structure, as seen in Figure 1.42. Pitting is considered to be
more dangerous that uniform corrosion because it is more difficult to predict and
design against. Corrosion products often cover the pits making their detection very
difficult. A small, narrow pit with minimal overall metal loss can lead to the failure of
the entire system. Heintz et al. published findings of pitting corrosion in the first
generation of Nitinol, a nickel-titanium alloy, in as little as 5 months of
implantation.160,161 Halwani et al. have more recently found corrosion in explanted
cardiovascular stents made of nitinol, stainless steel and cobalt based alloys.162
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Figure 1.42

(1). SEM image of a nitinol wire segment from a 16 month-old endovascular
graft, showing multiple pits of various sizes. (2). SEM images of an
irregularly shaped crater from a 21 month-old endovascular graft, showing
rugged margin and mottled pattern of corrosion throughout the defect. (3).
SEM image of a 34 month-old Cragg stent with a large defect, showing cracks
and kinking of the wire axis, in addition to pitting and irregular shaped craters.
(4). SEM image of complete disintegration of the nitinol wire 160

Another form of metal degradation is fretting corrosion. This type of corrosion occurs
due to a back and forward micro-motion between contacting metallic surfaces. This
motion can cause wear and disrupt the passive oxide layers on the opposing metal
surface. Even slight relative micro-motion between contacting surfaces may lead to
continuous disruption of their passive films leading to corrosion of the exposed
meal.159 The severity of fretting is dependent on many factors, for example, surface
roughness, coefficient of friction of the metal surface and mechanical properties.
Fretting corrosion has been observed in devices that have modular designs such as hip
and knee arthroplasty devices.163,164
Galvanic corrosion occurs when chemically dissimilar metals are in contact inside the
body. Corrosion is accelerated in one of the metals, an anode, while the other metal,
cathode, corrodes slower that it would alone. The rate of accelerated corrosion is
determined by the voltage differences and surface area ratio between the different
materials.159

1.7.4 Implantation, Biocompatibility and Corrosion Effects on the Body
Once an implantation has occurred within a the physiological environment, numerous
biological responses take place. These can be in relation to the surgery itself with acute
and chronic inflammation or associated with the implant with foreign-body reactions,
granulation tissue development, fibroses and formation of matrixes.165 Acute
inflammation increases the chance of blood clotting and thrombosis. This threat can
last up to minutes or days depending on the severity of the surgery. When comparing
both inflammatory responses, chronic is less uniform histologically. Chronic
inflammation is monitored by the presence of mononuclear cells, such as monocytes
and lymphocytes, at the site of surgery and is generally short lived. If both
inflammatory responses exceeds for a longer period of time, it can be an indication of
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post-surgery infection.

Once the inflammatory responses have subsided, the

identification of granulation tissue, in the form of macrophages, fibroblasts and
neovascularisation, can be seen from the healing tissue. Granulation tissue may be
seen as early as 3-5 days post-implantation, depending on the injury. The presence of
foreign body reactions with granulation tissues is considered a normal during the
healing process. Foreign-body reaction involves protein adsorption, macrophages,
multinucleated foreign body giant cells (also known as fused macrophages),
fibroblasts and angiogenesis. The outcome of these foreign-body reactions can result
in fibrosis and lead to rejection of the implant. One of the last tissue reactions is the
encapsulation of the medical implant in a thin fibrous tissue of collagen and
fibroblasts.166,167
One of the major factors influencing the patients reaction to medical implant is the
surface, due to its contact within the physiological environment. The influence of these
reactions determines the foreign-body reaction, the healing post-surgery and the
growth of the fibrous tissue around the implant. Failure to produce fibrous tissue
indicates a complication between the biomaterial and the physiological environment.
Factors effecting biomaterial/body interactions can be chemical composition, structure
and morphology of the implant.
Osteolysis is the active reabsorption of matrixes by osteoclasts and can be interpreted
as the reverse of ossification. This reabsorption coupled with the formation of a thick
fibrous layer between implant and bone can be indicative of poor biocompatibility.
Additionally, the formation of nanoparticles can lead to the development of an
inflammatory response, causing irritation of phagocytic cells and leading to
proinflammatory factors, for example cytokines and proteinase. These particles are
generally non-toxic and are generated from the medical implant, but left untreated can
lead bone damage in the form of chronic inflammation, fibroses, osteolysis and
porosis168 Nano-particles can accumulate by wear of the implant. These nano-particles
can lead to implant loosening as well as the formation of necrotic sites, granulomas
and osteolysis. Additionally, the accumulation of these nano-particles increases the
surface are of the implant and increases the concentration of the metal ions in the
body.169
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Additional to wear, nano-particles can also be generated by corrosion of implants. This
corrosion can create adverse effect to the surrounding environment, such as changing
the electrical behaviours of cells, changing the local chemical environment and the
metal ions can effect cellular metabolism.170 The release of these metallic particles
creates a local and system effect within the body.171 The physiological impact is
depending on the degree of corrosion that takes place. Lower levels of corrosion can
produce local tenderness, reddening and swelling of the implantation area. Systemic
effects form due to the release of metal ions and subsequently accumulate in different
organs and increases the bodies metal ion concentrations. This in turn can alter the
overall balance of the physiological tolerance to toxicity. An example of this can be
seen form patients that either has stainless steel or cobalt based joint replacements.
Once wear degradation and corrosion has taken place the patients had elevated levels
of metal ion concentrations within their blood and tissues, both locally and
systemically such as in the kidneys, liver and in urine.152
Due to the high levels of metals in the blood, metallosis can occur damaging tissue
and bone locally and systemically. Metal ions alone don’t contain the structural
complexity to harm the immune system, but coupled with specific proteins, found in
the skin, connective tissue and blood, can produce an immune response. Nickel,
chromium and cobalt are the most common complexes, nickel having the strongest
effects. These effects can be cell mediated immune reactions, provoking an
inflammatory reaction against exogenous and endogenous antigens. 172,173
The release of metal ions into the physiological environment do not always cause harm
on their own, however when combined with the wrong compound may change its
toxicity, as seen from Figure 1.43. The reactivity of this newly formed compound will
depend on the number and mass of the molecules. The types of reactions generally
involve water and inorganic anions, for example titanium ions readily react with
hydroxy anions, producing oxides and salts. Similarity, inactive anions exist, such as
copper and nickel, and no not react with water or inorganic anions. This results in the
metals existing in the ionic state for long periods of time and increasing the chance of
combining with biomolecules and exhibit toxicity.174
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Figure 1.43

Two possible toxicity routes for metal ions released into bodily fluids due to
corrosion and wear174

Figure 1.44173 represents the biologic effect of implant wear particles which causes a
local immune responses primarily medicated by macrophages. This in turn produces
reactive oxygen intermediates and pro-inflammatory cytokines that affect a host of
local cell types and induce a widening zone of soft-tissue damage and inflammation.

45

Figure 1.44

Metallic debris initiating an immune response and leading to the development
of reactive oxygen intermediates and pro-inflammatory cytokines, causing
local damage to the host173

Generally corrosion may not be of great concern, but when combined with mechanical
effect, restricted crevice-like geometries, inflammation or any side-effect,
considerably amplified corrosion rates, potentially leading to adverse host response or
implant failure. Table 1.2 displays a list of the adverse host response to metal ions.
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Table 1.2

The biological effect of certain metal ions that may be leached in-vivo due to
implant corrosion.121

Metal

Effect

Nickel (Ni)

Aluminium (Al)

The major cause of allergic contact dermatitis. The significant
biological parameter is the amount released to the skin during
exposure to human sweat. Threshold 0.5 mg.cm-2 week-1, at which
only a minor part of nickel sensitive subjects will react. Has toxic
effect with cellular damage in cell culture at high concentrations.
Harmful to bone in tissue cultures, although less than cobalt or
vanadium. Has a potency for carcinogenicity. A normal blood level
of nickel is about 5 mg.L-1
Its function is confined to its role in vitamin B12. Anaemia-B
inhibiting Fe absorption into the blood stream.
Ulcers and central nerve system disturbances. Blood level average
2.8 µg/100g. Its compounds are only poorly absorbed after oral
ingestion and storage of chromium(III) is largely confined to the
reticuloendothelial system. Chromium(VI) ion is able to pass the
plasma membrane freely in both directions.
Epileptic effects and Alzheimer’s disease.

Vanadium (V)

Toxic in the elementary state.

Molybdenum (Mo)

An essential dietary element. Its highest concentration is in the liver
at 1-3 ppm. It is necessary for the function of certain enzymes. It is
quite readily absorbed from the intestinal tract. Is toxic in large
doses, symptoms include, diarrhoea, coma, cardiac failure and
inhibition of activity of ceruloplasmin, cytochrome oxidase,
glutaminase, choline esterase and sulphite oxidase. High levels of
molybdenum can also interfere with calcium and phosphorus
metabolism.

Cobalt (Co)
Chromium (Cr)

Research into the biocompatibility of orthopaedic materials is becoming ever more
important as the use of implants steadily increases. As seen throughout chapter 1,
metals and their alloys can have both a positive and detrimental effect on the human
body. The elevated metal body content found in the body fluids and remote organs of
patients with metal implants is a matter of fact. Further understanding and monitoring
the effects of metal leaching into the physiological environments allows for a greater
understand of the damaging attributes metals possess. Despite the enormous evolution
of medical implants, there is still much research to be done. This advancement will
allow the understanding of specific chemical forms and distribution of metal
degradation products, thus changing their future design and development.
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Chapter 2
Results and
Discussion
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2.1

Introduction

This chapter explores the types of compounds synthesised within this project. The aim
was to achieve a series of multifunctional compounds that had metal binding and
polymerising capabilities. These compounds in turn could be coated evenly onto a
medical implant, improving its overall biocompatibility. The compounds synthesised
have been divided into three separate groups, for the purpose of this thesis named
series 1, series 2 and series 3. Series 1 – 3 all have a distinguishing factor of containing
nitrogen based heterocyclic functional groups. All compounds from Series 1 have
been synthesised using 2-(1H-tetrazol-5-yl)pyridine (1). Series 2, the polymerising
agents, compounds have been derived from pyrrole or 1,2-dimethyltetrahydrofuran.
Compounds from Series 1 and Series 2 were reacted together to achieve compounds
in Series 3.

2.2

Synthesis of 2-(1H-tetrazol-5-yl)pyridine (1)

A series of tetrazoles were synthesised utilising the 1,3-dipolar cycloaddition reaction
of sodium azide and a nitrile functional group, as described by Demko et al.39 Monosubstituted tetrazoles were formed from 2-cyanopyridine, as seen from Figure 2.1.

Figure 2.1

Synthesis of mono-tetrazoles prepared using sodium azide under inert
conditions

The desired product was obtained firstly by removing the insoluble salts via vacuum
filtration and the filtrate concentrated under reduced pressure. The residue was then
dissolved in water before being acidified with concentrated HCl to initiate
precipitation. The crude product was recrystallised from hot methanol to yield the
desired pure compound.
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2.2.1 Synthesis of 2-(1H-tetrazol-5-yl)pyridine40 (1)
Isolation of 2-(1H-tetrazol-5-yl)pyridine (1) yielded 67% of a white crystalline solid.
TLC analysis using an eluent system of 90:10, ethyl acetate : methanol provided an Rf
value of 0.03. The melting point of (1) was 215.7 – 216.5 oC, which is close to that of
the literature value of 211 oC.40 IR analysis showed the disappearance of the cyano
stretch (C≡N) at 2235 cm-1 and the presence of the broad (N-H) stretch at 3065 cm-1,
a (C=N) stretch at 1628 cm-1, a (C=C) stretch at 1537 cm-1, a (N=N) stretch at 1451
cm-1 and a (C-N) stretch at 1083 cm-1. Figure 2.2 contains the labelling system used
for NMR analysis. The formation of the tetrazole influenced the splitting of the
aromatic peaks in the proton NMR spectrum. The precursor 2-cyanopyridine
contained one complex multiplet for peaks Hb and Hc appearing between 8.01 – 8.07
ppm. In compound (1) these have separated from one another appearing at 8.20 – 8.22
ppm for peak Hb and 8.77 – 8.78 ppm for peaks Hc. This downfield shift indicated that
the formation of the tetrazole has a deshielding effect on the hydrogen atoms of the
pyridine. In the carbon NMR spectrum, the disappearance of the cyano peak at 117.4
ppm and the appearance of the C5 of the N1 substituted tetrazole, peak Cf, at 154.9
ppm indicated the formation of the tetrazole.
c
d

b
a

e

N

f

H
N

N N
Figure 2.2

N

Labelled atoms for 1H and 13C NMR analysis for compound (1)
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2.3

Synthesis of alkylated Tetrazoles (Series 1)

The same synthetic procedures were utilised in the synthesis of compounds (2) to (5),
as seen from Scheme 2.1. Initially the precursor 2-(1H-tetrazol-5-yl)pyridine (1) was
stirred in an appropriate amount of solvent until dissolved. Following consumption of
all starting material K2CO3 was added and the reaction was heated under reflux
conditions for 30 minutes before the addition of the appropriate dihalogenated alkyl
chains. The reactions were then heated under reflux conditions for a further 24 hours
for compound (3a) and (3b) and 48 hours for compounds (4a), (4b) and (5). Upon
completion the reactions were allowed to cool, the inorganic salts removed and the
crude product concentrated under reduced pressure. Flash column chromatography
was used to separate the different N1 and N2 substituted products using a eluent
system of 80:20 petroleum ether (40 – 60 oC) : ethyl acetate for compounds (3a), (3b)
and (5), while 70:30 petroleum ether (40 – 60 oC) : ethyl acetate was used for the
purification of compounds (4a) and (4b). The alkylation was not specific for one
regioisomer, but it was found that the N2 alkylated regioisomer was favoured as
opposed to the N1 regioisomer.
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N
BrCH2C6H4NC4H4, K2CO3
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N
N
N N
(2)
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H
N

NH4Cl, NaN3, LiCl
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CN

DMF, 110oC

N

N
N N

K2CO3

BrCH2CH2CH2Br, K2CO3
o

Acetonitrile, 90 C

C4H4NCH2CH2NH2, K2CO3

N

Acetonitrile, 90 oC

(1)

N

N

o

(13)

Br

N

N
N N

N
N N

Acetonitrile, 90 oC

N
N N
(3b)

ClCH2CH2OCH2CH2OCH2CH2Cl, K2CO3

N

N

C4H4NCH2CH2NH2, K2CO3

O

Acetonitrile, 90 C

O

(4b)

HN

N

N

N

N
N N

Acetonitrile, 90 oC

O
O

(14)

Cl

NH
N

N

BrCH2C5NH3CH2Br, K2CO3
Acetonitrile, 90 oC

N

N
N N

C4H4NCH2CH2NH2, K2CO3

N
Br

(5)

Scheme 2.1

Synthesis of compounds (1, 2, 3, 4, 5, 13 & 14), derivatives using alkylation reactions.
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Acetonitrile, 90 oC
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2.3.1 Synthesis of 2-(n-ethylphenylpyrrole-(2H-tetrazol-5-yl) pyridine (2)
Synthesis of compound (2) was carried out using the same synthetic procedures
utilised for compounds (1) to (5). Initally the precursor 2-(1H-tetrazole-5-yl) pyridine
(1) was stirred in an appropriate amount of solvent until dissolved. Following
comsumption of all the starting material, K2CO3 was added and the reaction heated at
reflux conditions for 30 minutes before the addition of 1-[3-(bromomethyl)phenol]
pyrrole, as displayed in Figure 2.3. The reaction was then heated under reflux
conditions for a further 48 hours. Upon completion the reaction was allow cool, the
inorganic salts removed and the crude product concentrated under reduced pressure.
Flash column chromatorgraphy was used to isolated the desired product using an
eluent system of 80:20 petroleum ether (40 – 60 oC) : ethyl acetate.

N

N

NH
N N

1-[3-(bromomethyl)phenol]pyrrole,
K2CO3
Acetonitrile, 90 oC

N

N

N
N N
(14)

(1)

N
Figure 2.3

Synthesis of compound (2)

Isolation of compound (2) yielded 19% of a yellow oil. TLC analysis using an eluent
system of 80:20 petroleum ether (40 – 60 oC) : ethyl acetate provided an Rf value of
0.19. IR analysis showed the disappearance of the broad (N-H) stretch at 3065 cm-1
and the appearance of the phenyl (C-H) signal at 2955 cm-1. This is indicative that
substitution has taken place.
Figure 2.4 contains the labelled atoms used for NMR analysis. The substitution of the
pyridine group did not result in any major shifts to the pryidine ring protons when
comparing it to the starting precursor (1). However new peaks were evident in the
proton spectra equating to Hg, Hh, Hi, Hj, Hk, Hl, Hm and Hn, confirming its
substitution. The aromatic pyridine protons were evident at 8.69 ppm (Ha), 8.31 ppm
(Hd), 8.31ppm (Hc) and 7.84 ppm (Hb) and the aromatic phenyl protons at 6.89 ppm
(Hh), 7.63 ppm (Hi), 7.28 ppm (Hj) and 7.04 ppm (Hl). The two pyrrole peaks
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appearing at 6.89 ppm (Hm) and 5.21ppm (Hn). The largest difference observed was
the shift in the CH2 (Hg) from 4.18 ppm to 5.21 ppm, meaning the tetrazole is having
a deshielding effect apposed to the bromine atom situated on the precursor. When
looking at the

13

C NMR the results are similar to previously discussed. The largest

difference observed is the shift in the CH2 (Hg) from 32.6 ppm to 56.5 ppm showing
once again the deshielding effect the tetrazole ring has compared to the bromine atom.
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Figure 2.4

Labelled atoms for 1H and 13C NMR analysis for compound (2)

2.3.2 Synthesis of 2-(bromopropyl-(1-tetrazol-5-yl)pyridine (3a) & 2(bromopropyl-(2-tetrazol-5-yl)pyridine (3b)
Isolation of 2-(n''-bromopropyl-(1-tetrazol-5-yl)pyridine (3a) yielded 13% of a yellow
crystalline solid while 2-(n''-bromopropyl-(2-tetrazol-5-yl)pyridine (3b) yielded 38%
of an orange crystalline solid. TLC analysis using an eluent system 90:10, ethyl
acetate: methanol provided an Rf value of 0.01 for compound (3a) and Rf value of 0.03
for compound (3b). In both compounds, IR analysis showed the disappearance of the
broad (N-H) stretches at 3065 cm-1 and the appearance of a (C-H) stretch at 2983cm-1
for (3a) and 2980 cm-1 for compound (3b). A substitution of the alkyl group in both
compound (3a) and compound (3b) is indicated by this. Figure 2.5 contains the
labelled atoms used for NMR analysis while Table 2.1 details the position and
multiplicity of the 1H peaks and Table 2.2 details the position and multiplicity of the
13

C peaks. The substitution of the bromopropyl chain did not result in any major shifts

to the pyridine ring protons when comparing the starting compound (1), however new
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peaks were observed in the proton spectra in both compounds. Protons Hg, Hh and Hi
have all been assigned to the bromoalkyl chain confirming its substitution.
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Figure 2.5

Labelled atoms for 1H and
(3b)

Table 2.1:

Infrared spectroscopic analysis of compounds (3a) and (3b).

C NMR analysis for compound (3a) &

Compound Number and Relevant Wavenumber (cm-1)

Group

(3a)

(3b)

C-H

2983

2980

C=N

1589

1586

C=C

1567

1556

N=N

1533

1502

C=N

1469

1447

C-N

1283

1249

Table 2.2:

1

H NMR analysis of compounds (3a) and (3b) in d6-DMSO.
Compound Number and Chemical Shift (ppm)

Group

(3a)

(3b)

Ha

8.78 (m)

8.75 (m)

Hd

8.26 (m)

8.37 (m)

Hc

7.87 (m)

7.93 (m)

Hb

7.41 (m)

7.46 (m)

Hg

4.91 (t)

5.15 (t)

Hh

2.65 (m)

2.57 (m)

Hi

3.46 (t)

3.47 (t)
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For compound (3a), the N1 regioisomer, the appearance of two triplet signals at 5.15
ppm (Hg) corresponded to the exact shift observed for the N-CH2 signal and 3.47 ppm,
which was the triplet signal for CH2-Br (Hi). Both were indicative that the alkylation
had occurred. The 13C NMR spectrum confirmed no difference in the aromatic region
from that of the precursor 2-(1H-tetrazol-5-yl)pyridine (1) and the aromatic signals
were observed at 149.5 ppm, 144.7 ppm, 137.5 ppm, 124.4 ppm and 124.5 ppm. The
signals for the N-CH2 and the CH2-Br were easily identified at 48.2 ppm and 32.8 ppm
respectively. The other methylene signal was observed at 31.1 ppm. For compound
(3b), the N2 regioisomer, the 1H spectrum was almost identical to that of the N1
isomer. The aromatic protons were observed at 8.78 ppm (Ha), 8.26 ppm (Hd), 7.87
ppm (Hc) and 7.41 ppm (Hb) and two triplets at 4.91 ppm (Hg) and 3.46 ppm (Hi)
corresponding to the exact expected shift observed from the N-CH2 signal and the
CH2-Br signal. The 13C NMR spectrum was almost identical to the N1 isomer apart
from the tetrazole carbon signal observed at 164.9 ppm and the methylene carbon
signal adjacent to the tetrazole nitrogen observed further downfield than the N1 isomer
and was observed at 151.8 ppm.

Table 2.3:

13

C NMR analysis of compounds (3a) and (3b) in d6-DMSO.
Compound Number and Chemical Shift (ppm)

Group

(2a)

(2b)

Cf

151.8

164.9

Ca

149.5

150.3

Ce

144.7

145.6

Cc

137.5

137.4

Cb

125.4

124.9

Cd

124.5

122.4

Cg

48.2

51.5

Ch

34.8

31.8

Ci

31.1

28.7
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2.3.3 Synthesis of 2-(n''-chloroethoxyethane-(2-tetrazol-5-yl)pyridine (4a)
& 2-(n''-chloroethoxyethane-(1-tetrazol-5-yl)pyridine (4b)
Isolation of 2-(n''-chloroethoxyethane-(2-tetrazol-5-yl)pyridine (4a) yielded 54% of
an orange oil while 2-(n''-chloroethoxyethane-(1-tetrazol-5-yl)pyridine (4b) yielded
26% of a yellow oil. TLC analysis using an eluent system 60:40, petroleum ether (40
– 60 oC) : ethyl acetate provided and Rf value of 0.25 for compound (4a) and an Rf
value of 0.51 for compound (4b). In both compounds, IR analysis showed the
disappearance of the broad (N-H) stretch at 3065 cm-1 and the appearance of a (C-H)
stretch at 2957 cm-1 for compound (4a) and 2959 cm-1 for compound (4b). The
appearance of a (C-O-C) stretch at 1119 cm-1 for compound (4a) and 1132 cm-1 for
compound (4b) indicates the substitution of the alkyl grouping.
Figure 2.6 contains the labelled atoms used for NMR analysis. The addition of the
chloroalkyl chain displayed similar shift to the pyridine protons as seen in the starting
compound (1) and in compounds (4a) and (4b). However, new peaks were observed
in the proton spectra for both compounds illustrating the substitution of an alkyl chain.
For compound (4a), N2 regioisomer, the appearance of two triplet signals at 4.95 ppm
(Hg) corresponding to the exact shift observed for the N-CH2 signal and at 4.04 ppm
(Hl), which is the triplet for CH2-Cl. The other peaks appeared as a multiplet at 3.57
ppm and corresponded to CH2-O-CH2CH2-O-CH2 signals. All indicative that the
alkylation occurred. The 13C NMR spectrum confirmed no difference in the aromatic
region to that of the precursor 2-(1H-tetrazol-5-yl)pyridine (1) and the aromatic
signals were observed at 150.6 ppm, 146.8 ppm, 138.1 ppm, 125.7 ppm and 122.8
ppm. The signals for the N-CH2 and the CH2-Cl were easily identified at 70.9 ppm
and 53.5 ppm respectively. The other ethoxy signals were observed at 70.1 ppm, 69.0
ppm, 68.8ppm and 43.9 ppm.
For compound (4b), N1 regioisomer, the 1H spectrum was nearly identical to that of
the N2 isomer. The aromatic protons were observed at 8.75 ppm (Ha), 8.23 ppm (Hd),
8.09 ppm (Hc) and 7.76 ppm (Hb) and the two triplets at 5.13 ppm (Hg) and at 3.89
ppm (Hl) corresponding to the expected shift observed from the N-CH2 signal and the
CH2-Cl signal. The 13C NMR spectrum was almost identical to the N1 isomer apart
from the tetrazole carbon signal observed at 164.6 ppm and the methylene carbon
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signal adjacent to the tetrazole nitrogen observed further downfield than the N1
isomer, that was observed at 152.6 ppm. The remaining signals were almost identical
to the N2 substituted isomer.
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Labelled atoms for 1H and
(4b)

Table 2.4:

Infrared spectroscopic analysis of compounds (4a) and (4b)

C NMR analysis for compounds (4a) &

Compound Number and Relevant Wavenumber (cm-1)

Group

(4a)

(4b)

C-H

2957

2959

C=N

1593

1591

C=C

1577

1574

N=N

1521

1533

C=N

1431

1431

C-O-C

1119

1132

C-N

1044

1249

2.3.4 Synthesis of 2-(2-bromomethylpyridine-(2-tetrazol-5-yl)pyridine (5)
The product 2-(n’’-bromomethylpyridine-(2-tetrazol-5-yl)pyridine (5) was obtained
as an orange oil with a 31% yield. TLC analysis using an eluent system 50:50
petroleum ether (40 – 60 oC) : ethyl acetate provided an Rf value of 0.1. From the IR
analysis, the disappearance of the broad (N-H) stretch at 3065 cm-1 and the appearance
of a (C-H) stretch at 2958 cm-1 could be seen. This is indicative that the substitution
had occurred.
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Figure 2.7 contains the labelled atoms used for NMR analysis. The substitution of the
pyridine group did not result in any major shift to the pyridine ring protons when
comparing it to the staring compound (1). However, new peaks were evident in the
proton spectra equating to Hg, Hi, Hj, Hk and Hm, confirming its substitution. The
aromatic protons were evident at 8.66 ppm (Ha), 8.28 ppm (Hd), 8.06 ppm (Hc), and
7.58 ppm (Hb). The appearance of two singlet signals at 6.33 ppm corresponding to
the exact shift observed for the N-CH2 (Hg) signal and at 4.48 ppm, indicating the
CH2-Br (Hm) signal. Both were indicative that the addition had occurred. The
substituted pyridine peaks could be found further upfield opposed to the pyridinetetrazole protons display the shielding effect of tetrazoles. These signals were found
in the aromatic region at 7.79 ppm, 7.42 ppm and 7.22 ppm. The 13C NMR spectrum
confirmed no difference in the aromatic region to that of the precursor 2-(1H-tetrazol5-yl)pyridine (1) and the aromatic signals were observed at 150.1 ppm, 144.6 ppm,
138.6 ppm, 126.3 ppm and 124.6 ppm. The N-CH2-pyr and the pyr-CH2-Br were
identified at 53.7 ppm and 34.8 ppm. The substituted pyridine signals were found at
156.8 ppm, 154.7 ppm, 138.8 ppm, 123.2 ppm and 121.6 ppm.
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Labelled atoms for 1H and 13C NMR analysis for compound (5)
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2.4

Synthesis of pyrrole-based compounds (Series 2)

Series 2 explores different types of pyrrole based compounds that have been
synthesised, as shown in Scheme 2.2. This type of compound has been synthesised
based on their electropolymerisation potential due to the vacant alpha carbon position.
The synthesis of N-substituted pyrroles suitable for electropolymerisation or the
addition to series 1 compounds are discussed herein.
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H2O, CH3COOH, CH3COONa

Br

(6)

NH2CH2CH2CH2NH2

10% KOH

N
O

CH3COOH, C3H8O2

O

O

N
NH2

HN
O

CH3COONa

(8)

(7)

H2O/CH3COOH, 70 oC

HO

N

NH2CH2CH2COOH

OHCH2C6H3O2H2

H2O, CH3COOH, CH3COONa, DCE

OH

Toluene, TSA

N

OH

O

(9)

O
O

N

C6H12N4H6
H2O, CH3COOH, CH3COONa, DCE

N
N
(10)

Scheme 2.2

Synthesis of compounds (6) – (10)
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N

2.4.1 Synthesis of
propylamine (8a)

1-(3-bromopropyl)-1H-pyrrole

(6)

&

3-pyrrol-1-yl-

Alkyl pyrroles can be synthesised directly from 2,5-dimethoxytetrahydrofurans as
reported by Gondron et al.175 Lieby-Muller et al.176 describes the synthetic route for
N-substituted pyrroles, for example bromopropyl and ethylamine chains, as seen from
Scheme 2.2. The same synthetic procedures were utilised in the synthesis of
compounds 5 – 9, excluding compound (8b). Initially the precursor 2,5dimethoxytetrahydrofurans was stirred in an appropriate amount of solvent until
dissolved. Following depletion of all starting material, sodium acetate was added
along with the appropriate amount of the amino chain and the reaction was refluxed
for 4 hours.

2.4.2 Synthesis of 1-(3-bromopropyl)-1H-pyrrole (6)
1-(3-Bromopropyl)-1H-pyrrole (6) was synthesised following the procedure
published by Gondron et al.175, whereby 2,5-dimethoxytetrahydrofuran, sodium
acetate and 3-bromopropylamine hydrobromide were heated to reflux for 4 hours.
Upon completion, the aqueous layer was removed and extracted using diethyl ether.
This was concentrated via vacuum filtration and the crude product was purified by
flash chromatography using silica gel and a hexane eluent system.
Isolation of 1-(3-bromopropyl)-1H-pyrrole (6) yielded 60% of a dark red oil. TLC
analysis using an eluent system 90:10 hexane: ethyl acetate provided and Rf value of
0.55. IR analysis provided a characteristic fingerprint (C-Br) peak at 617 cm-1. Figure
2.8 contains labelled atoms of compound (6) for NMR analysis. The proton NMR
spectra shows evidence of the pyrrole functional group formation in the form of two
characteristic triplet peaks at 6.73 ppm (Hb) and 6.23 ppm (Ha). The other signals
present equate to the (CH2) groups at 4.13 ppm (Hc), 3.36 ppm (He) and 2.31 ppm
(Hd). The carbon NMR spectrum shows evidence of the formation of the characteristic
pyrrole signals as 120.7 ppm (Cb) and 108.5 ppm (Ca). All changes indicating the
successful synthesis of compound (6).
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Labelled atoms for 1H and 13C NMR analysis for compound (6)

2.4.3 Synthesis of N-(3-(1H-pyrrol-1-yl)propyl) acetamide (7)
3-pyrrol-1-yl-propylamine (8a) was synthesised following the procedure published by
Lieby-Muller et al.176 whereby an acyl amine was initially formed followed by
hydrolysis under alkaline conditions. Isolation of compound (8a) was achieved by
refluxing N-(3-(1H-pyrrol-1-yl)propyl) acetamide (7) with 10% KOH for 2 hours,
allowed to cool and extracted into chloroform. Purification was carried out on silica
gel using hexane as the eluent. This was concentrated under reduced pressure to afford
a light brown oil.
Isolation of N-(3-(1H-pyrrol-1-yl)propyl) acetamide (7) yielded 70% yield of a dark
brown oil. TLC analysis using an eluent system of 90:10 dichloromethane : methanol
provided an Rf value of 0.62. IR analysis showed the formation of the broad (N-H)
stretch at 2950 cm-1 and a sharp (C=O) stretch at 1729 cm-1. Figure 2.9 contains the
labelled atoms used for NMR analysis of compound (7). As seen previously, from
compound (6), the formation of the characteristic pyrroles peaks are yet again present
in the 1H NMR spectrum appearing as two triplet peaks in the range of 6.74 ppm for
Hb and 5.97 ppm for Ha. The formation of a singlet at 1.95 ppm (Hh) indicates the
formation of compound (7). In the carbon NMR spectrum, again the characteristic
signals for the pyrrole functional group at 120.9 ppm (Cb) and 107.9 ppm (Ca) are
evident. The signal at 172.4 ppm shows the formation of the carbonyl (Cg) and a (CH3)
at 23.1 ppm (Ch). The remaining signals, (CH2) equate to (Cc) at 48.7 ppm, (Cd) at
46.5 ppm and (Ce) at 41.0 ppm.
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Labelled atoms for 1H and 13C NMR analysis for compound (7)

2.4.4 Synthesis of 3-pyrrol-1-yl-propylamine (8a)
Isolation of 3-pyrrol-1-yl-propylamine (8a) yielded 35% of a light brown / yellow oil.
TLC analysis using an eluent system of 90:10 dichloromethane : methanol providing
an Rf value of 0.69. IR analysis showed the disappearance of the sharp (C=O) stretch
at 1729 cm-1 and the broad (N-H) stretch was evident at 2933 cm-1. Figure 2.10
contains the labelled atoms used for NMR analysis of compound (8a). 1H NMR results
show the disappearance of the singlet (CH3) peak at 1.95 ppm and the formation of a
broad (NH2) stretch at 1.25 ppm. The upfield shift occurred due to the hydrolytic
cleavage of the amide forming the amine. This is comparable to the results generated
by Lieby-Muller et al.176. In the carbon NMR spectrum, the disappearance of the
carbonyl signal shows hydrolysis had indeed taken place in addition to the
disappearance of the (CH3) signal at 23.1 ppm. These changes are indicative of the
formation of the amine rather than the amide.
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Labelled atoms for 1H and 13C NMR analysis for compound (8a)

64

2.4.5 Synthesis of 3-pyrrol-1-yl-propylamine (8b)
Isolation of 3-pyrrol-1-yl-propylamine (8b) yielded 85% of a light brown / yellow oil.
TLC analysis using an eluent system of 90:10 dichloromethane : methanol providing
an Rf value of 0.66. IR analysis showed the disappearance of the sharp (C=O) stretch
at 1729 cm-1 and the broad (N-H) stretch became evident at 2924 cm-1. Figure 2.11
contains the labelled atoms used for NMR analysis of compound (8a). 1H NMR results
show the disappearance of the singlet (CH3) peak at 1.95 ppm and the formation of a
broad (NH2) stretch at 1.25 ppm. The upfield shift occurred due to the hydrolytic
cleavage of the amide forming the amine. In the carbon NMR spectrum, the
disappearance of the carbonyl signal shows hydrolysis had indeed taken place in
addition to the disappearance of the (CH3) signal at 23.1 ppm. These changes are
indicative of the formation of the amine rather than the amide and are comparable to
the result generated in compound (8a) and literature.176
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Labelled atoms for 1H and 13C NMR analysis for compound (8b)

2.4.6 Synthesis of 4-(pyrrol-1-yl)-butyric acid (9)
4-(pyrrol-1-yl)-butyric acid (9), was synthesised from the procedure described by
Gracia et al.177 whereby 2,5-dimethoxytetrahydrofuran and 4-aminobutyric acid was
refluxed in a mixed solution of water, sodium acetate, acetic acid and 1,2dichloroethane, as seen from Figure 2.12. The reaction was quenched with 1M HCl
and extracted with dichloromethane.

OH

H2N
O

2,5-dimethoxytetrahydrofuran

N

H2O, NaOAc, AcOH, 1,2-DCE, 90 oC

OH
O
(9)

Figure 2.12

Synthesis of 4-(pyrrol-1-yl)-butyric acid (9)
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Isolation of the compound (9) yielded 85% of a colourless oil. TLC analysis using an
eluent system of 50:50 petroleum ether (40 – 60 oC) : ethyl acetate provided and Rf
value of 0.12. IR analysis showed the appearance of a broad (O-H) stretch at 3100 cm1

and a sharp (C=O) stretch at 1709 cm-1. Figure 2.13 contains the labelled atoms used

for NMR analysis of compound (9). 1H NMR shows the formation of the characteristic
triplet pyrrole signals at 6.72 ppm (Hb) and 6.23 ppm (Ha) as well as a signal at 10.95
ppm signifying the acidic OH (Hg). It can be seen from the carbon NMR the
characteristic pyrrole carbon signals at 120.6 (Cb) and 108.4 (Ca), as well as the
carbonyl (Cf) peak at 179.5 ppm, confirming the formation of compound (9).
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Labelled atoms for 1H and 13C NMR analysis for compound (9)

2.4.7 Synthesis of tris(2-(1H-pyrrol-1-yl)ethyl) amine (10)
The synthesis of compound (10) was carried out in a similar fashion to compound (9),
as described by Gracia et al.177 whereby 2,5-dimethoxytetrahydrofuran and 4aminobutyric acid was refluxed in a mixed solution of water, sodium acetate, acetic
acid and 1,2-dichloroethane, as seen for Figure 2.14. The reaction was quenched with
1M HCl and extracted with dichloromethane.
N

H2N
N

NH2

2,5-dimethoxytetrahydrofuran

N

H2O, NaOAc, AcOH, 1,2-DCE, 90 oC

N

NH2

(10)

Figure 2.14

Synthesis of 4-(pyrrol-1-yl)-butyric acid (10)
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N

Isolation of the triethylamino pyrrole 10), yielded 88% of a black oil. TLC analysis
using an eluent system of 9:1, dichloromethane : methanol provided an Rf value of
0.34. IR analysis showed the disappearance of the broad (N-H) band at 3345 cm-1 and
the formation of (C=C) stretch at 1498 cm-1 indicating the formation of the pyrrole.
Figure 2.15 contains the labelled atoms used for NMR analysis of compound (10).
Proton NMR shows the formation of the two characteristic (C-H) triplet signals at 6.66
ppm, (Hb), and 5.95 ppm, (Ha), additional peaks can be seen as triplets at 3.74 ppm,
(Hc), and 2.70 ppm, (Hd), signalling the (CH2) signals. The 13C NMR similarly shows
the formation of the (C-H) signal at 121.3 ppm for (Cb), and 107.8 ppm for (Ca).
Likewise the other signals equating to the (CH2) functional groups at 56.0 ppm for
(Cc) and 48.1 ppm for (Cd). All these changes are indicative of the formation of
compound (10).
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Figure 2.15

Labelled atoms for 1H and 13C NMR analysis for compound (10)

2.4.8 Synthesis of 1-(2-aminoethyl)pyrrole (11)
The synthesis of 1-(2-aminoethyl)pyrrole (11), was carried out following the synthetic
procedure described by He et al.178 whereby 1H-pyrrole was added to a solution of
tetrbutylammonium hydrogen sulphate and NaOH, as shown in Figure 2.16. This
solution was allowed stir at room temperature for 30 minutes bofore the additon of 2chloroethylamine hydrochloride and refluxed for 24 hours. The reaction was quenched
by pouring the reaction into iced water and extracted using diethyl ether. Isolation of
compound (11) was carried out using flash column chromatography with an eluent,
90:10 dichloromethane : methanol.
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Acetonitrile, 90 oC
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Figure 2.16

NH2

Synthesis of 1-(2-aminoethyl)pyrrole (11)

Isolation of compound (11) yielded 86% of a yellow oil. TLC analysis using an eluent
system of 90:10 dichloromethane : methanol provided an Rf value of 0.66. IR analysis
shows the appearance of the broad (N-H) signal at 2930 cm-1 and the disappearance
of the (C-Cl) stretch at 743 cm-1 from the starting material 2-chloroethylamine
hydrochloride. Figure 2.15 contains the labelled atoms used for NMR analysis of
compound (10). Proton NMR shows the formation of the two pyrrole triplet signals at
6.68 ppm for (Hb) and 6.14 ppm for (Ha). The other (CH2) signals appeared as triplets
at 3.83 ppm for (Hc) and 2.80 ppm for (Hd) and the appearance of a broad singlet at
1.67 ppm for (He). The 13C spectrum shows the pyrrole signals appear at 119.1 ppm
(Cb) and 105.8 ppm for (Ca). An additional two signals appeared at 50.5 ppm for (Cc)
and 41.7 ppm for (Cd), all signalling the formation of compound (11).
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Figure 2.17

Labelled atoms for 1H and 13C NMR analysis for compound (11)

2.4.9

Synthesis of 4,4′-(((ethane-1,2-diylbis(oxy))bis(ethane-2,1diyl))bis(oxy))dibenzaldehyde (14) and 1,8-bis[4-((1H-pyrrol1-yl)ethylamine) phenoxy]-3,6-dioxaoctane (12)

The synthesis of compound (12) was carried out using the synthetic procedure
described by Hu et al.179 4-hydroxybenzaldehyde and potassium carbonate were
refluxed using DMF as the solvent for 1 hour before the addition of 1,2-bis(2chloroethoxy)ethane and subsequently refluxed for an additonal 28 hours, (Scheme
2.3). After this time the reaction was quenched by pouring into 100 mL of iced cold
water to initiate precipitation. This was collected via vacuum filtration and purified by
recrystallisation in hot methanol.
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Scheme 2.3

Synthesis of 4,4′-(((ethane-1,2-diylbis(oxy))bis(ethane-2,1diyl))bis(oxy))dibenzaldehyde (12)

Isolation of compound 4,4′-(((ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl)) bis(oxy))
dibenzaldehyde (12) yielded 63% of a white needle like crystals. TLC analysis using
an eluent system 6:4, petroleum ether (40 – 60 oC) : ethyl acetate provided an Rf value
of 0.5. The melting point of (12) was 131 – 133 oC, which was close to the literature
value of 134 – 136 oC179. IR analysis showed the disappearance of the broad (O-H)
stretch at 3195 cm-1 from the starting material of 4-hydroxybenzaldehyde, and the
formation of (C-O-C) stretch at 1269 cm-1. The (C-H) aldehyde signal was present at
2884 cm-1 and the (C=O) signal was present at 1689 cm-1. Figure 2.18 contains the
labelled atoms used for NMR analysis of compound (12). Proton NMR shows the
disappearance of (O-H) stretch at 10.65 ppm. The signals identified equates to an
aldehyde peak at 9.86 ppm (Ha), a (C-H) aromatic peak at 7.84 ppm (Hc), another (CH) at 7.12 ppm (Hd) and two (CH2) signals at 4.21 ppm for (Hf) and 3.78 ppm for (Hh).
The 13C NMR showed a signal at 191.8 ppm for (Ca), a quaternary peak at 130.1 ppm
(Cb) and a second quaternary signal at 163.9 ppm for (Ce). The aromatic carbons can
be found at 132.3 ppm and 115.4 ppm. The remaining (CH2) signals was seen at 69.2
ppm and 68.1 ppm, all signalling the formation of compound (12).
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Labelled atoms for 1H and 13C NMR analysis for compound (12)
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2.5

Synthesis of Pyridine-Tetrazole-Pyrrole based compounds (Series 3)

Series 3 compounds are derived from previously synthesised products from Series 1
and Series 2, as shown in Schematic 2.4. The aim of these new novel compounds are
to adhere to metallic surfaces and reduce the risk of metal corrosion. The complexation
will occur from the series 1 compounds, while series 2 will act as the polymerising
agents to allow adhesion through electropolymerising to a metal surface due to the
vacant alpha carbon position.

N
N
N
N

N
N

N
N

R

N
HN
N

(13)

N

R = H (1)
N

R = CH2CH2CH2Br (3)

N

R = CH2CH2OCH2CH2OCH2CH2Cl (4)

N
N

N

O

O

(14)

NH

N

Schematic 2.4

Synthesis of compounds (13) – (14)

2.5.1 Synthesis of compound 2-(n''-propyl-3-amino pyrrol-1-yl-ehtyl-(1tetrazol-5-yl) pyridine (13) and 2-(2,2-diethoxyethane-3aminopyrrol-1-yl ethyl-(1-tetrazol-5-yl) pyridine (14)
The same synthetic procedures were utilised in the synthesis of compounds (13) and
(14). Initially the precursor 1-(2-aminoethyl)pyrrole (11) was stirred in an appropriate
amount of solvent until dissolved. Following consumption of all starting material an
appropriate amount of K2CO3 was added and the reaction was heated at reflux
conditions for 30 minutes before the addition of the appropriate Series 2 compounds,
2-(n''-bromoalkyl-(2-tetrazol-5-yl)pyridine (3b) and 2-(n''-chloroethoxyethane-(2tetrazol-5-yl)pyridine (4b), as seen from Figure 2.19. Reaction mixtures were held at
reflux conditions for a further 24 hours. After this time the inorganic salts were
removed and the crude product concentrated under reduced pressure. Purification was
carried out with column chromatography, using silica gel and the eluent system 90:10
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ethyl acetate: petroleum ether (40 – 60 oC), followed by the removal of the base spot
using 10% methanol in dichloromethane and 0.5 mL of 10% ammonium chloride.

N

N

1-(2-aminoethyl)pyrrole
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N R
N N

N R
N N

R = CH2CH2CH2NHCH2CH2NC4H4 (13)
R = CH2CH2OCH2CH2OCH2CH2NHCH2CH2NC4H4 (14)

R = CH2CH2CH2Br (3)
R = CH2CH2OCH2CH2OCH2CH2Cl (4)

Figure 2.19

N
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Synthesis of compound (13) and compound (14)

Isolation of compound (13) yielded 90% of an orange oil. TLC analysis using an eluent
system 20:80 ethyl acetate : petroleum ether (40 – 60 oC) provided and Rf value of
0.01. IR analysis showed the appearance of a broad (N-H) stretch at 3350 cm-1
indicating the formation of compound (13). Figure 2.20 contains labelled atoms for
NMR analysis for compound (13). The proton NMR spectrum displays signals
indicating the previously seen pyridine protons at 8.75 ppm (Ha), 8.15 ppm (Hd), 8.02
ppm (Hc) and 7.56 ppm (Hb) in addition to this the alkyl chain signals appear at 4.80
ppm (Hg), 2.59 ppm (Hi) and 2.11 ppm (Hh). Table 2.5 shows a comparison between
the precursor compound (3b) and the newly formed compound (13). The aromatic
protons are similar to that of the precursor, the changes appear in the alkyl chain of
the newly synthesised compound. Hg for both compounds are very similar but when
looking at Hh an upfield shift of 0.54 ppm was observed. This is also evident when
looking at Hi an upfield shift of 0.87 ppm. This indicated the addition of compound
(11) has a shielding effect during the displacement of the bromine atom.
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Labelled atoms for 1H and 13C NMR analysis for compound (13)
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1

Table 2.5

H NMR analysis of compounds (3a) and (13) in d6-DMSO.
Compound Number and Chemical Shift (ppm)

Group

(3b)

(13)

Ha

8.78 (m)

8.75 (m)

Hd

8.26 (m)

8.15 (m)

Hc

7.87 (m)

8.02 (m)

Hb

7.41 (m)

7.56 (m)

Hg

4.91 (t)

4.80 (t)

Hh

2.65 (m)

2.11 (m)

Hi

3.46 (t)

2.59 (m)

When comparing the precursor (3b) and the compound (13) the 13C NMR spectrum
supported the proton NMR displaying little change in the aromatic region, signals
appearing at 164.6 ppm, 150.6 ppm, 146.8 ppm, 138.1 ppm, 125.8 ppm and 123.1
ppm. As seen with the proton NMR, the changes occur in the alkyl chain, with the
largest change appearing at (Ch) and (Ci). Table 2.6 shows the discrepancies in the 13C
spectrum when comparing compound (3a) and (13). For both (Ch) and (Ci) there were
upfield shifts of 5.5 ppm and 8.5 ppm. These changes indicate the successful addition
of compound (11) has taken place, thus forming compound (13).
Table 2.6:

13

C NMR analysis of compounds (3a) and (13)
Compound Number and Chemical Shift (ppm)

Group

(3b)

(13)

Cf

151.8

164.6

Ca

149.5

150.6

Ce

144.7

146.8

Cc

137.5

138.1

Cb

125.4

125.8

Cd

124.5

123.1

Cg

48.2

51.5

Ch

34.8

29.3

Ci

31.1

22.6
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Isolation of compound (14) yielded 90% of an orange oil. TLC analysis using an eluent
system 20:80 petroleum ether (40 – 60 oC) : ethyl acetate provided and Rf value of
0.01. IR analysis showed the appearance of a broad (N-H) stretch at 3288 cm-1
indicating the formation of compound (14). Figure 2.21 contains labelled atoms for
NMR analysis for compound (14). The proton NMR spectrum displays signals
indicating the previously seen pyridine protons at 8.79 ppm (Ha), 8.26 ppm (Hd), 7.88
ppm (Hc) and 7.42 ppm (Hb). It is also evident based on the formation of two triplet
peaks at 6.55 ppm (Hp) and 6.13 ppm (Hq). In addition to this, the -C-O-C- chain
signals appear at 5.04 – 4.60 ppm (Hg-l), 2.59 ppm (Hi) and 2.11 ppm (Hh), as well as
a broad peak at 5.63 ppm (Hm). The 13C NMR spectrum supported the proton NMR
displaying little changes in the aromatic region, signals appearing at 165.1 ppm, 150.4
ppm, 146.5 ppm, 137.2 ppm, 125.1 ppm and 124.6 ppm. As seen with the proton
NMR, changes occur with the addition of peaks at 122.6 (Cp) and 108.7 (Cq), showing
the successful addition of the pyrrole functional group. These changes indicate the
successful formation of compound (14).
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Figure 2.21

Labelled atoms for 1H and 13C NMR analysis for compound (14)

2.5.2 Synthesis of compound (15)
Synthesis of compound (15) followed the same synthetic procedure, as seen in Figure
2.22, described by Demko et al.39 The mono-substituted tetrazole was formed from 1(2-cyanoethyl) pyrrole. The desired product was obtained by firstly removing the
insoluble salts via vacuum filtration and the filtrate concentrated under reduced
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pressure to 10 mL. This was then acidified with concentrated HCl (3 mL) to initiate
precipitation. The product was collect and purified via recrystallisation from hot
ethanol.

N

BrCH2CH2CH2Br, K2CO3

N

NH4Cl, NaN3, LiCl
Ethanol, 85 oC

N

Ethanol, 85 oC

N
N
N N

N
NH
N N

CN

Br

(15)

Figure 2.22

Synthesis of compound (15)

Isolation of compound (15) yielded 87% of a white solid. TLC analysis using 40:60
petroleum ether (40 – 60 oC) : ethyl acetate provided an Rf value of 0.1. IR analysis
showed the disappearance of the (C≡N) at 2249 cm-1 and the appearance of a broad
(N-H) peak at 3065 cm-1. In addition to this the appearance of (C=N) signal at 1665
cm-1 and (N=N) signal at 1463 cm-1 strengthens the indication of tetrazole formation
has taken place. Figure 2.23 contains the labelled atoms used for NMR analysis. From
the proton NMR spectrum two characteristic triplet signals at 6.81 ppm (Hb) and 6.00
ppm (Ha) indicate two pyrrole protons. Additional signals can be seen at 4.14 ppm and
2.96 ppm relating to the two CH2’s at (Hc) and (Hd). The

13

C NMR sees the

disappearance of the (C≡N) stretch at 90.9 ppm and the appearance of quaternary (CN)
(Ce) at 164.8 ppm. The two pyrrole signals appeared at 116.7 ppm (Cb) and 101.9 ppm
(Ca), and the other remaining signals equate to the two CH2’s at 74.6 ppm (Cc) and
29.7 ppm for (Cd).

a

d

b

N
Figure 2.23

c

e

H
N N
N N

Labelled atoms for 1H and 13C NMR analysis for compound (15)
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Conclusion

A series of compounds have been synthesised and are characterised into three
categories. Series 1 have been synthesised using 2-(1H-tetrazol-5-yl)pyridine (1).
Series 2 compounds have been derived from pyrrole or 1,2-dimethyltetrahydrofuran.
Compounds from Series 1 and Series 2 were reacted together to achieve compounds
in Series 3.
When looking at the compounds generated in series 1, it can be seen that the N1 & N2
substituted tetrazoles were only obtained for compounds 3a, 3b, 4a and 4b. Compound
2 and 5 only gave the N2 substituted version. It is possible that N1 formation occurred
but in very low yields and could not be purified. It is believed that compounds 3a – 4a
underwent a SN2 substitution reaction while compounds 2 and 5 could undergo SN2 or
sn1 substitution. Deprotonation of the tetrazole ring, produces the nucleophile, allows
sn1 substation to take place displacing the bromine atom. The charge generated can
be balanced around the cyclic nature of the substituting groups.
Interestingly, only the mono substituted tetrazole compounds were obtained in series
1. The bis substituted compound may have been formed in low concentrations and
could not be purified. The mono substituted tetrazole was targeted for this project as
it would allow for additional substitution to take place, with the aim of getting the
desired product. If conditions and reaction stoichiometry were altered, possibly the bis
substituted compound could be achieved.
Series 2 compounds all have the distinguishing feature of containing a pyrrole
functional group. Compounds 6 – 10 were synthesised using the Claisen
rearrangement mechanism, from 1,2-dimethyltetrahydrofuran. Compound 10 was
synthesised via direct substitution onto 1H-pyrrole. Once synthesised all compounds
were stored under a nitrogen atmosphere and in the dark to prevent degradation.
Series 3 compounds were generated by reacting series 1 with series 2, undergoing SN2
substitution. These compounds contain a pyridine-tetrazole group, a spacer chain and
a pyrrole functional group, as seen from compound 13 & 14.
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Chapter 3
Experimental

77

3.1

General Experimental Procedures

All solvents were of HPLC grade or AR grade, obtained from Sigma-Aldrich or
Lennox. Reactions which required anhydrous conditions were carried out under a
nitrogen atmosphere. All inorganic salts were pre-dried in a vacuum oven at 60 oC
before use for at least two hours.
Melting point analysis was carried out using Stewart Scientific SMP1 melting point
apparatus and were uncorrected. Elemental analyses were carried out by the
Microanalytical Laboratory of University College Dublin, Belfield on a CE 440
Elemental Analyser. Infrared spectra were obtained from a Nicolet Impact 410 FT-IR
spectrometer using the ‘Omnic’ software package. Samples were prepared as
dispersions in KBr disks and oil samples were suspended between NaCl disks.
1

H- and 13C-NMR spectra were obtained using a Bruker Avance III 500 spectrometer

operating at 500 MHz using CDCl3 as the solvent unless stated otherwise. The typical
resolution of this instrument is 0.11 Hz or 0.00022 ppm. Chemical coupling constant
(J) values are accurate to ± 0.22 Hz. For 13C spectra it operates at 125 MHz, with a
typical resolution of 0.45 Hz or 0.0036 ppm. The characterisation of compounds was
achieved with the aid of DEPT-90, DEPT-135, COSY, HSQC and HMBC
experiments. Tetramethylsilane (TMS) was used as the internal standard. Chemical
shifts are expressed in parts per million (dppm) from TMS.
Thin Layer Chromatography was carried out with the stated eluent system in a
equilibrated elution tank using silica gel 60F 254 (20 cm x 20 cm x 0.02 cm) aluminium
backed plates. Compounds were visualised by ultraviolet light or by development in
an iodine tank.
Flash Column Chromatography was carried out with the stated eluent system using
silica gel particle size (<40 µm – >60 µm).
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Caution: Owing to their potentially explosive nature, all preparations of and
subsequent reactions with organotin azides and tetrazoles were conducted under an
inert atmosphere behind a ridged safety screen.
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3.2

Experimental Design for Pyridine Tetrazole Based Compounds

3.2.1 Preparation of 2-(1H-tetrazol-5-yl)pyridine (1)
c
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N N
Figure 3.1
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Labelled atoms for 1H and 13C NMR analysis for compound (1)

To a suspension of 2-cyanopyridine (5.11 g, 49.1 mmol), in anhydrous DMF (100 mL),
was added sodium azide (3.47 g, 53.8 mmol), ammonium chloride (2.88 g, 53.8
mmol), and anhydrous lithium chloride (1.51, 24.2 mmol). The solution was stirred
under nitrogen for 10 hours at 110 oC. The solution was then cooled and the insoluble
salts removed via vacuum filtration. The filtrate was concentrated under reduced
pressure and the residue was dissolved in deionised water (200 mL) and acidified with
concentrated HCl (3 mL) to initiate precipitation. The crude product was filtered and
washed with deionised water (3 x 40 mL). The crude solid was recrystallised from hot
ethanol, giving a white crystalline solid (67%). M.p. 215.7 – 216.5 oC (Lit.39 211 oC).
Rf 0.03 (90:10 Ethyl Acetate : Methanol). nmax (KBr)/cm-1: 3065 (N-H), 1628 (C=N),
1537 (C=C), 1451 (N=N), 1083 (C-N) cm-1. dH/ppm (500 MHz, d6-DMSO): 8.77 (d,
1H, J =7.9 Hz, Ha), 8.20 (d, 1H, J =7.9 Hz, Hd), 8.05 (t, 1H, J =7.9 Hz, Hc), 7.60 (t,
1H, J =7.9 Hz, Hb), ppm. dC/ppm (500 MHz, d6-DMSO): 154.9 (Cf), 150.1 (Ca), 143.7
(Ce), 138.3 (Cc), 126.2 (Cb), 122.7 (Cd) ppm.

80

3.2.2 Preparation of 2-(n-ethylphenylpyrrole-(2H-tetrazol-5-yl) pyridine (2)
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1
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Labelled atoms for H and C NMR analysis for compound (2)

To a suspension of 2-(1H-tetrazol-5-yl)pyridine (0.42 mmol) dissolved in acetonitrile
(30 mL) was added K2CO3 (4.24 mmol). This was stirred and heated at reflux under
N2 for 30 minutes. After this time 1-[3-(bromomethyl)phenol] pyrrole (0.42 mmol)
was added and the reaction refluxed for 48 hours. The inorganic salts were removed
and the solution was then concentrated under vacuum. The crude product was purified
by column chromatography 80:20, petroleum ether (40 – 60 oC) : ethyl acetate, to give
product (2) with a 19% yield. Rf 0.19 (80:20 petroleum ether (40 – 60 oC) : ethyl
acetate). Microanalysis: C17H14N6, calculated, C 67.53%, H 4.67%, N 27.80%, found,
C 67.71%, H 4.51%, N 27.91%. nmax (KBr)/cm-1: 2955 (phenyl CH stretch), 1739
(C=N), 1560 (C=C), 1495 (N=N), 1049 (C-N), 792 (pyrrole C-H) cm-1. dH/ppm (500
MHz, CDCl3): 8.69 (m, 1H, Ha), 8.31 (m, 1H, Hd), 7.84 (m, 1H, Hc), 7.63 (m, 1H, Hi),
7.40 (m, 1H, Hb), 7.28 (m, 1H, Hj), 7.04 (m, 1H, Hl), 6.89 (m, 1H, Hh), 6.78 (t, 2H, J
= 1.9 Hz, Hm), 5.93 (t, 2H, J = 1.9 Hz, Hn), 5.21 (s, 2H, Hg) ppm. dC/ppm (500 MHz,
CDCl3): 164.6 (Cf), 150.6 (Ca), 146.8 (Ce), 138.1 (Cc), 125.8 (Cb), 123.1 (Cd), 121.2
(Cm), 107.9 (Cn), 133.2 (Ck), 129.7 (Ch), 129.5 (Ci), 122.1 (Cj), 114.4 (Cl), 56.5 (Cg)
ppm.
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3.2.3 Preparation of 2-(n''-bromoalkyl-(1-tetrazol-5-yl)pyridine (3a) & 2-(n''bromoalkyl-(2-tetrazol-5-yl)pyridine (3b) 180
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Labelled atoms for 1H and 13C NMR analysis for compound (3a) & (3b)

To a suspension of 2-(1H-tetrazol-5-yl)pyridine (1) (2.00 g, 13.6 mmol) dissolved in
acetonitrile (60 mL) was added anhydrous potassium carbonate (18.8 g, 136 mmol).
The resulting solution was heated at reflux temperature for 30 minutes and to the hot
solution was added 1,3-dibromopropane (48.0 mmol). The reaction mixture was then
stirred at reflux temperature for a further 24 hours. After cooling, the inorganic
material was removed by filtration and the solvent removed under reduced pressure to
afford an oil, which was purified by column chromatography on silica gel, initially at
a ratio of petroleum ether (40 – 60 oC) : ethyl acetate 80:20, followed by the ratio of
60:40. This gave the two products 2-(n’’-bromoalkyl-(2-tetrazol-5-yl)pyridine (38%)
and 2-(n’’-bromoalkyl-(1-tetrazol-5-yl)pyridine (13%).
2-(n''-bromoalkyl-(2-tetrazol-5-yl)pyridine (3a)
M.p. 215.7 – 216.5 oC (Lit.180 190 – 192 oC). Rf 0.03 (90:10 Ethyl Acetate : Methanol).
nmax (KBr)/cm-1: 2983 (pyridyl C-H), 1589 (C=N), 1548 (C=C), 1533 (N=N), 1469
(C=N pyridine), 1283 (C-N) cm-1. dH/ppm (500 MHz, d6-DMSO): 8.78 (m, 1H, Ha),
8.26 (m, 1H, Hd), 7.87 (m, 1H, Hc), 7.41 (m, 1H, Hb), 4.91 (t, 2H, J =6.7 Hz, Hg), 3.46
(t, 2H, J =6.2 Hz, Hi), 2.65 (m, 2H, Hh) ppm. dC/ppm (500 MHz, d6-DMSO): 164.9
(Cf), 150.3 (Ca), 146.6 (Ce), 137.4 (Cc), 124.9 (Cb), 122.4 (Cd), 51.5 (Cg), 31.8 (Ci),
28.7 (Ch) ppm.
2-(n''-bromoalkyl-(1-tetrazol-5-yl)pyridine (3b)
M.p. 190 – 192 oC (Lit.180 158 – 160 oC). Rf 0.01 (90:10 Ethyl Acetate : Methanol).
nmax (KBr)/cm-1: IR (KBr): 2980 (pyridyl C-H), 1586 (C=N), 1556 (C=C), 1502
(N=N), 1447 (C=N pyridine), 1249 (C-N) cm-1. dH/ppm (500 MHz, d6-DMSO): 8.75
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(m, 1H, Ha), 8.37 (m, 1H, Hd), 7.93 (m, 1H, Hc), 7.47 (m, 1H, Hb), 5.15 (t, 2H, J =6.8
Hz, Hg), 3.47 (t, 2H, J =6.4 Hz, Hi), 2.57 (m, 2H, Hh) ppm. dC/ppm (500 MHz, d6DMSO): 151.8 (Cf), 149.5 (Ca), 144.7 (Ce), 137.5 (Cc), 125.4 (Cb), 124.5 (Cd), 48.2
(Cg), 34.8 (Ci), 31.1 (Ch) ppm.

3.2.4 Preparation of 2-(n''-chloroethoxyethane-(2-tetrazol-5-yl)pyridine (4a)
& 2-(n''-chloroethoxyethane-(1-tetrazol-5-yl)pyridine (4b)
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Cl

C NMR analysis for compounds (4a) &

To a suspension of 2-(1H-tetrazol-5-yl)pyridine (2.0 g, 13.59 mmol) dissolved in
acetonitrile (60 mL) was added anhydrous potassium carbonate (6.0 g, 43.41 mmol).
The resulting solution was heated at reflux temperature for 30 minutes and to the hot
solution was added 1,2-Bis(2-chloroethoxy)ethane (40.78 mmol). The reaction was
allowed to stirred at reflux temperature for a further 48 hours. After cooling the
inorganic salts were removed by vacuum filtration and the solvent removed under
reduced pressure to afford an oil, which was purified by column chromatography on
silica gel, initially petroleum ether (40 – 60 oC) : ethyl acetate 70:30. This gave the
two products 2-(n''-chloroethoxyethane-(2-tetrazol-5-yl)pyridine (orange oil, 54%)
and 2-(n''-chloroethoxyethane-(1-tetrazol-5-yl)pyridine (yellow oil, 26%).
2-(n''-chloroethoxyethane-(2-tetrazol-5-yl)pyridine (4a)
Rf 0.25 (60:40 petroleum ether (40 – 60 oC) : ethyl acetate). Microanalysis:
C12H16N5O2, calculated, C 48.41%, H 5.42%, N 23.52%, O 10.75%, Cl 11.91%, found,
C 47.97%, H 5.37%, N 22.98%, O 11.05%, Cl 11.76%. nmax (KBr)/cm-1: 2957 (phenyl
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CH), 1593 (C=N), 1572 (C=C), 1431 (N=N), 1119 (C-O-C), 1044(CN) cm-1. dH/ppm
(500 MHz, d6-DMSO): 8.80 (m, 1H, Ha), 8.14 (m, 1H, Hd), 8.01 (m, 1H, Hc), 7.55 (m,
1H, Hb), 4.95 (t, 2H, J =5.4 Hz, Hg), 4.04 (t, 2H, J =5.3 Hz, Hl), 3.57 (m, 8H, Hh, Hi,
Hj, Hk) ppm. dC/ppm (500 MHz, d6-DMSO): 164.6 (Cf), 150.6 (Ca), 146.8 (Ce), 138.1
(Cc), 125.7 (Cb), 122.8 (Cd), 70.9 (Ck), 70.1 (Ch), 69.0 (Cj), 68.8 (Ci), 53.5 (Cg), 43.9
(Cl) ppm.
2-(n''-chloroethoxyethane-(1-tetrazol-5-yl)pyridine (4b)
Rf 0.51 (60:40 petroleum ether (40 – 60 oC) : ethyl acetate). Microanalysis:
C12H16N5O2, calculated, C 48.41%, H 5.42%, N 23.52%, O 10.75%, Cl 11.91%, found,
C 48.13%, H 5.26%, N 22.95%, O 10.83%, Cl 11.87%. nmax (KBr)/cm-1: 2959 (pyridyl
CH), 1591 (C=N), 1576 (C=C), 1431 (N=N), 1132 (C-O-C), 1022(CN) cm-1. dH/ppm
(500 MHz, d6-DMSO): 8.75 (m, 1H, Ha), 8.23 (m, 1H, Hd), 8.09 (m, 1H, Hc), 7.64 (m,
1H, Hb), 5.129 (t, 2H, J =5.4 Hz, Hg), 3.89 (t, 2H, J =5.3 Hz, Hl), 3.49 (m, 8H, Hh, Hi,
Hj, Hk) ppm. dC/ppm (500 MHz, d6-DMSO): 152.6 (Cf), 150.2 (Ca), 144.8 (Ce), 138.7
(Cc), 126.4 (Cb), 124.8 (Cd), 70.8 (Ck), 70.1 (Ch), 69.9 (Cj), 68.8 (Ci), 49.1 (Cg), 43.9
(Cl) ppm.

3.2.5 Preparation of 2-(n''-bromomethylpyridine-(2-tetrazol-5-yl)pyridine (5)
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Labelled atoms for 1H and 13C NMR analysis for compound (5)

To a suspension of 2-(1H-tetrazol-5-yl)pyridine (0.5 g, 3.40 mmol) dissolved in
anhydrous acetonitrile (30 mL) was added K2CO3 (4.69 g, 33.98 mmol). The resulting
solution was stirred under nitrogen at reflux temperature for 30 minutes before the
addition of 2,6-bis(bromomethyl) pyridine (0.98 g, 3.74 mmol). The reaction was
stirred under nitrogen at reflux for an additional 48 hours. After the allotted time the
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solution was allowed cooled, the inorganic salts removed and concentrated under
reduced pressure. This afforded a crude oil that was purified by column
chromatography on silica gel, initially petroleum ether (40 – 60 oC) : ethyl acetate
90:10 finishing with 60:40. This in turn gave the product 2-(n’’-bromomethylpyridine(2-tetrazol-5-yl) pyridine, an orange oil with a 31% yield. Rf 0.1 (50:50 petroleum
ether (40 – 60 oC) : ethyl acetate). Microanalysis: C13H11N6Br, calculated, C 47.13%,
H 3.35%, N 25.38%, Br 24.13%, found, C 47.53%, H 3.22%, N 25.54%, Br 23.98%.
nmax (KBr)/cm-1: 2958 (pyridyl C-H), 1593 (C=N), 1571 (C=C), 1472 (N=N), 1419
(C=N pyridine), 1250 (CN), 737 (C-Br) cm-1. dH/ppm (500 MHz, d6-DMSO): 8.66 (m,
1H, Ha), 8.28 (m, 1H, Hd), 8.06 (m, 1H, Hc), 7.79 (t, 1H, J =7.9 Hz, Hj), 7.58 (m, 1H,
Hb), 7.42 (d, 1H, J =7.6 Hz, Hi), 7.22 (d, 1H, J =7.7 Hz, Hk), 6.33 (s, 2H, Hg), 4.48 (s,
2H, Hm) ppm. dC/ppm (500 MHz, d6-DMSO): 156.8 (Ch), 154.7 (Cl), 152.9 (Cf), 150.1
(Ca), 144.6 (Ce), 138.8 (Cj), 138.6 (Cc), 126.3 (Cb), 123.2 (Ci), 121.6 (Ck) 124.6 (Cd),
53.7 (Cg), 34.8 (Cm) ppm.

3.2.6 Attempted synthesis of 2-(n''-propyl-3-pcybenzahdehyde)-(1-tetrazol-5yl) pyridine
To a suspension of 3-hydroxybenzaldehyde (6.22 mmol) dissolved in anhydrous
Acetonitrile (20 mL) was added K2CO3 (9.41 mmol) and heated at reflux for 30
minutes. After this time 2-(n’’-bromoalkyl-(2-tetrazol-5-yl)pyridine (5.63 mmol) was
added and the reaction refluxed for 16 hours. The product was allowed cool and the
inorganic salts removed via vacuum filtration. The crude product was concentrated
under reduced pressure giving a brown oil. TLC analysis (using an eluent system 40:60
petroleum ether (40 – 60 oC) : ethyl acetate) showed that only started materials were
present. NMR analysis showed the presence of only starting materials. The starting
materials was recovered quantitatively using preparative TLC.
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3.2.7 Preparation of 1-(3-bromopropyl)-1H-pyrrole (6) 175
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Labelled atoms for 1H and 13C NMR analysis for compound (6)

To a suspension of 2,3-dimethoxytetrahydrofuran (50.0 mmol) in a mixture
water/acetic acid (3/2 v/v) was added 3-bromopropylamine hydrobromide (50.0
mmol) and sodium acetate (55.4 mmol). The solution was stirred at 70 oC for 4 hours.
After this time the aqueous layer was separated and extracted with diethyl ether. This
was subsequently washed with water, brine and dried over MgSO4. After evaporation
to dryness, the crude solid was purified by filtration on silica gel using hexane as the
mobile phase. Fractions were collected, evaporated to dryness and the crude product
purified by column chromatography gel using hexane as the eluent to obtained a pure
dark red oil with a 60% yield. Rf 0.55 (10% AcOEt : hexane). nmax (KBr)/cm-1: 617
(C-Br) cm-1. dH/ppm (500 MHz, CDCl3): 6.73 (t, 2H, J =2.1 Hz, Hb), 6.23 (t, 2H, J
=2.1 Hz, Ha), 4.13 (t, 2H, J =6.5 Hz, Hc), 3.36 (t, 2H, J =6.2 Hz, He), 2.31 (q, 2H, J
=6.3 Hz, Hd) ppm. dC/ppm (500 MHz, CDCl3): 120.7 (Cb), 108.5 (Ca), 47.1 (Cc), 34.2
(Cd), 30.4 (Ce) ppm.

3.2.8 Preparation of N-(3-(1H-pyrrol-1-yl)propyl) acetamide (7) 176
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Labelled atoms for 1H and 13C NMR analysis for compound (7)
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To a suspension of 2,5-dimethoxy tetrahydrofuran (98.37 mmol) in acetic acid:
dioxane (150:200 mL) was added 1,3-diaminopropane (94.43 mmol), stirred and
heated to reflux for 4 hours. After this time the solution was allowed cool and stirred
over night at room temperature. The solution was concentrated under reduced pressure
and the crude reconstituted in chloroform. This was then washed with 10% NaHCO3
(3 x 15 mL). The organic layer was separated, washed with water, brine and dried over
MgSO4. The solution was concentrated under reduced pressure to give a dark brown
oil with a 70% yield. Rf 0.62 (dichloromethane : methanol 90:10). nmax (KBr)/cm-1:
2950 (N-H), 1720 (C=O) cm-1. dH/ppm (500 MHz, CDCl3): 6.74 (t, 2H, J =2.1 Hz,
Hb), 5.97 (t, 2H, J =2.1 Hz, Ha), 5.85 (s, 1H, Hf), 5.02 (m, 2H, J =2.7 Hz, He), 3.87 (t,
2H, J =6.9 Hz, Hc), 2.99 (m, 2H, J =5.8 Hz, Hd), 1.95 (s, 3H, Hh) ppm. dC/ppm (500
MHz, CDCl3): 172.4 (Cg) 120.9 (Cb), 107.9 (Ca), 48.7 (Cc), 46.5 (Cd), 41.0 (Ce), 23.1
(Ch) ppm.

3.2.9 Preparation of 3-pyrrol-1-yl-propylamine (8a)
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Labelled atoms for 1H and 13C NMR analysis for compound (8a)

To a suspension of N-(3-(1H-pyrrol-1-yl)propyl) acetamide (7) was added 10%
aqueous KOH and was allowed to refluxed for 2 hours. After this time the reaction
was collected and extracted into chloroform several times (3 x 15 mL). The combined
chloroform extracts were washed with 10% HCl solution (100 mL). The aqueous layer
was separated, rendered basic with 50% aqueous NaOH and extracted into chloroform.
This was then dried over MgSO4, the solvent removed under vacuum to give a light
brown crude oil. The product was purified by flash chromatography, with the eluent
dichloromethane : methanol (90:10), giving a yellow oil with an 35% yield. This
product was subsequently stored in the dark under nitrogen until further use. Rf 0.69
(90:10 dichloromethane : methanol). nmax (KBr)/cm-1: 2933 (N-H) cm-1. dH/ppm (500
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MHz, CDCl3): 6.75 (t, 2H, J =2.1 Hz, Hb), 6.25 (t, 2H, J =2.1 Hz, Ha), 4.12 (t, 2H, J
=6.5 Hz, Hc), 3.34 (t, 2H, J =6.2 Hz, Hc), 2.36 (q, 2H, J =6.3 Hz, Hd), 1.25 (s, 2H, Hf)
ppm. dC/ppm (500 MHz, CDCl3): 121.3 (Cb), 108.8 (Ca), 53.1 (Cc), 43.7 (Cd), 34.7 (Ce)
ppm.

3.2.10 Preparation of 3-pyrrol-1-yl-propylamine (8b) 181
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Labelled atoms for 1H and 13C NMR analysis for compound (8b)

To a suspension of 1H-pyrrole (10 mmol) in acetonitrile (30 mL) was added sodium
hydroxide (50 mmol) and tetrabutylammonium hydrogen sulphate (TBAS) (0.5
mmol). After the solution was stirred at room temperature for 30 minutes, 2chloroethylamine hydrochloride (12 mmol) was added. Then the reaction mixture was
refluxed for 24 hours. After this time the mixture was poured onto iced water (100
mL), then extracted with diethyl ether, dried over MgSO4 and concentrated under
reduced pressure to give a crude product. The product was purified by flash
chromatography, with the eluent dichloromethane : methanol (90:10), giving a yellow
oil with an 85% yield. This product was subsequently stored in the dark under nitrogen
until further use. Rf 0.66 (90:10 dichloromethane : methanol). nmax (KBr)/cm-1: 2924
(N-H) cm-1. dH/ppm (500 MHz, CDCl3): 6.73 (t, 2H, J =2.1 Hz, Hb), 6.23 (t, 2H, J
=2.1 Hz, Ha), 4.13 (t, 2H, J =6.5 Hz, Hc), 3.36 (t, 2H, J =6.2 Hz, He), 2.31 (q, 2H, J
=6.3 Hz, Hd), 1.25 (s, 2H, Hf) ppm. dC/ppm (500 MHz, CDCl3): 121.0 (Cb), 108.6 (Cb),
52.9 (Cc), 43.5 (Cd), 34.5 (Ce) ppm.
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3.2.11 Preparation of 4-(pyrrol-1-yl)-butyric acid (9) 177
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Labelled atoms for 1H and 13C NMR analysis for compound (9)

To a suspension of 4-aminobutyric acid (97.0 mmol) in mixture of water (150 mL),
NaOAc (97.5 mmol), AcOH (50 mL) and 1,2-dichloroethane (150 mL) was added 2,5dimethoxytetrahyrdofuran (97.1 mmol) and refluxed at 90 oC for 15 hours. The
reaction mixture was quenched with aqueous HCl (1 M) and extracted with CH2Cl2.
The pH was adjusted to 10 with the saturated aqueous solution of NHCO3 and the
organic phase removed. The aqueous layer was made acidic with concentrated HCl
solution and extracted with CH2Cl2. The organic phase was dried over MgSO4 and
concentrated under reduced pressure to afford a colourless oil with a 85% yield. Rf
0.12 (50:50 petroleum ether (40 – 60 oC) : ethyl acetate). nmax (KBr)/cm-1: 3100 (OH), 1709 (C=O) cm-1. dH/ppm (500 MHz, CDCl3): 10.95 (s, 1H, Hg), 6.72 (t, 2H, J
=2.1 Hz, Hb), 6.23 (t, 2H, J =2.1 Hz, Ha), 4.02 (t, 2H, J =6.9 Hz, Hc), 2.39 (t, 2H, J
=6.9 Hz, He), 2.15 (q, 2H, J =7.0 Hz, Hd) ppm. dC/ppm (500 MHz, CDCl3): 179.5 (Cf),
120.6 (Cb), 108.4 (Ca), 48.3 (Cc), 30.8 (Cd), 26.5 (Ce) ppm.

3.2.12 Attempted synthesis of 2-(2,4-dihydroxyethylbenzoate)-ethyl pyrrole
O
HO

O

N
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Figure 3.11 Attempted synthesis of 2-(2,4-dihydroxyethylbenzoate)-ethyl pyrrole
To a suspension of 4-(pyrrole-1-yl)butanoic acid (1.87 g, 12.21 mmol|) and benzylyic
alcohol (2.16 g, 15.41 mmol) dissolved in toluene (30 mL) was added toluene-4sulphonic acid (2.64 g, 13.88 mmol). The reaction was fitted with a Dean-Stark trap
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and heated to reflux temperature untill 3 mL of water was collected in the marcussion
device. After this time the inorganic material removed and the solvent removed under
reduced pressure and cooled to 4 oC. No precipitation occurred. TLC (using an eluent
system dichloromethane : methanol, 90:10) analysis showed that there was only
starting material present. The solvent was removed under reduced pressure and a crude
NMR of the residue was obtained which confirmed the presence of only the starting
materials. The starting material was recovered quantitatively using preparative TLC.

3.2.13 Preparation of tris(2-(1H-pyrrol-1-yl)ethyl) amine (10)
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Labelled atoms for 1H and 13C NMR analysis for compound (10)

To a suspension of tris(2-aminoethyl) amine (13.7 mmol), in a mixture of water (36
mL), NaOAc (21.2 mmol), AcOH (12 mL) and 1,2-dichloroethane (36 mL) was added
2,5-dimethoxytetrahydrofuran (68.4 mmol) and refluxed at 90 oC for 15 hours. The
reaction mixture was quenched with aqueous HCl (1 M) and extracted with CH2Cl2.
The pH was adjusted to pH 10 with a saturated aqueous solution of NHCO3 and the
organic phase was removed. The aqueous layer was made acidic with concentrated
HCl solution and extracted with CH2Cl2. The organic phase was dried over MgSO4
and concentrated to afford a black oil with a 88% yield. Rf 0.34 (90:10
dichloromethane : methanol). Microanalysis: C18H24N4, calculated, C 72.93%, H
8.16%, N 18.91%, found, C 73.11%, H 8.32%, N 18.69%. nmax (KBr)/cm-1: 1498
(C=C), 1283 (3oN), 1090 (C-N), 727 (C-H) cm-1. dH/ppm (500 MHz, d6-DMSO): 6.66
(t, 6H, J =2.1 Hz, Hb), 5.95 (t, 6H, J =2.1 Hz, Ha), 3.74 (t, H6, J =6.6 Hz, Hc), 2.70 (t,
6H, J =6.6 Hz, Hd) ppm. dC/ppm (500 MHz, d6-DMSO): 121.3 (Cb), 107.8 (Ca), 56.0
(Cc), 48.1 (Cd) ppm.
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3.2.14 Preparation of 1-(2-aminoethyl)pyrrole (11) 178
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Labelled atoms for 1H and 13C NMR analysis for compound (11)

To a suspension of 1H-pyrrole (1.34 g, 19.97 mmol) in acetonitrile (30 mL), was added
to NaOH (4.0 g, 10.0 mmol) and tetrabutylammonium hydrogen sulphate (0.34 g, 1.0
mmol). The solution was allowed stir at room temperature for 30 minutes before the
addition on 2-choloethylamin hydrochloride (5.29 g, 24.14 mmol). The reaction was
then stirred, heated to reflux and left for 24 hours. After the alotted time the reaction
was poured onto 100 mL of iced water, extracted with diethyl ether, dried over MgSO4
and concentrated under reduced pressure. The crude product was then purified by flash
column chromatography eluent, dichloromethane : methanol, 90:10. The result was a
yellow oil with 86% yield. Rf 0.66 (90:10 dichloromethane : methanol) nmax (KBr)/cm1

: 3330 (NH) cm-1. dH/ppm (500 MHz, CDCl3): 6.68 (t, 2H, J =2.1 Hz, Hb), 6.14 (t,

2H, J =2.1 Hz, Ha), 3.83 (t, 2H, J =6.5 Hz, Hc), 2.80 (t, 2H, J =6.5 Hz, Hd), 1.67 (s,
2H, He) ppm. dC/ppm (500 MHz, CDCl3): 119.1 (Cb), 105.8 (Ca), 50.5 (Cc), 41.7 (Cd)
ppm.
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3.2.15

Preparation
of
4,4′-(((ethane-1,2-diylbis(oxy))bis(ethane-2,1
diyl))bis(oxy))dibenzaldehyde (12)
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Figure 3.14

Labelled atoms for 1H and 13C NMR analysis for compound (12)

To a suspension of 4-hydroxybenzaldehyde (1.5 g, 12.3 mmol) in anhydrous DMF (60
mL), was added anhydrous K2CO3 (2.6 g, 18.4 mmol) and heated to reflux for 1 hour
under nitrogen. After this time 1,2-bis(2-chloroethoxy)ethane (0.7 g, 3.7 mmol) was
added drop wise and the reaction refluxed for 28 hours. Upon completion the solution
was poured into 100 mL iced water, initiating precipitation of a white solid. This solid
was removed via vacuum filtration, washed with iced water (3 x 15 mL), and dried.
The crude product was recrystallised in MeOH, to give a while solid needle like
crystals with a 63% yield. M.p. 131 – 133 oC (Lit.179 134 – 136 oC). Rf 0.5 (60:40
petroleum ether (40 – 60 oC) : ethyl acetate). nmax (KBr)/cm-1: 2884 (C-H aldehyde),
1689 (C=O), 1269 (C-O-C). dH/ppm (500 MHz, d6-DMSO): 9.86 (s, 2H, Ha), 7.84 (d,
4H, J =8.8 Hz, Hc), 7.12 (d, 4H, J =8.8 Hz, Hd), 4.21 (t, 4H, J =4.5 Hz, Hf), 3.78 (t,
4H, J =4.5 Hz, Hg) ppm. dC/ppm (500 MHz, d6-DMSO): 191.8 (Ca), 163.9 (Ce), 132.3
(Cc), 130.1 (Cb), 115.4 (Cd), 69.2 (Cf), 68.1 (Cg) ppm.
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3.2.16

Attempted synthesis of
phenoxy]-3,6-dioxaoctane

1,8-bis[4-((1H-pyrrol-1-yl)ethylamine)

Figure 3.15 Attempted synthesis 1,8-bis[4-((1H-pyrrol-1-yl)ethylamine) phenoxy]3,6-dioxaoctane
To

a

suspension

of

4′-(((ethane-1,2-diylbis(oxy)bis(ethane-2,1-diyl))bis(oxy))

dibenzaldehyde (12) (1.95 mmol) dissolved in acetonitrile (30 mL) was added 1-(2aminoethyl)pyrrole (11) (7.89 mmol) and the reaction heated at reflux for 6 hours.
After this time the crude product was concentrated under reduced pressure to afford a
black oil. TLC (using an eluent system dichloromethane : methanol, 90:10) analysis
showed that there was only starting material present. The solvent was removed under
reduced pressure and a crude NMR of the reside was obtained which confirmed the
presence of only starting materials. The starting material was recovered quantitatively
using preparative TLC.
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3.2.17

Preparation of 2-(n''-propyl-3-amino pyrrol-1-yl-ehtyl-(1-tetrazol-5yl) pyridine (13)
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Figure 3.16 Labelled atoms for 1H and 13C NMR analysis for compound (13)
To a suspension of 1-(2-aminoethyl) pyrrole (0.56 mmol) dissolved in acetonitrile (30
mL) was added anhydrous K2CO3 (2.73 mmol). The resulting solution was allowed to
stir at reflux temperature for 30 minutes before the addition of 2-(n”-bromoalkyl-(2tetrazol-5-yl)pyridine (0.37 mmol). This solution was allowed to stir at reflux for an
additional 24 hours. After this time the inorganic salts were removed and the crude
product concentrated. Purification was carried out with column chromatography, using
silica gel, eluent system ethyl acetate : petroleum ether (40 – 60 oC) 90:10 followed by
the removal of the base spot using 10% methanol in DCM with 1 mL of 10%
ammonium chloride. This resulted in an orange oil with 90% yield. Rf 0.01 (20:80
petroleum ether (40 – 60 oC) : ethyl acetate). Microanalysis: C15H19N7, calculated, C
60.59%, H 6.44%, N 32.97%, found, C 60.81%, H 6.21%, N 32.72%. nmax (KBr)/cm1

: 3350 (N-H), 2945 (pyridyl C-H), 1593 (C=N), 1562 (C=C), 1499 (N=N), 1282 (C-

N), 725 (pyrrole C-H). dH/ppm (500 MHz, CDCl3): 8.75 (m, 1H, Ha), 8.15 (m, 1H,
Hd), 8.02 (m, 1H, Hc), 7.56 (m, 1H, Hb), 6.74 (t, 2H, J =1.9 Hz, Hn), 5.95 (t, 2H, J =1.9
Hz, Hm), 4.80 (t, 2H, J =6.8 Hz, Hg), 3.92 (t, 2H, J =6.5 Hz, Hl), 2.85 (t, 2H, J =6.4
Hz, Hk), 2.59 (t, 2H, J =6.6 Hz, Hi) 2.11 (q, 2H, J =6.8 Hz, Hh) ppm. dC/ppm (500
MHz, CDCl3): 164.6 (Cf), 150.6 (Ca), 146.8 (Ce), 138.1 (Cc), 125.8 (Cb), 123.1 (Cd),
121.2 (Cm), 107.9 (Cn), 51.5 (Cg), 45.8 (Ck), 43.5 (Cl), 29.3 (Ch), 23.6 (Ci) ppm.
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3.2.18

Preparation of 2-(2,2-diethoxyethane-3amino-pyrrol-1-yl ethyl-(1tetrazol-5-yl) pyridine (14)
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Figure 3.17 Labelled atoms for 1H and 13C NMR analysis for compound (14)
To a suspension of 1-(2-aminoethyl) pyrrole (13.93 mmol) dissolved in acetonitrile
(30 mL) was added anhydrous K2CO3 (57.01 mmol). The resulting solution was
allowed stir at reflux temperature for 30 minutes before the addition of compound 4(b)
(2.92 mmol). This solution was allowed stir at reflux for an additional 24 hours. After
this time the inorganic salts were removed and the crude product concentrated.
Purification was carried out with column chromatography, using silica gel, eluent ethyl
acetate : petroleum ether (40 – 60 oC) 90:10 followed by the removal of the base spot
using 10% methanol in DCM with 1 mL of 10% ammonium chloride. This gave an
orange oil with 90% yield. Rf 0.01 (20:80 petroleum ether (40 – 60 oC) : ethyl acetate).
Microanalysis: C15H25N7O2, calculated, C 53.71%, H 7.51%, N 29.24%, O 9.54%,
found, C 53.97%, H 7.45%, N 29.08%, O 9.31%. nmax (KBr)/cm-1: 3288 (N-H), 2966
(pyridyl C-H), 1659 (C=N), 1555 (C=C), 1380 (N=N), 1283 (C-N), 724 (pyrrole CH). dH/ppm (500 MHz, CDCl3): 8.79 (m, 1H, Ha), 8.26 (m, 1H, Hd), 7.88 (m, 1H, Hc),
7.42 (m, 1H, Hb), 6.55 (t, 2H, J =1.9 Hz, Hp), 6.13 (t, 2H, J =1.9 Hz, Hq), 5.62 (s,
broad, Hm), 5.04 – 4.60 (m, 6H, Hg-l), 2.02 (m, 4H, Hn-o) ppm. dC/ppm (500 MHz,
CDCl3): 165.1 (Cf), 150.4 (Ca), 146.5 (Ce), 137.2 (Cc), 125.1 (Cb), 124.6 (Cd), 122.6
(Cp), 108.7 (Cq), 54.2 – 48.1 (Cg-l), 25.2 (Cn), 22.7 (Co) ppm.
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3.2.19 Preparation of 5-(2-Pyrrol-1-yl-ethyl)-1H-tetrazole (15)

a
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Figure 3.18
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N N
N N

Labelled atoms for 1H and 13C NMR analysis for compound (15)

To a suspension of 1-(2-cyanoethyl)pyrrole (42.53 mmol) in absolute ethanol (25 mL)
was added sodium azide (83.06 mmol), ammonium chloride (63.75 mmol) and
anhydrous lithium chloride (24.84 mmol). The solution was stirred under nitrogen for
48 hours at 90 oC. The solution was subsequently cooled and the insoluble salt removed
via vacuum filtration. The filtrate was concentrated under reduced pressure to
approximately 10 mL and acidified with concentrated HCl (3 mL) to initiate
precipitation. The crude product was filtered and the solid recrystallized from hot
ethanol, giving white solid (87%). Rf 0.1 (40:60 petroleum ether (40 – 60 oC) : ethyl
acetate). nmax (KBr)/cm-1: 3065 (N-H), 1685 (C=C), 1665 (C=N), 1463 (N=N), 995 (CN) cm-1. dH/ppm (500 MHz, CDCl3): 6.81(t, 2H, J =2.1 Hz, Hb), 6.00 (t, 2H, J =2.1
Hz, Ha), 4.14 (t, 2H, J =6.5 Hz, Hc), 2.96 (t, 2H, J =6.5 Hz, Hd) ppm. dC/ppm (500
MHz, CDCl3): 164.8 (Ce), 116.7 (Cb), 101.9 (Ca), 74.6 (Cc), 29.7 (Cd) ppm.
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3.2.20

Attempted Synthesis 2-(bromopropyl-(2-pyrrol-1-yl) tetrazole

To a suspension of 5-(2-pyrrol-1-yl-ethyl)-1H-tetrazole (8.30 g, 50.86 mmol) in
ethanol (100 mL) was added anhydrous potassium carbonate (35.15 g, 254.3 mmol)
and heated to reflux for 30 minutes. After this time 1,3-dibromopropane was added
dropwise and the reaction heated for an additional 48 hours. Upon completion the
inorganic salts were removed and the solution concentrated under reduced pressure,
affording a dark viscous crude oil. TLC analysis (using an eluent system 40:60
petroleum ether (40 – 60 oC) : ethyl acetate) showed that there was only starting
material present. The solvent was removed under reduced pressure and a crude NMR
of the residue was obtained which confirmed the presence of only the starting
materials. The starting material was recovered quantitatively using preparative TLC.
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Chapter 4
Stent Coating &
Corrosion Studies
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4.1

Introduction

This chapter explores the coating, characterisation and corrosion of pre-selected
compounds, the synthesis of which has been described in Chapter 3. The preliminary
results gathered are for some novel compounds, a novel electropolymerisation
technique and a novel corrosion method. Electropolymerisation coating was selected
over a dipping method due to the chemical reactions that can take place at the metal
surface, while in a dipping method these covalent interactions are not taking place.
This would result in stronger coating adherence to the stent surface and a more evenly
distributed coating.182
The compounds selected, as shown in Figure 4.1, contain pyrrole, tetrazole and alkyl
chain functional groups of varying length. The pyrrole functional group was selected
based on its known ability to undergo polymerisation through the unsubstituted α-C
position. Additionally, copious amounts of research is available on the
electropolymerisation of pyrrole and its derivatives.175,183 The aim of the pyrrole
functional group is to transform synthesised monomer compounds into coatings that
will adhere to a substrate and create an evenly distributed coating. A tetrazole
functional group was included based on its ability to bind metals. This work was
carried out previously within the research group.10 Ti6Al4V substrates were selected
as they are the most commonly used medical stent on the biomaterials market.
Characterisation of the coatings was carried out using SEM and AFM analysis. SEM
provides a topographic view of the bare and coated stents, and how that changes based
on the application of the coating. Similarly, AFM provides topographic results of the
coating, with the addition of force analysis to provide information regarding the
hardness of the coating on the substrate.

99

N
N

N
N

N

N

O

N

OH

NH2

N

2

9

8

N
N
N

N

N

N

N

N

NH2

N
HN
N

N

10

13

11

N

N

N

N
N

N

O

O

NH

N

N

14

N

N

15

Figure 4.1

NH

Synthesised compounds that were used as coatings.

4.1.1 Coating Techniques
The most common surface modification process is the deposition of a material onto
the surface, called a coating. However, since the range of deposition methods are vast,
in 2018 a set of criteria were established to sub-categorise these methods and
materials. The categories are based on the substrate material, applications of the
coating material and the coating layer thickness.184 There are numerous coating
methods offering a range of capabilities, however, only a few of these techniques are
sufficiently reliable to be applied for bio-application purposes.185 These techniques
simultaneously provide corrosion resistance and biocompatibility enhancement for the
substrate. The four methods most relevant to our research study are outlined below.

4.1.1.1 Plasma Spray Coating
Plasma spray coating is one of the most investigated methods of material deposition.
Due to its versatility, many material types can be deposited , including metallic alloys,
oxides, ceramics and composites. This process in turn offers a wide range of
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applications in biomaterial and body implant coatings.186,187 Figure 4.2 represents a
schematic overview of a working plasma spray setup and the position of the target
substrate to perform an effective coating experiment. The basic operation is to
introduce solid particles into a plasma stream. The accelerated particles get hot and
soften through the plasma stream and cover the surface upon impact with the substrate.
The coating molecules can penetrate the substrate due to the impact of high energy.
Alternatively, the flattened particles accumulate after a series of spraying with high
energy and cover the surface of the substrate. Owing to the presence of multitype
pores, or cracks, plasma sprayed coatings can be viewed as unique porous structures.
It is widely accepted that the plasma spraying is highly cost effective, which offers
significant advantages in preparing protective coatings for wear and corrosion, in
particular on large size components.

Figure 4.2

Schematic plasma spray coating technique and target substrate188

4.1.1.2 High-Velocity Suspension Flame Spray Coating
Compared to plasma sprayed coating, High-Velocity Suspension Flame Spray
(HVSFS) coating is capable of providing a denser coating and one which is less
susceptible to oxidation. HVSFS is a modified type of high-velocity oxy-fuel coating
process that utilises suspensions with the desired composition, to deposit a coating
later on the desired substrate.189 Figure 4.3 displays a schematic overview of an
experimental HVSFS setup. This method utilises an inlet that pushes the coating
materials into the stream of hot flames and accelerates them towards the target
substrate. The advantage of using this process is a significantly increased coating
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speed, and a larger area of coverage.190,191 This is regarded a straightforward process
and inexpensive.

Figure 4.3

Schematic illustration of a HVSFS experimental setup192

4.1.1.3 Sol-gel Coating
Recently, sol-gel technologies have generated much attention from research groups.
Sol-gel coating methods offer simplicity, flexibility, and low operational costs.184 This
process provides a reliable enhancement of coating adhesion on the substrate of
metallic biomaterials. Sol-gels contain two specific components, i.e. a sol and a gel.
The sol component is made up of calcium-phosphate based precursors in ethanol and
water to produce phosphate pentoxide (P2O5)/triethyl phosphate (C6H15O4P), that
results in elevated hydrolysis levels of the sol component. The aqueous gel component
is silica based with the addition of varying amounts of other elements, such as Al, Ca,
Na and Zr. These silica gels can are prepared by polymerisation of silicon alkoxides
such as tetraethyl orthosilicate (Si(OC2H5)4).193,194 In the next part of the process, the
sol and gel components are mixed together carefully and the liquid medium removed
via evaporation. This process is completed numerous times until the desired viscosity
of the sol-gel is obtained. Coating of the substrate is carried out using a dipping
technique in three steps: dipping, removal and air-drying. Dipping and removal are
carried out at a controlled constant speed, ensuring no air bubbles and a non-uniform
layer thickness of the coating medium occurs.195 An advantage of this method, over
previously discussed methods, is the option of altering the procedure to obtain
composite and multi-layer coatings by altering the sol-gel medium and repetition of
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the dipping, removal and drying stages.184 Figure 4.4 represents a summary of the solgel coating process.

Figure 4.4

Flowchart of sol-gel coating process coating steps196

4.1.1.4 Electrochemical Coating
Electrochemical coating is the most widely used method of coating materials, where
the coating is deposited on metals like titanium and titanium alloy substrates.197
Figure 4.5 represents a working schematic overview of an electrophoretic coating
setup. Coating takes place by the incorporation of the monomer into the electrolyte
solution, passing a current through the cell set-up and resulting in the deposition of the
monomer on the substrate. This process utilises the potential difference between
cathodic and anodic poles of an electrical circuit to form micro-arcs or to exchange
ions between anion and cation sides.198199 The coating process takes places in two
steps called electrophoretic and electrolytic deposition. The former is responsible for
deposition of large suspension particles existing inside the electrolyte, while the latter
is in charge of depositing fine materials and structure. These two steps may be
considered as two distinct processes or as separate steps of a single coating process.200
One of the main advantages of the electrochemical deposition is the uniformity in
thickness of the deposited layer throughout the substrate.
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Figure 4.5

Schematic view of simple electrophoretic deposition process201

4.1.2 Corrosion
Corrosion at the surface of a metal in aqueous or biological fluids is electrochemical
in nature. It causes release of ionic species into the fluid and results in mass loss on
the metal surface. Therefore, studies to monitor corrosion rely on current/voltage
difference measurements and associated mass loss. Studies have shown the release of
toxic and side-effect metal ions, such as V5+ and Al3+202, cause local immune
dysfunction, inflammation and cytotoxic reactions in the human body, to name but a
few.203
In the 1950’s, while studying the electrochemical behaviours of iron samples with
different carbon content Bonhoeffer and Jena204 found that the slope of the
current/voltage curves were related to the degree of corrosion and developed the
concept of ‘polarisation resistance’ and ‘corrosion potential’, and devised a series of
equations to measure corrosion rates. They employed an extrapolation method
developed in 1905 by Julius Tafel to validate their experimental relationship between
resistance and rate of corrosion which is now commonly referred to as Tafel analysis.
Various electrochemical techniques have been developed to assess the behaviours of
corrosion, for example, open-circuit voltage, potentiodynamic polarisation
(commonly referred to as Tafel analysis) and electrochemical impedance
spectroscopy. Tafel analysis, as seen in Figure 4.6, is a well-established
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electrochemical technique, which involves the recording of the current when the opencircuit potential is imposed on a metal sample.
Polarisation resistance (Rp) is the resistance of the metal to oxidation during the
application of an external potential and is expressed in Equation 4.1. This estimates
the corrosion rate using linear approximation of polarisation behaviour at potentials
near the corrosion potential. This method is based on the assumption that polarisation
currents change linearly with potential within certain range from the corrosion
potential, usually between 10 to 20 mV. The Stern-Geary relationship is Equation 4.1
expresses the change in potential as a function of the change in polarising current.

Equation 4.1

! $ !%
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Where Rp is the polarisation resistance (in Ω), βa (in mV/dec) is the anodic Tafel slope and βc (in
mV/dec) is the cathodic Tafel slope, and icorr is the corrosion current (in A).

By plotting potential vs current on a linear graph, Rp can be obtained from the slope
of the curve near the corrosion potential, while Tafel constants can be obtained from
the potentiodynamic polarisation plot or literature. The value of the Tafel constant
used in this experiment was 120 mV/decade for both anodic and cathodic Tafel
constants, this was consistent with the work carried out my Bakin et al.197. In order to
find the corrosion rate, Equation 4.1 is modified to yield Equation 4.2 and 4.3.

Equation 4.2
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Where icorr is the corrosion current (in A), Rp is the polarisation resistance (in Ω), βa (in mV/dec)
is the anodic Tafel slope and βc (in mV/dec) is the cathodic Tafel slope. Where B is referred as
Stern Geary constant (V).

The equation used for calculating the corrosion rate (CR) is indicated in Equation 4.3
and is measured in millimetres per year.

Equation 4.3

78 =
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Where K is the constant that defines the units of the CR, EW is the equivalent weight (in g/equivalent),
d is the density (in g/cm3), A = sample area (in cm2).
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Figure 4.6

Tafel analysis carried out in an acidic medium205

4.1.3 General Coating Characterisation Techniques
4.1.3.1 Atomic Force Microscopy (AFM)
The atomic force microscope is one of the family of scanning probe microscopies.
Figure 4.7 (a) illustrates a schematic set up of an AFM. The AFM uses a flexible
cantilever as a type of spring to measure the force between the tip and the sample. The
cantilever is attached to the substrate, ideally ridged, that can be held fixed, and
depending whether the interaction at the tip is attractive or repulsive, the cantilever
will deflect.206 Topographic measurements in AFM are performed in either contact
mode or tapping mode.
Contact-mode AFM
In contact mode the cantilever tip is placed in contact with the sample surface, where
it experiences short-range repulsive Coulombic interactions between the atoms of the
tip and sample, as shown in Figure 4.7 (b). The force with which the cantilever is
pressed against the surface is controlled by the cantilever deflection as measured by
laser reflection from the back side of the cantilever into a four-quadrant positionsensitive detector. As the tip is rastered across the sample surface, variations in surface
topography give rise to changes in the cantilever deflection which can be translated
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into a topographic map. The cantilever used for contact AFM is soft allowing the
subtle variations in the repulsive force between the tip and sample to be resolved. In
addition to the topographic image, which is produced by feedback control of the
cantilever deflection, contact-mode AFM produces deflection and friction images. The
deflection image relates to the vertical bending of the cantilever, and can be thought
of as an error-signal image that shows how well the feedback control responds to
variations in the surface topography. The friction signal relates to the lateral bending
of the cantilever, and arises due to frictional forces between the sample and the tip as
it is rastered across the surface.207

Figure 4.7

(a) Schematic of AFM layout. 1 – 650 nm laser, 2 – Alignment mirror, 3- fourquadrant photo-sensitive detector, 4 – amplifier, 5 - DAQ convertor, 6 – sample,
7 – tip, 8 – cantilever. (b) Interaction zones between the tip and sample, at long
separations the forces are attractive while at short separations they are
repulsive206

Tapping-mode AFM
In the case of tapping mode AFM, the cantilever is oscillated at a frequency close to
its resonance frequency (~300 kHz) by a drive piezo on the scanner head. The
oscillation amplitude of the cantilever is monitored via the laser/photo-sensitive
detector arrangement and when the cantilever is brought sufficiently close to the
surface this amplitude is damped by the interaction between the tip and sample. In this
regime, the tip makes intermittent contact with the surface. During contact the tip
experiences short-range repulsive Coulombic forces, while away from the surface it
experiences long-range attractive forces due to van der Waals forces. In ambient
microscopes, the sample is covered by a thin film of water, which produces additional
capillary forces when the tip interacts with it. Variations in topography as the tip is
rastered across the surface give rise to changes in the damping of the oscillation
amplitude, which in turn is subject to feedback control where the tip-sample separation
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is adjusted to maintain a constant pre-set value of the oscillation amplitude.208
Cantilevers for tapping-mode AFM tend to be stiffer (nominal spring constant, k = 42
N/m). The topographic image is generated from the voltage applied to the scanner zpiezo, which the feedback control uses to regulate the tip-sample separation. In
addition to the topographic image, tapping-mode AFM also produces an amplitude
image and a phase image. The amplitude image maps the error-signal due to the
response of the feedback control to variations in the surface topography. The phase
image shows the phase difference between the driver piezo, which oscillates the
cantilever, and the oscillation of the cantilever as measured by the photo-sensitive
detector. There can be a phase shift between these two signals due to interactions
between the tip and surface, e.g. variations in the surface elasticity.207
Force spectroscopy
Force spectroscopy was conducted with aim of measuring film thickness and
roughness properties associated with deposited coatings. If the force between the tip
and sample is measured as the tip approaches contact with the sample and as it is
retracted, then quantitative information on the mechanical properties of the sample,
such as the elastic modulus, can be determined.206,209 Force spectroscopy is performed
by monitoring the deflection of the cantilever as it is brought into contact with the
surface and as it is retracted from it again. Far from the surface there is no interaction
between the tip and sample so that there is no deflection of the cantilever as it moves
towards the surface. When the long-range interactions (van der Waals, capillary
forces) come into play the cantilever will suddenly jump into contact. As the cantilever
is moved closer to the sample by the scanner z-piezo, the cantilever will start to bend
due to the repulsive contact. If the sample is soft, the force applied by the cantilever
tip on the sample surface can cause the surface to deform, creating an indentation.
Once a certain maximum force has been applied (i.e. maximum cantilever deflection)
the tip retract is initiated. The cantilever tip adheres to the surface as it is retracted,
giving rise to an overshoot in the negative deflection of the cantilever. This produces
a trough in the retract curve, whose depth is proportional to the adhesion of the
cantilever tip to the surface. At some point the cantilever is pulled upwards with
sufficient force to overcome the adhesion force.
Figure 4.8 (a) illustrates the interactions between the cantilever tip and sample and
stages using force curve measurements, while Figure 4.8 (b) shows the curves
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produced as a result. In Figure 4.8 (a) the flat part of the curves to the right correspond
to the stage where the cantilever is far from the surface and there is no deflection. The
retract curve (blue) is offset laterally from the approach curve (red) due to the
hysteresis of the z-piezo.

Figure 4.8

(a) Schematic showing the interactions between the tip and sample at various
stages of a force-curve measurement. (b) Force-curve measurement, which shows
the approach and retract curves produced as a result of these interactions208

The force between the tip and sample may be extracted from the cantilever deflection
if the following are known;
(i)

Cantilever deflection sensitivity (nm/V) – the four-quadrant photo-sensitive

detector outputs a voltage signal that is proportional to the deflection of the cantilever,
as shown in Figure 4.9. It is possible to determine the cantilever bending in
nanometers by measuring the cantilever deflection as the tip is pressed into a hard,
incompressible surface such as silicon or glass. The value is extracted from the inverse
of the slope of the deflection (cantilever bending) versus z-piezo displacement (how
much the cantilever is moved towards the surface) in an approach curve once the tip
is in contact with the sample. The deflection sensitivity must be calibrated for each
cantilever and each alignment of the laser/photo-sensitive detector (even if the same
cantilever is used).
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Figure 4.9

(ii)

Force curve (cantilever displacement vs. z-piezo displacement) obtained using a
tapping-mode cantilever (k = 42 N/m) on glass. The slope of the curve rises
sharply when the cantilever tip comes into contact with the sample. The inverse
of the slope in this region gives the cantilever deflection sensitivity, in this case
it will be about 52 nm/V209

Cantilever spring constant (N/m) – once the cantilever bending in nm/V is

determined, the force between the tip and sample can be calculated by multiplying the
deflection sensitivity by the cantilever spring constant. Cantilever manufacturers
specify a nominal spring constant for their cantilevers based on the cantilever
geometry and dimensions. In the case of a flat, rectangular cantilever beam, the spring
constant can be calculated using the Equation 4.3:

?=

Equation 4.3
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where E (GPa) is the Young’s modulus of the cantilever material (E = 169 GPa for Si<110>, E =
130 GPa for Si<100>),210 b (µm) is the cantilever width, h (nm) is the cantilever thickness and L
(µm) is the cantilever length.

In reality, the actual spring constant of every cantilever has a unique value that can
vary substantially from the nominal values specified by the manufacturer. Usually, the
spring constant of each cantilever is measured before a force spectroscopy
measurement by measuring the thermal fluctuation of the cantilever.209 While it is
technically possible to do this in the Agilent 5500 AFM, the additional DAQ card
required for these measurements was not present in the microscope used for the
experiments. It would also have been possible to measure the cantilever spring
constant by performing force-curve measurements using a calibrated cantilever of
known spring constant as the sample. However, these were also unavailable at the time
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of the experiments. Consequently, the manufacturer-specified nominal values were
adopted for the determination of the Young’s modulus values.
The force between the tip and sample can be calculated by multiplying the cantilever
deflection by the deflection sensitivity and the cantilever spring constant. The applied
force is typically in the pN to nN range.
In the case of soft samples, the tip will indent the sample surface if sufficient force is
applied. The deformation of the sample under a given stress (force/area) yields the
Young’s modulus of the sample material in the elastic regime. In order to calculate the
deformation of the sample, the cantilever deflection, calculated by multiplying the
deflection by the deflection sensitivity, must be subtracted from the z-piezo
displacement. Once this is done, a deformation vs. force curve (also known as an
indentation vs. force curve) can be plotted. The slope of this curve is proportional to
the Young’s modulus of the sample. To accurately determine this a few things must
be known in addition to the force applied by the tip. The shape of the tip is important
as this will determine the contact area between the tip and the sample, and therefore
the stress applied by the tip on the sample. The contact area will increase as the tip
indents further into the sample surface. The compressibility of the sample material
must be taken into account by assuming a value for its Poisson’s ratio. For example,
an incompressible, perfectly elastic material like rubber will have a Poisson’s ratio of
0.5, while a compressible material like a metal will have a Poisson’s ratio of around
0.3. It is also important to account for the elastic modulus and compressibility of the
tip material, which are given by the Young’s modulus and Poisson’s ratio,
respectively. Several mechanical models have been developed to model the
indentation of different-shaped tips into a flat sample surface. The simplest of these,
the Hertz and Sneddon models,209 describe the deformation of a surface by a spherical
and a conical tip, respectively. More complex models, such as the DMT and JKR
models,209 take into account the long-range interactions between the cantilever tip and
the sample. In the case of the Hertz model, the sample deformation can be related to
the elastic modulus by210 as shown in Equation 4.4:
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Equation 4.4

E=

C

;

B

√8K I
( FGH I

where F (N/m) is the loading force applied by the tip, E (GPa) and v (GPa) are the Young’s modulus
and Poisson’s ratio of the sample, respectively, R (nm) is the radius of curvature of the tip and δ (GPa)
is the sample deformation. If R and v are known, then E can be determined from the slope of a plot of
F vs. δ3/2.

4.1.3.2 Scanning Electron Microscopy (SEM)
Scanning electron microscopy provides high resolution micrographs of a surface.
These micrographs appear as 3-dimensional images and are therefore useful for
analysing the surface structure of particular samples. Electrons strike the surface of
the sample to generate different types of signals, categorised by elastic or inelastic
interactions,211 as shown in Figure 4.10. The elastic scattering results from the
deflection of indecent electrons by atomic nuclei or shell electrons with similar energy.
This, in turn, results in backscattering electrons (BSE) with negligible energy loss and
scattering angles larger than 90o. Inelastic scattering derives from interactions of the
incident electrons with the nuclei and core electrons of the material, and generates
signals with substantial energy loss. Auger electrons and x-ray emissions belong to
this group. The incident beam has a characteristic penetration volume in the sample
and each signal originates from a different part of the sample. The BSE have ample
energy (E > 50 eV) to emerge from underneath the sample surface. Images from BSE
are characterised by Z contract, with the brightness of the elements proportional to the
atomic number (Z) as the backscattering yield increases with increasing Z. the
resolution of these images is of the order of 1 µm because of the high energy of the
BSE. The secondary electrons have lower energy (E < 50 eV) and provide
topographical information of the sample surface. The low energy of secondary
electrons allows resolution of approximately 100 nm.212
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Figure 4.10

4.2

Schematic representation of the signals generated by the electron-beam
interaction in the SEM and the regions from which the signals can be detected213

Sample Preparation and Experimental Set Up

Cylindrical grade 5 titanium (Ti6Al4V) (obtained from www.ti-shop.com) wires were
used in this study. The Ti6Al4V wires were 1 mm in diameter and cut to a length of
40 mm. Prior to testing, the samples were ultrasonically cleaned in baths of acetone,
70% isopropanol and distilled water for 10 minutes each. Samples were then allowed
dry and stored under nitrogen until use.
The experimental setup for the electrochemical measurements consisted of a threeelectrode glass cell. The volume of the test cell was 100 mL. The Ti6Al4V wire alloy
specimens, a platinum wire and a saturated calomel electrode (SCE) were used as
working electrodes, a counter electrode, and a reference electrode, respectively.
The electropolymerisation was carried out with a 0.1 M tetrabutylammonium
perchlorate (TBAP) electrolyte solution made up in anhydrous acetonitrile and 50 mM
of coating compound. This solution was degassed prior to use and all coated samples
were dried and stored under nitrogen until further analysis. A constant potential of 1.2
V versus a SCE reference was applied with a scan rate of 0.2 v/s using a CH
Instruments, Inc., CHI420A electrochemical workstation in a three-electrode
configuration.
The corrosion properties of coated Ti6Al4V were studied though potentiodynamic
polarisation (Tafel analysis). The stimulated body fluid (SBF) medium consisted of
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NaCl, MgCl•6H2O, KCl, K2HPO4•3H2O, NaHCO3, CaCl2 and Na2SO4 (also known as
Hanks solution) in deionised water with pH 7.3 at 37 oC. The SBF was used as the
electrolyte. The SBF was selected as it mimics human blood plasma ionic
concentrations and was maintained at 37 oC to simulate a physiological environment.
Potentiodynamic polarisation analysis was carried out using an CH Instruments, Inc.,
CHI420A electrochemical workstation. The corrosion cell contained 50 mL of the
electrolyte united with a three-electrode setup. The SCE and platinum wire was
employed as reference and the counter electrode, respectively. The coated Ti6Al4V
wire was used as the working electrode with a soaked geometric area of 1 cm2. During
the corrosion rate measurements, a nitrogen atmosphere was maintained about the
solutions. All corrosion tests were conducted at 37±1 oC using freshly prepared
specimens and electrolyte. At least three replicates were used for every corrosion rate
measurement.
AFM measurements were performed on an Agilent 5500 atomic force microscope
using Pico View 1.12 software. Both contact and tapping mode cantilevers with Al
reflex coating, supplied by Nanosensors GmbH., were used. The manufacturer’s
nominal value for the spring constant of the contact-mode cantilevers was 0.2 N/m,
while that of the tapping-mode cantilevers was 42 N/m.
Cantilever deflection sensitivity was measured using an 8x8 measurement grid over a
5 µm x 5 µm area of a glass microscope slide, which was mounted beside the stent
sample on the sample stage so that it was possible to simply move the cantilever across
to the stent after the deflection sensitivity calibration without touching the optical
alignment of the laser and photo-sensitive detector.
Scanning Electron Microscopy (SEM) was performed on a Hiachi, 3200N and the data
processed with Inca Energy, Oxford Instruments Software.
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4.3

Characterisation of Coatings

4.3.1 Polymerisation and SEM results
The surface morphology of the all coated and uncoated stents were viewed using SEM.
Figure 4.12 shows SEM images of a bare stent. From image (a) the manufacturing
marks and striations are evident along with debris adhering to the surface. Image (b),
a higher magnification scan, surface pitting with bowl shaped pits are observed. In
addition, clearer manufacturing marks are visible as well as the surface roughness.

a
Figure 4.12

b
SEM view of uncoated Ti6Al4V stent at 200 µm (a) and 10 µm (b)

From the series of compounds synthesised, eight of these were selected with the aim
of coating onto the surface of the Ti6Al4V stent. These monomers were selected to
undergo electropolymerisation as they all possess pyrrole functional groups, which is
well known for its polymerisation properties. The aim of this process was to create an
even coating on the medical stent and improve the overall biocompatibility. Figure
4.13 shows the selected compounds.
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Electropolymerisation of compound (14) was found to be successful with the
formation of a polymer film on the Ti6Al4V stent. From Figure 4.14, the oxidation
potential of the monomer can be seen at -0.3 V. On the return scan, the reduction
potential of the monomer can be seen at -1.8 V. This process was cycled 15 times,
resulting in the polymer growth of compound (14).

Figure 4.14

Polymerisation by potential cyclic of compound (14). 0.5M compound (14) in
0.1M TBAP acetonitrile
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Following the coating of compound (14), SEM analysis was carried out. Figure 4.15
displayed good coverage of the stent surface by compound (14). No bare regions of
the surface were evident, indicating a continuous film layer. Similar to the analysis of
compound (2), surface indentations are evident once again. Markings did appear on
the surface which are either accidental or were produced during the polymerisation
process. Little to no particulates were present during the SEM imaging process,
indicating no clustering of the coating occurred during the electropolymerisation
stage.

a
Figure 4.15

b
SEM view of compound (14) showing partial covering at 200 µm (a), at 100 µm
(b)

Electropolymerisation of compound (2) was successful and a polymer film can be
achieved. In Figure 4.16, the oxidation potential of the monomer is located at -0.5
V. On the return scan, the resulting polymer is reduced at -1.2 V. This process was
cycled 15 times, resulting in polymer growth of compound (2).
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Figure 4.16

Polymerisation by potential cyclic of compound (2). 0.5M compound (2) in 0.1M
TBAP acetonitrile

Following successful polymerisation of compound (2), the coated stent was viewed
under SEM, as shown in Figure 4.17. Image (a) shows continuous film growth, that
was absent when imaging compounds (6), (11) and (13). There appears to be little
evidence of the pitting morphology that is associated with the bare stent. Image (b)
presents cavities within the coating. It is unclear if these markings were created during
the polymerisation process or made during the removal of the stent from the
electrochemical cell. Particulates are present on the surface of the coated stent, and it
is unclear if these are associated with the polymerisation or made during the removal
process.

a
Figure 4.17

b
SEM view of compound (2) showing partial covering at 200 µm (a), at 20 µm (b)

Compounds (8), (12) and (15) provided thin, partially broken coatings. Figure 4.18
contains SEM views obtained. From image (a) it is evident that coating can be seen
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on the surface on the stent, although manufacturing striation marks are still visible.
Images (b) and (c) provides surface morphology where the breaks within the coating
can be seen at a higher magnification. Surface pitting can be seen on the bare surface
and on the covered area. The presence of pitting was evident on the coated area
indicates a very thin coating. Despite an even coating being physically obtained, it is
clear that clustering of coated compound has taken place, as shown in image (b).

A

b

c
Figure 4.18

SEM view of compound (15) showing partial covering at 500 µm (a), at 20 µm
(b) and at 10 µm (c)

Electropolymerisation of some compounds were not successful. For compounds (7),
(9) and (10) no polymerisation takes place in a solution of the chosen electrolyte, and
little to no polymer deposition was observed at the stent surface. The cyclic
voltammograms obtained for these conditions, shown in Figure 4.19, are very
different from those observed for a classical pyrrole monomer, as no oxidation takes
place on the forward scan, however a reduction current peak at 1.7 V was evident.
Subsequently for increasing scans, similar behaviour was observed, but the reduction
current decreased with increasing scan number. The absence of polymer deposition at
the electrode surface suggests that the nucleophilic amino group prevents radical
cation formation which would allow the polymerisation to progress. The same
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behaviour has been previously observed from other pyrrole monomers where an amino
group has been attached to the pyrrole functional group.183,214

Figure 4.19

Polymerisation by potential cyclic of compound (10). 0.5M compound (10) in
0.1M TBAP acetonitrile

This lack of polymer deposition is also evident from the SEM images obtained, as
shown from Figure 4.20. It can be seen that small cluster like deposition was present,
however the surface morphology was more similar to that of the bare Ti6Al4V stent.

a
Figure 4.20

b
SEM view from compound (10) showing clustering effect at 20 µm (a) and 10
µm (b)
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4.3.2 AFM Results
The manufacturer’s nominal value for the spring constant of the contact-mode
cantilevers was 0.2 N/m, while that of the tapping-mode cantilevers was 42 N/m.
According to a data published by Bruker instruments215, these cantilevers should be
suitable for force-curve measurements of materials with elastic moduli in the 0-15 MPa
and 0.2-8 GPa ranges, respectively. Imaging was carried out in an area of 60 µm x 60
µm, which was further divided into a 3 x 3 field of 20 µm x 20 µm squares. Forcecurve measurements were performed on each 20 µm x 20 µm square, using a 32 x 32
measurement grid, giving in total 1024 approach/retract curves were obtained on each
square. Up to 1000 data points were acquired for each curve. Force-curve
measurements were performed sequentially across each of the nine 20 µm x 20 µm
squares, with the maximum load force successively increased or reduced with each
new square. In this way, a fresh area of the sample surface, not deformed or stressed
by previous spectroscopic measurements, was examined. Moreover, by varying the
maximum load force, it was expected that different indentation depths would be
obtained. It has been shown that the elastic modulus values measured by AFM can be
dependent on the indentation depth216. AFM topographic data were processed and
analysed using the Gwyddion package217. Typically, only global plane fitting was
applied, although sometimes line-by-line flattening was also used. Force-curve
measurements were processed using AtomicJ218, applying either the Hertz or Sneddon
models, taking a value of v = 0.3 for the Poisson’s ratio of the sample and assuming a
tip radius of 10 nm and a half-angle of 25°.
The bare stent surface was characterised by longitudinal striations that were
observed in large-area scans and surface pitting with bowl-shaped pits, which were
observed at higher magnifications. There were also some particulates present on the
bare stent surface. The surface roughness values calculated for Figure 4.21 (c) are
average roughness, Sa = 160.6 nm and rms roughness, Sq = 199.6 nm.
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Figure 4.21

The bare stent surface imaged with tapping-mode AFM. (a) 80 µm x 80 µm, (b)
50 µm x 50 µm, (c) 30 µm x 30 µm

Figure 4.22 shows the surface of the sample coated with a thick pyrrole film, which
was the thickest film investigated. A granular film is clearly evident, with surface
roughness parameters measured in Figure 4.22 (a) being are Sa = 420.7 nm and Sq =
534.0 nm.

Figure 4.22

Tapping-mode AFM images of the surface of a stent coated by thick pyrrole film.
(a) 40 µm x 40 µm tapping-mode image. (b) 20 µm x 20 µm contact-mode image

Film thickness was investigated at two sites, firstly where the stent was immersed in
the electrolyte solution, and secondly across an area where the film flaked off the stent
due onto the adhesive pads used during the mounting of the sample. The images are
shown in Figure 4.23 along with their corresponding line-profiles. The thickness of
the film is in the range of 2-3 µm. In the region corresponding to the air-electrolyte
interface, it can be seen that the film terminates by gradually becoming thinner over a
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distance of around 10 µm, while in the case where the film flaked off from the stent
surface there is an abrupt step.

Figure 4.23

AFM images of the boundary between the thick pyrrole film and the bare stent
surface. (a) 40 µm x 40 µm contact-mode image of the natural boundary produced
at the air-electrolyte interface. (b) 60 µm x 60 µm tapping-mode image of the
abrupt boundary where part of the film has flaked off the stent. (c) and (d) show
the line profiles measured along the lines shown in the AFM images. Note that
while the images shown were globally plane-fitted, the line profiles were
obtained on images where a local three-point plane-fit was applied

Figure 4.24 shows the topography of coating of compound (10). Some particulates
are visible on parts of the stent surface and roughness values measured, as seen in
Figure 4.24 (b) are Sa = 308.9 nm and Sq = 379.1 nm, suggesting that there is some
material present on the stent surface. It should be noted that the roughness parameters
reported here and in later cases are not a particularly reliable measure due to the
roughness and curvature of the underlying stent surface. The pitting of the bare stent
surface is readily visible, indicating that the film is discontinuous and does not
completely cover the stent surface.
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Figure 4.24

Contact-mode AFM images of Sample (10) (taken with a k = 42 N/m tappingmode cantilever). (a) 80 µm x 80 µm, (b) 60 µm x 60 µm, (c) 20 µm x 20 µm

Figure 4.25 shows contact-mode AFM images of the coating of compound (8). There
is evidence of large granular particles in large-area scans and regions of the stent
surface are covered by what appears to be a continuous film. However, the film is not
continuous across the entire surface of the stent, large areas of the surface appear to
have negligible coverage with the pitting typical of the bare stent surface clearly
evident. The roughness values measured in Figure 4.25 (b) are Sa = 152.0 nm and Sq
= 189.3 nm.

Figure 4.25

Contact-mode AFM images of compound (8) (taken with a k = 42 N/m tappingmode cantilever). (a) 80 µm x 80 µm, (b) 60 µm x 60 µm, (c) 40 µm x 40 µm, (d)
20 µm x 20 µm
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Figure 4.26 shows the topographic images of coated stent containing compound (9).
The coverage of this film is better than that of compound (8). There is still some
evidence of pitting of the bare surface visible in some regions. The roughness values
measured in Figure 4.26 (a) are Sa = 148.8 nm and Sq = 192.6 nm after application of
a global plane fit and flattening to the image to remove surface waviness due to the
longitudinal striations present on the stent surface, while the roughness values
measured in Figure 4.26 (b) are Sa = 139.4 nm and Sq = 165.6 nm.

Figure 4.26

Contact-mode AFM images of Sample (9) (taken with a k = 42 N/m tappingmode cantilever). (a) 80 µm x 80 µm, (b) 20 µm x 20 µm, (c) 20 µm x 20 µm, (d)
20 µm x 20 µm. Note that the smaller-area scans were recorded with a smaller
resolution of 256 x 256 points compared to the large-area scan, which has 512 x
512 resolution

Figure 4.27 shows the topographic images of compound (2) on Ti6Al4V. The
coverage of this film appears to be more or less continuous across the surface. There
is little evidence of the pitting, which is associated with the bare surface. However,
pits are present on the thinner coated areas, indicating an even coating has not been
achieved. There are also some particulates present on top of the film in some regions.
The roughness values measured in Figure 4.27 (a) are Sa = 196.1 nm and Sq = 258.7
nm after application of a global plane fit and flattening to the image, while the
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roughness values measured in Figure 4.27 (b) after the same treatment are Sa = 209.0
nm and Sq = 262.3 nm. It can be seen in the smaller-area scans that there appear to be
scratches running across the film. These can be seen running from top to bottom in
Figure 4.27 (b) and (c) for example. From closer examination of Figure 4.27 (d) it
appears that these topographical features are actually the result of film growth, which
indicates some anisotropic growth or crystallinity, rather than being physical damage
caused by film post-deposition.

Figure 4.27

Contact-mode AFM images of Sample (2) (taken with a k = 42 N/m tappingmode cantilever). (a) 80 µm x 80 µm, (b) 60 µm x 60 µm, (c) 20 µm x 20 µm, (d)
20 µm x 20 µm

Figure 4.28 shows the topographic images of compound (15). There appears to be a
thin granular film present on the surface that partially obscures the pitting typical of
the bare stent surface. The roughness values measured in Figure 4.28 (a) are Sa = 94.8
nm and Sq = 127.5 nm after application of a global plane fit and flattening to the image,
while the roughness values measured in Figure 4.28 (b) after global-plane fitting are
Sa = 64.0 nm and Sq = 79.6 nm.
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Figure 4.28

Contact-mode AFM images of Sample (15) (taken with a k = 0.2 N/m contactmode cantilever). (a) 60 µm x 60 µm, (b) 20 µm x 20 µm

Figure 4.29 shows the topographic images of compound (10). In this case, a
continuous film is not formed. Instead, the deposit aggregates into large particulates
that are typically 1-2 µm in size. The roughness values measured in Figure 4.29 (a)
are Sa = 398.1 nm and Sq = 502.1 nm after application of a global plane fit to the image
(flattening the image reduces these values by around 14-18 %), while the roughness
values measured in Figure 4.29 (b) after global-plane fitting are Sa = 237.6 nm and Sq
= 282.8 nm.

Figure 4.29

Contact-mode AFM images of Sample (10) (taken with a k = 0.2 N/m contactmode cantilever). (a) 60 µm x 60 µm, (b) 20 µm x 20 µm. (c) Line profile
measured along the line indicated in (b)

The topographic AFM images of compound (14), as shown in Figure 4.30, suggest a
good coverage of the stent surface by a granular film. No bare regions of the surface
can be observed, indicating that a continuous layer is formed across the surface. The
roughness values measured in Figure 4.30 (a) are Sa = 79.3 nm and Sq = 102.5 nm
after application of a global plane fit and flattening to the image, while the roughness
values measured in Figure 4.30 (b) using the same treatment are Sa = 68.3 nm and Sq
= 84.5 nm.
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Figure 4.30

Contact-mode AFM images of Sample (14) (taken with a k = 0.2 N/m contactmode cantilever). (a) 60 µm x 60 µm, (b) 20 µm x 20 µm

Figure 4.31 shows the topographic AFM images of compound (13). Again, there
appears to be complete coverage of the stent surface by a granular film with no bare
regions visible. The roughness values measured in Figure 4.31 (a) are Sa = 91.5 nm
and Sq = 118.4 nm after application of a global plane fit and flattening to the image,
while the roughness values measured in Figure 4.31 (c) using the same treatment are
Sa = 94.9 nm and Sq = 126.9 nm.

Figure 4.31

Contact-mode AFM images of Sample (13) (taken with a k = 0.2 N/m contactmode cantilever). (a) 60 µm x 60 µm (512 x 512), (b) 60 µm x 60 µm (512 x 512),
(c) 20 µm x 20 µm (256 x 256)

Force-curve measurements were performed on all the coated stent samples in the
manner described above in Section 4.2. Figure 4.32 shows a selection of results
obtained for such a measurement on compound (2), to measure the Young’s modulus
(or Elastic Modulus). The aim of finding the Young’s Modulus is to understand the
ability of the coating to withstand changes in tension or compression Figure 4.32 (a)
shows the approach and retract curves, the red point indicates the point of contact
between the tip and sample, while the blue dot indicates the point at which the switch
from approach to retract occurs. This corresponds to the point at which the maximum
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load force is applied, resulting in the maximum indentation of the sample. The red line
indicates the fit of the mechanical model to the slope of the approach curve between
the red and blue dots. Figure 4.32 (b) shows the corresponding force vs. indentation
curve, which is calculated from the contact point (red dot) to the transition point (blue
dot) since this is the region where the tip indents into the sample. It is from this curve
that the Young’s modulus may be determined. The Young’s modulus is mapped across
the 32 x 32 grid points in Figure 4.32 (c). A correlation between variations in the
Young’s modulus values with the surface topography was not observed. Figure 4.32
(d) shows a histogram of the values shown in (c). For every sample measured, the
Young’s modulus values show a right-skewed distribution with a large tail to the right.
Therefore, only the median value for the Young’s modulus, along with the first and
third quartile values are reported in Table 4.2. This table also shows the mean
maximum force applied to the stent, as well as the mean indentation depth causing
force displacement of the coating and stent.

Figure 4.32

(a) Force-curve measurement obtained on compound (2). (b) Corresponding
force vs. indentation curve. (c) Map of the Young’s modulus values measured
across compound (2) in a 32 x 32 grid over a 20 µm x 20 µm area of the sample.
(d) Histogram showing the right-skewed distribution of the Young’s modulus
values shown in (c)
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Table 4.2

Summary of the elastic modulus values measured using AFM force-curve
measurements on all samples.

Sample number

Mean Max.
Load
Force (nN)

Mean Indentation depth
(nm)

11

7,424
8,612
8,957
7,690
6,373

57
64
92
44
20

8

14,722
9,886
6,377
3,334
4,125

61
37
14
5
8

9

12,158
10,148
8,125
7,096
5,994
4,909
3,875

176
121
104
86
69
51
37

2

13,185
7,904
2,742
6,191
4,818
3,421

66
15
4
11
7
8

15

40
44
12

27
13
2

10

30
32
54
35
32
44
40
20
28

32
23
43
21
11
24
20
3
12

14

30
42
53
70
83
95
97

26
32
30
69
80
107
36

13

64
87
110
97
132
158
27

75
89
136
62
101
95
17

Young’s Modulus
Median value

First Quartile

Third Quartile

(GPa)
4.3
4.1
3.4
7.6
15.9
(GPa)
15.1
16.8
17.2
11.1
11.9
(GPa)
3.8
4.0
3.6
4.0
3.8
4.7
5.5
(GPa)
12.3
22.0
9.2
21.5
13.5
7.4
(MPa)
66.4
28.9
64.0
(MPa)
70.3
71.9
66.3
83.5
78.3
71.0
64.9
50.3
41.7
(MPa)
56.4
62.9
91.1
50.3
52.8
50.3
142.8
(MPa)
45.9
55.1
42.8
88.2
67.0
81.5
61.6

(GPa)
2.7
2.4
2.3
4.3
8.7
(GPa)
9.3
8.6
9.9
6.1
7.8
(GPa)
3.2
3.6
3.0
2.7
3.0
3.2
3.6
(GPa)
9.1
12.7
5.9
13.8
9.0
5.2
(MPa)
42.9
16.1
34.3
(MPa)
28.6
38.9
36.6
38.0
33.9
36.5
33.3
21.2
20.6
(MPa)
34.7
44.5
60.8
37.9
40.3
37.9
92.0
(MPa)
25.8
34.2
32.5
45.5
42.9
57.5
26.9

(GPa)
7.2
7.3
5.6
12.5
39.0
(GPa)
27.1
31.4
30.6
20.5
20.0
(GPa)
4.4
4.8
4.5
5.4
5.2
6.5
7.8
(GPa)
15.9
36.7
18.9
39.9
27.2
12.1
(MPa)
121.5
56.5
264.7
(MPa)
142.3
148.0
122.4
178.5
175.5
165.0
152.1
136.0
37.8
(MPa)
107.8
103.9
138.5
71.9
73.4
71.9
252.1
(MPa)
108.3
102.2
57.2
168.4
138.1
142.5
200.7

Samples (11), (8), (7) and (2) were measured with a stiff cantilever (k = 42 N/m), while Samples
(15), (10), (14) and (13) were measured with a soft cantilever (k = 0.2 N/m). Each value is an
average of 256 force curves measured on a 3 x 3 field of 20 µm x 20 µm sample squares. The
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maximum load force was reduced for each successive measurement in the 3 x 3 field. In some
cases, there was not sufficient time to measure the full 3 x 3 field

Force-curve measurements were performed on Samples (11), (8), (9) and (2) using a
k = 42 N/m tapping-mode cantilever, while Samples (15), (10), (14) and (13) were
measured with a k = 0.2 N/m contact-mode cantilever to determine the Young’s
modulus of the sample. It was found that the value obtained was strongly dependent
upon the stiffness of the cantilever used, as described elsewhere,219 with average
values in 10-80 MPa range measured using the softer cantilever, and values in the 420 GPa range measured using the stiffer cantilever. It is also worth noting that the
average thickness of the films in all are less than 1 µm, and therefore, the substrate
may dominate sample response to indentation by the tip in the force-curve
measurements.216 Some variation in the measured Young’s modulus value as a
function of indentation depth and maximum load force were observed, but this needs
further investigation to clarify the trends.
Fruos et al. reports Young Modules results of 47 – 89 GPa for coatings on titanium
stents with a coating thickness of 50 µm.220 Similarly, Zhou et al. reports a Youngs
modules figure of 89 GPa for coatings and a film thickness of 150 µm.221 Literature
results regarding coating thickness seems to vary and no results have been sourced
stating thickness of 1 µm.
From the coatings subjected to the coating technique it has been found that compounds
(8), (10) and (11) did not undergo polymerisation. Compounds (9), (13) and (15)
displayed a redox potential and thin, partially broken coatings were obtained.
Compounds (14) and (2) provided an even layer of coating with striation marks present
in both instances. It is unknown whether theses striations were made during the
polymerisation technique of were accidental marks when handling the coated stents.
If more time permitted, designing a new electrochemical cell would have been
explored where the entire stent could be submerged in the electrolyte and monomer
solution. This could remove the formation of these accidental striation marks and
clarify if they are generated during the polymerisation stage. The AFM results are
consistent with those of the electropolymerisation and SEM. Compounds (8), (10) and
(11) appeared to have clusters on the surface as well as pitting of the bare stent being
evident. Compounds (9), (13) and (15) displayed a thin, partially broken coating with
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evident of clustering. Compounds (14) and (2) provided the best results with an overall
evenly coated surface area. The surface roughness measurements generated show the
more coating deposited on the stent the stent the lower the roughness. This would
indicate that the striations and pitting characteristics associated with the bare stent are
covered by a smooth, evenly distributed coating.
Levels of surface roughness varies among research groups. Ordikhani and coworkers
report an increases roughness of implants coated with a chitosan-vancomycin
coating,222 while studies from the same authors report lower roughness values from
oxide/chitosan film coatings.223 Interestingly, Ordikhani et al. used electro-deposition
and obtained varying roughness values, while GhavamiNejad et al. used
electropolymerisation as their coating method and found a much smoother surface
area. They report that electropolymerisation leads to a more homogeneous deposited
coating, compared to a electro-deposition method.224 There finding are consistent with
the results generated within this research.

4.3.4 Corrosion studies – Tafel Polarisation Results
All samples that underwent the coating process were exposed to a potentiodynamic
polarisation technique that was used to determine the corrosion rate for both uncoated
and coated Ti6Al4V stents. Upon immersion of the electrodes into the corrosive
electrolyte, the working electrode was immediately polarised from -100 mV vs. SCE
for 5 minutes. After this polarisation step, the electrode was left at an open circuit
potential for 10 minutes in order to stabilise the corrosion potential, (Ecorr).
Potentiodynamic polarisation tests were carried out by sweeping the potential at a scan
rate of 10 mV/s from -200 mV to 100 mV (vs. SCE). Potentiodynamic scan data of all
uncoated and coated samples were collected to determine the electrochemical
parameters, as shown in Table 4.3: corrosion potential (Ecorr), corrosion current (icorr),
cathodic slope (ßc), anodic slope (ßb) and linear polarization resistance (Rp). The
anodic Tafel slope and cathodic Tafel slope were determined for different samples by
scanning the potential at 10 mV/s from Ecorr to = 200 mV and from Ecorr to -200 mV
(vs. SCE), respectively.
Figure 4.33 shows an example of Tafel polarisation curves of uncoated and coated
Ti6Al4V. The equilibrium Ecorr of the bare stent is -1.254 V, the icorr is 3.298 µA/cm2
and the linear polarisation is 12436 Ω. Polarisation parameters, Ecorr and icorr values
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were derived from the obtained polarisation curves. From the polarisation curves it
can be noted that the current densities of coated samples at the cathodic and anodic
regions are reduced compared to that of the uncoated Ti6Al4V. These results indicate
a reduction in cathodic and anodic reaction rates of coated samples compared to that
of the uncoated.

Figure 4.33

Tafel polarization curves of uncoated Ti6Al4V (Red), Pyrrole (Blue), Compound
(13) (Green), Compound (14) (Green) and Compound (2) (Green), in Hank’s
Solution

The electrochemical parameters were obtained by fitting the polarisation curves. As
seen from the results, the uncoated sample exhibits an icorr of 3.997 µA/cm2 with an
Ecorr of -0.998 V. All the coated samples exhibit a significant reduction in icorr and also
shift in Ecorr towards the positive potential confirming the improvement in corrosion
resistance of the coatings. Coatings (14) and (2) exhibit the biggest reductions in icorr
values with a positive shift in Ecorr of 0.328 V for coating (14) and 0.25 V for (2)
indicating the improved corrosion resistance. Similarly, samples (14) and (2)
displayed the highest linear polarisation resistance with an improvement of 51123 Ω
for (14) and 45509 Ω (2). These two samples also showed the best corrosion rate with
0.227 µm/year and 0.246 µm/year for samples (14) and (2), respectively. The results
generated confirm the theory of coatings acting as a barrier and effectively resist the
aggressive corrosion from the electrolyte solution.
Similar results have been reported by Raluca et al., obtaining an icorr value of 0.492
µA/cm2 and an Ecorr value of -0.492 V for a bare Ti6Al4V stent.225 The same research
group also reports a twofold decrease in corrosion from a biomedical alloy coating.
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Table 4.3

Results obtained from Tafel Analysis

Sample
Uncoated Ti6Al4V
Pyrrole
3-pyrrol-1-yl-propylamine
(8)
4-(Pyrrol-1-yl) Butyric acid
(9)
tris(2-(1H-pyrrol-1yl)ethyl) amine (10)
1-(2-aminoethyl) pyrrole
(11)
2-(n''-propyl-3-amino
pyrrol-1-yl-ehtyl-(1tetrazol-5-yl) pyridine (13)
2-(2,2-diethoxyethane3amino-pyrrol-1-yl ethyl(1-tetrazol-5-yl) pyridine
(14)
2-(n-ethylphenylpyrrole(2H-tetrazol-5-yl) pyridine
(2)
5-(2-Pyrrol-1-yl-ethyl)-1Htetrazole (15)

Ecorr
(V)
-1.254
-0.418

icorr
(µA/cm2)
3.298
2.485

Cat Slp
(1/V)
2.531
4.85

Ano Slp
(1/V)
42.531
5.382

Lin Pol R
(ohm)
12436
17102

Rate
(µm/year)
1.208
9.100

-0.891

1.492

6.335

3.99

28223

5.464

-0.755

1.379

5.711

2.714

37418

5.051

-0.947

2.776

5.892

3.686

16352

1.017

-0.895

1.187

6.485

3.252

37645

4.348

-0.922

1.576

5.895

4.258

27167

5.773

-1.004

0.6213

7.192

3.819

63559

0.227

-0.926

0.6720

7.637

3.529

57945

0.246

-0.717

1.483

6.089

2.631

33620

5.431
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4.4

Conclusion

From this exploratory research, pyridyl-tetrazole compounds were successfully
synthesised and coated onto Ti6Al4V medical stents. An improvement was observed
in anti-corrosion profiles of the bare and coated stents. The results generated within
this research are comparable to coatings that are currently being used on the medical
implant market. The best coatings were found to be compounds (2) and (14). These
coatings gave the best overall coating on the stent surface via polymerisation, SEM
and AFM. The thickness of coatings ranged between 2-3 µm. Additionally, coatings
(2) and (14) gave a 5-fold reduction in corrosion when compared to the uncoated
Ti6Al4V stent. These corrosion values are similar to some coatings currently used on
the market and better than others.225
If more time permitted a time scale profile could be conducted by immersing stents in
the balanced salts solution over a set periods of time and measuring the degree of
corrosion versus time. Additionally, biological studies could be conducted on the best
coatings, investigate their biocompatibility to see if they would be compatible as
medical implant coatings.
A limitation encountered, was the thinness of the coatings synthesised and coated onto
the medical stent, resulting in them being difficult to analyse. Raman Spectroscopy
and DSC was carried out on a selection of coatings. It was found that the coatings
were too thin and burned when exposed to these techniques. The incorporation of
crosslinking polymers could improve the thickness of the coatings. These thicker
coatings could also improve the adhesion properties of the coatings, making them
more robust. In turn these coatings could be applied to more a wider range analytical
testing, e.g. FT-IR, Raman Spectroscopy, and confocal laser scanning microscopy.
Additionally, these more robust coatings could be subjected to mechanical property
testing such as scratch resistance, conductivity, thermal stability and how they may
affect cure profiles.
Further force-curve measurements are required to obtain reliable values for the
Young’s modulus (E) of the sample. It would be useful to use stiffer cantilevers (k ≥
100 N/m) to see if higher values of E are obtained. The values obtained depend on the
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sensitively on the fit of the mechanical model to the data, and also rely on a good
knowledge of the tip geometry (radius of curvature and half-angle) and spring
constant. The latter could be determined by performing force-curve measurements on
calibrated cantilevers of known spring constant. The former may be determined using
scanning electron microscopy measurements, or by AFM imaging of tip calibration
standards. Finally, further work in this area would benefit greatly from measurements
of control samples (e.g. polystyrene films) of well-defined thickness in order to better
understand the force-curve measurements on the questioned samples. Having thick,
continuous films on the stent surface would probably also make it easier to measure
mechanical properties of the deposited polymer materials using AFM.
Improvements could be made to the galvanic cell used for the electropolymerisation.
As the stent was only partially immersed in electrolyte solution a teardrop effect could
be seen during the analysis. This resulted in a larger amount of coating being at the
bottom of the stent and gradually thinning as it neared the electrolyte surface. Being
able to immerse the entire stent within the electrolyte solution may provide a more
evenly distributed coating.
Another interesting area to explore would the quantitative determination of leeching
metals from medical implants. This was considered during this project, but it was
found that due to time and financial constraints other areas of the project would be
more applicable to explore. Other research groups have explored this area using ICPMS, in the parts per trillion range.226,227
An interesting area to further develop would be in use of macrocyclic type compounds
that could be incorporated into the polymer matrix. The hydrophobic/hydrophilic
nature of these compounds could act as effective barrier to the metal decomposition.
Additionally, exploring the complexation capabilities of these compounds in relation
to the degradation metals could lead to the development of other uses for the
compounds, for example in water treatment facilities. These heavy metals are present
throughout the environment and the ability to remove them is greatly desired.

136

137

Chapter 5 – References
(1)

(2)
(3)

(4)

(5)

(6)

(7)

(8)
(9)
(10)
(11)
(12)
(13)
(14)

Evans, J. T.; Blom, A. W.; Timperley, A. J.; Dieppe, P.; Wilson, M. J.;
Sayers, A.; Whitehouse, M. R. Factors Associated with Implant Survival
Following Total Hip Replacement Surgery: A Registry Study of Data from
the National Joint Registry of England, Wales, Northern Ireland and the Isle
of Man. PLOS Med. 2020, 17 (8), e1003291.
https://doi.org/10.1371/JOURNAL.PMED.1003291.
Correa, D. Medical Implant Market 2021 Overview, Top Companies Analysis
Report, Registering Over 7.2% Growth – AMR Study | BioSpace; Portland,
2021.
Grand View Research, Orthopedic Implants Market Analysis, by Application
(Spinal Fusion, Long Bone, Foot & Ankle, Craniomaxillofacial, Joint
Replacement, Dental), And Segment Forecasts to 2024,
https://www.grandviewresearch.com/industry-analysis/orthopedic-implantsmarket/toc
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.;
International Agency for Research on Cancer. Overall Evaluations of
Carcinogenicity : An Updating of IARC Monographs, Volumes 1 to 42.;
International Agency for Research on Cancer, 1987.
Ladon, D.; Doherty, A.; Newson, R.; Turner, J.; Bhamra, M.; Case, C. P.
Changes in Metal Levels and Chromosome Aberrations in the Peripheral
Blood of Patients after Metal-on-Metal Hip Arthroplasty. In Journal of
Arthroplasty; 2004; Vol. 19, pp 78–83.
https://doi.org/10.1016/j.arth.2004.09.010.
Sansone, V.; Pagani, D.; Melato, M. The Effects on Bone Cells of Metal Ions
Released from Orthopaedic Implants. A Review. Clinical Cases in Mineral
and Bone Metabolism. January 2013, pp 34–40.
https://doi.org/10.11138/ccmbm/2013.10.1.034.
de Leon, A.; Advincula, R. C. Conducting Polymers with Superhydrophobic
Effects as Anticorrosion Coating. In Intelligent Coatings for Corrosion
Control; Elsevier Inc., 2015; pp 409–430. https://doi.org/10.1016/B978-0-12411467-8.00011-8.
Adya, N.; Alam, M.; Ravindranath, T.; Mubeen, A.; Saluja, B. Corrosion in
Titanium Dental Implants: Literature Review. J. Indian Prosthodont. Soc.
2005, 5 (3), 126. https://doi.org/10.4103/0972-4052.17104.
Concerns about Metal-on-Metal Hip Implants | FDA
https://www.fda.gov/medical-devices/metal-metal-hip-implants/concernsabout-metal-metal-hip-implants
Newman, G. Design and Evaluation of New Antimicrobial Biomaterials,
Institute of Technology Tallaght, 2018.
Gilchrist, T. L. (Thomas L. Heterocyclic Chemistry / T.L. Gilchrist; Longman
Scientific & Technical ; Wiley, 1992.
Bruice, P. Y. Organic Chemistry, 5th ed.; Pearson Prentice Hall, 2007.
De Luca, L. Naturally Occurring and Synthetic Imidazoles: Their Chemistry
and Their Biological Activities. Curr. Med. Chem. 2006, 13 (1), 1–23.
https://doi.org/10.2174/092986706775197980.
Kumar, M.; Kumar, D.; Raj, V. Studies on Imidazole and Its Derivatives with
Particular Emphasis on Their Chemical/Biological Applications as Bioactive
138

(15)
(16)
(17)
(18)
(19)

(20)

(21)

(22)

(23)

(24)

(25)
(26)
(27)

Molecules/Intermediated to Bioactive Molecule. Curr Synth. Sys Biol 2017, 5,
1. https://doi.org/10.4172/2332-0737.1000135.
Bordwell, F. G. Equilibrium Acidities in Dimethyl Sulfoxide Solution. Acc.
Chem. Res. 1988, 21 (12), 456–463. https://doi.org/10.1021/ar00156a004.
Gonnet, L.; Baron, M.; Baltas, M. Synthesis of Biologically Relevant 1,2,3and 1,3,4-Triazoles: From Classical Pathway to Green Chemistry. Molecules
2021, 26 (18). https://doi.org/10.3390/MOLECULES26185667.
Bladin, J. A. Ueber von Dicyanphenylhydrazin Abgeleitete Verbindungen.
Berichte der Dtsch. Chem. Gesellschaft 1885, 18 (1), 1544–1551.
https://doi.org/10.1002/cber.188501801335.
Benson, F. R. The Chemistry of the Tetrazoles. Chem. Rev. 1947, 41 (1), 1–
61. https://doi.org/10.1021/cr60128a001.
Fischer, N.; Karaghiosoff, K.; Klapötke, T. M.; Stierstorfer, J. New Energetic
Materials Featuring Tetrazoles and Nitramines - Synthesis, Characterization
and Properties. Zeitschrift fur Anorg. und Allg. Chemie 2010, 636 (5), 735–
749. https://doi.org/10.1002/zaac.200900521.
Szimhardt, N.; Wurzenberger, M. H. H.; Beringer, A.; Daumann, L. J.;
Stierstorfer, J. Coordination Chemistry with 1-Methyl-5: H -Tetrazole:
Cocrystallization, Laser-Ignition, Lead-Free Primary Explosives-One Ligand,
Three Goals. J. Mater. Chem. A 2017, 5 (45), 23753–23765.
https://doi.org/10.1039/c7ta07780g.
Sabatini, J. J.; Raab, J. M.; Hann, R. K.; Damavarapu, R.; Klapötke, T. M.
High-Nitrogen-Based Pyrotechnics: Development of Perchlorate-Free GreenLight Illuminants for Military and Civilian Applications. Chem. - An Asian J.
2012, 7 (7), 1657–1663. https://doi.org/10.1002/asia.201200036.
Yeung, K. S.; Qiu, Z.; Yang, Z.; Zadjura, L.; D’Arienzo, C. J.; Browning, M.
R.; Hansel, S.; Huang, X. S.; Eggers, B. J.; Riccardi, K.; et al. Inhibitors of
HIV-1 Attachment. Part 9: An Assessment of Oral Prodrug Approaches to
Improve the Plasma Exposure of a Tetrazole-Containing Derivative.
Bioorganic Med. Chem. Lett. 2013, 23 (1), 209–212.
https://doi.org/10.1016/j.bmcl.2012.10.125.
Morjan, R. Y.; Al-Attar, N. H.; Abu-Teim, O. S.; Ulrich, M.; Awadallah, A.
M.; Mkadmh, A. M.; Elmanama, A. A.; Raftery, J.; Abu-Awwad, F. M.;
Yaseen, Z. J.; et al. Synthesis, Antibacterial and QSAR Evaluation of 5-Oxo
and 5-Thio Derivatives of 1,4-Disubstituted Tetrazoles. Bioorganic Med.
Chem. Lett. 2015, 25 (18), 4024–4028.
https://doi.org/10.1016/j.bmcl.2015.04.070.
Łukowska-Chojnacka, E.; Mierzejewska, J.; Milner-Krawczyk, M.; Bondaryk,
M.; Staniszewska, M. Synthesis of Novel Tetrazole Derivatives and
Evaluation of Their Antifungal Activity. Bioorganic Med. Chem. 2016, 24
(22), 6058–6065. https://doi.org/10.1016/j.bmc.2016.09.066.
Huisgen, R. 1,5,-Electrocyclizations—An Important Principle of Heterocyclic
Chemistry. Angew. Chemie Int. Ed. English 1980, 19 (12), 947–973.
https://doi.org/10.1002/anie.198009473.
Mansoori, Y.; Sarvari, R. New Polynuclear Nonfused Bis(1,3,4-Oxadiazole)
Systems. J. Mex. Chem. Soc. 2014, 58 (2), 205–210.
Malik, M. A.; Wani, M. Y.; Al-Thabaiti, S. A.; Shiekh, R. A. Tetrazoles as
Carboxylic Acid Isosteres: Chemistry and Biology. Journal of Inclusion
Phenomena and Macrocyclic Chemistry. Springer April 24, 2014, pp 15–37.
https://doi.org/10.1007/s10847-013-0334-x.
139

(28) Allen, F. H.; Groom, C. R.; Liebeschuetz, J. W.; Bardwell, D. A.; Olsson, T.
S. G.; Wood, P. A. The Hydrogen Bond Environments of 1 H -Tetrazole and
Tetrazolate Rings: The Structural Basis for Tetrazole-Carboxylic Acid
Bioisosterism. J. Chem. Inf. Model. 2012, 52 (3), 857–866.
https://doi.org/10.1021/ci200521k.
(29) Eicher, T.; Hauptmann, S.; Speicher, A. The Chemistry of Heterocycles:
Structures, Reactions, Synthesis, and Applications; 2013; Vol. 75.
(30) Bladin, J. A. Ueber Das Triazol. Berichte der Dtsch. Chem. Gesellschaft
1892, 18 (25), 1412. https://doi.org/10.1002/cber.189202501119.
(31) Thiele, J. Ueber Azodicarbonsäure (Diimiddicarbonsäure). Justus Liebig’s
Ann. der Chemie 1892, 271 (1), 127–136.
https://doi.org/10.1002/jlac.18922710120.
(32) Pinner, A. No Title. Berichte der Dtsch. Chem. Gesellschaft 1894, 27, 990.
(33) Freund, M.; Paradies, T. No Title. Berichte der Dtsch. Chem. Gesellschaft
1901, 43, 3115.
(34) Stollé, R.; Ehrmann, K.; Rieder, D.; Wille, H.; Winter, H.; Henke-Stark, F.
Über Tetrazolabkömmlinge. J. für Prakt. Chemie 1932, 134 (9–12), 282–309.
https://doi.org/10.1002/prac.19321340902.
(35) Huisgen, R.; Szeimies, G.; Möbius, L. 1.3-Dipolare Cycloadditionen, XXXII.
Kinetik Der Additionen Organischer Azide an CC-Mehrfachbindungen.
Chem. Ber. 1967, 100 (8), 2494–2507.
https://doi.org/10.1002/cber.19671000806.
(36) Himo, F.; Demko, Z. P.; Noodleman, L.; Sharpless, K. B. Why Is Tetrazole
Formation by Addition of Azide to Organic Nitriles Catalyzed by Zinc(II)
Salts? J. Am. Chem. Soc. 2003, 125 (33), 9983–9987.
https://doi.org/10.1021/ja030204q.
(37) Finnegan, W. G.; Henry, R. A.; Lofquist, R. An Improved Synthesis of 5Substituted Tetrazoles. J. Am. Chem. Soc. 1958, 80 (15), 3908–3911.
https://doi.org/10.1021/ja01548a028.
(38) Treitler, D. S.; Leung, S.; Lindrud, M. Development and Demonstration of a
Safer Protocol for the Synthesis of 5-Aryltetrazoles from Aryl Nitriles. Org.
Process Res. Dev. 2017, 21 (3), 460–467.
https://doi.org/10.1021/acs.oprd.7b00016.
(39) Demko, Z. P.; Sharpless, K. B. Preparation of 5-Substituted 1H-Tetrazoles
from Nitriles in Water. J. Org. Chem. 2001, 66 (24), 7945–7950.
https://doi.org/10.1021/jo010635w.
(40) Roy, A.; Rahman, M.; Das, S.; Kundu, D.; Kundu, S. K.; Majee, A.; Hajra, A.
Zinc Chloride as an Efficient Catalyst for Chemoselective Dimethyl
Acetalization. Synth. Commun. 2009, 39 (4), 590–595.
https://doi.org/10.1080/00397910802412859.
(41) HUFF, B. E.; STASZAK, M. A. ChemInform Abstract: A New Method for
the Preparation of Tetrazoles from Nitriles Using
Trimethylsilylazide/Trimethylaluminum. ChemInform 2010, 25 (13), no-no.
https://doi.org/10.1002/chin.199413178.
(42) McMurray, J. S.; Khabashesku, O.; Birtwistle, J. S.; Wang, W. Convenient
Preparation of 4-(Tetrazol-5-Yl)-Phenylalanine for Use in Fmoc-Based SolidPhase Peptide Synthesis. Tetrahedron Lett. 2000, 41 (34), 6555–6558.
https://doi.org/10.1016/S0040-4039(00)01135-7.
(43) Aureggi, V.; Sedelmeier, G. 1,3-Dipolar Cycloaddition: Click Chemistry for
the Synthesis of 5-Substituted Tetrazoles from Organoaluminum Azides and
140

(44)

(45)

(46)

(47)

(48)

(49)
(50)

(51)

(52)
(53)
(54)

(55)
(56)

Nitriles. Angew. Chemie Int. Ed. 2007, 46 (44), 8440–8444.
https://doi.org/10.1002/anie.200701045.
Amantini, D.; Beleggia, R.; Fringuelli, F.; Pizzo, F.; Vaccaro, L. TBAFCatalyzed Synthesis of 5-Substituted 1H-Tetrazoles under Solventless
Conditions. J. Org. Chem. 2004, 69 (8), 2896–2898.
https://doi.org/10.1021/jo0499468.
Lakshmi Kantam, M.; Kumar, K. B. S.; Sridhar, C. Nanocrystalline ZnO as an
Efficient Heterogeneous Catalyst for the Synthesis of 5-Substituted 1HTetrazoles. Adv. Synth. Catal. 2005, 347 (9), 1212–1214.
https://doi.org/10.1002/adsc.200505011.
Lakshmi Kantam, M.; Balasubrahmanyam, V.; Shiva Kumar, K. B. Zinc
Hydroxyapatite - Catalyzed Efficient Synthesis of 5-Substituted 1HTetrazoles. Synth. Commun. 2006, 36 (12), 1809–1814.
https://doi.org/10.1080/00397910600619630.
Sreedhar, B.; Kumar, A. S.; Yada, D. CuFe2O4 Nanoparticles: A
Magnetically Recoverable and Reusable Catalyst for the Synthesis of 5Substituted 1H-Tetrazoles. Tetrahedron Lett. 2011, 52 (28), 3565–3569.
https://doi.org/10.1016/j.tetlet.2011.04.094.
Heravi, M. M.; Fazeli, A.; Oskooie, H. A.; Beheshtiha, Y. S.; Valizadeh, H.
Click Synthesis of 5-Substituted 1H-Tetrazoles from Aldehydes,
Hydroxylamine, and [Bmim]N3 via One-Pot, Three-Component Reaction.
Synlett 2012, 23 (20), 2927–2930. https://doi.org/10.1055/s-0032-1317671.
Spear, R. J. Positional Selectivity of the Methylation of 5-Substituted
Tetrazolate Anions. Aust. J. Chem. 1984, 37 (12), 2453–2468.
https://doi.org/10.1071/CH9842453.
Bond, A. D.; Fleming, A.; Kelleher, F.; McGinley, J.; Prajapati, V. Reactions
of 1,4-Bis(Tetrazole)Benzenes: Formation of Long Chain Alkyl Halides.
Tetrahedron 2006, 62 (41), 9577–9581.
https://doi.org/10.1016/j.tet.2006.07.093.
Fleming, A.; Gaire, J.; Kelleher, F.; McGinley, J.; McKee, V. Synthesis and
Characterisation of Macrocycles Containing Both Tetrazole and Pyridine
Functionalities. Tetrahedron 2011, 67 (18), 3260–3266.
https://doi.org/10.1016/j.tet.2011.02.080.
Purchase, C. F.; White, A. D. Alkylation of Tetrazoles Using Mitsunobu
Conditions. Synth. Commun. 1996, 26 (14), 2687–2694.
https://doi.org/10.1080/00397919608004585.
Mitsunobu, O.; Yamada, M. Preparation of Esters of Carboxylic and
Phosphoric Acid via Quaternary Phosphonium Salts . Bull. Chem. Soc. Jpn.
1967, 40 (10), 2380–2382. https://doi.org/10.1246/bcsj.40.2380.
Yan, W.; Liao, T.; Tuguldur, O.; Zhong, C.; Petersen, J. L.; Shi, X. Mitsunobu
Reaction of 1,2,3-NH-Triazoles: A Regio- and Stereoselective Approach to
Functionalized Triazole Derivatives. Chem. - An Asian J. 2011, 6 (10), 2720–
2724. https://doi.org/10.1002/asia.201100357.
Swamy, K. C. K.; Kumar, N. N. B.; Balaraman, E.; Kumar, K. V. P. P.
Mitsunobu and Related Reactions: Advances and Applications. Chem. Rev.
2009, 109 (6), 2551–2651. https://doi.org/10.1021/cr800278z.
Laha, J. K.; Cuny, G. D. Synthesis of Fused Imidazoles, Pyrroles, and Indoles
with a Defined Stereocenter α to Nitrogen Utilizing Mitsunobu Alkylation
Followed by Palladium-Catalyzed Cyclization. J. Org. Chem. 2011, 76 (20),
8477–8482. https://doi.org/10.1021/jo201237h.
141

(57) Lisakova, A. D.; Ryabukhin, D. S.; Trifonov, R. E.; Ostrovskii, V. A.;
Vasilyev, A. V. Alkylation of 5-Substituted NH-Tetrazoles by Alcohols in the
Superacid CF 3 SO 3 H. ChemInform 2016, 47 (14).
https://doi.org/10.1002/chin.201614133.
(58) Špulák, M.; Lubojacký, R.; Šenel, P.; Kuneš, J.; Pour, M. Direct C-H
Arylation and Alkenylation of 1-Substituted Tetrazoles: Phosphine as
Stabilizing Factor. J. Org. Chem. 2010, 75 (1), 241–244.
https://doi.org/10.1021/jo902180u.
(59) Onaka, T.; Umemoto, H.; Miki, Y.; Nakamura, A.; Maegawa, T.
Cu(OH)(TMEDA)2Cl2-Catalyzed Regioselective 2-Arylation of 5Substituted Tetrazoles with Boronic Acids under Mild Conditions. J. Org.
Chem. 2014, 79 (14), 6703–6707. https://doi.org/10.1021/jo500862t.
(60) Xiong, Q.; Dong, S.; Chen, Y.; Liu, X.; Feng, X. Asymmetric Synthesis of
Tetrazole and Dihydroisoquinoline Derivatives by Isocyanide-Based
Multicomponent Reactions. Nat. Commun. 2019, 10 (1), 1–10.
https://doi.org/10.1038/s41467-019-09904-5.
(61) Daugherty, N. A.; Brubaker, C. H. Complexes of Copper(II) and Some 5Substituted Tetrazoles. J. Am. Chem. Soc. 1961, 83 (18), 3779–3782.
https://doi.org/10.1021/ja01479a012.
(62) Gaponik, P. N.; Ivashkevich, O. A. PHYSICO-CHEMICAL PROPERTIES
AND APPLICATION. Chem. Probl. Dev. New Mater. Technol. Minsk 2003,
193–233.
(63) Paul Gleeson, M.; Leeson, P. D.; Waterbeemd, H. van de. Physicochemical
Properties and Compound Quality. In The Handbook of Medicinal Chemistry;
Royal Society of Chemistry, 2015; pp 1–31.
https://doi.org/10.1039/9781782621836-00001.
(64) Ndagi, U.; Mhlongo, N.; Soliman, M. E. Metal Complexes in Cancer Therapy
– An Update from Drug Design Perspective. Drug Design, Development and
Therapy. Dove Medical Press Ltd. March 3, 2017, pp 599–616.
https://doi.org/10.2147/DDDT.S119488.
(65) Gaponik, P. N.; Voitekhovich, S. V; Ivashkevich, O. A. Metal Derivatives of
Tetrazoles. Russ. Chem. Rev. 2006, 75 (6), 507–539.
https://doi.org/10.1070/rc2006v075n06abeh003601.
(66) Popova, E. A.; Trifonov, R. E.; Ostrovskii, V. A. Advances in Synthesis of
Tetrazoles Coordinated to Metal Ions. Arkivoc 2011, 2012 (1), 65.
https://doi.org/10.3998/ark.5550190.0013.102.
(67) Das, L. K.; Kadam, R. M.; Bauzá, A.; Frontera, A.; Ghosh, A. Differences in
Nuclearity, Molecular Shapes, and Coordination Modes of Azide in the
Complexes of Cd(II) and Hg(II) with a “Metalloligand” [CuL] (H 2L = N, N
’-Bis(Salicylidene)-1,3-Propanediamine): Characterization in Solid and in
Solutions, and Theoretical Calculations. Inorg. Chem. 2012, 51 (22), 12407–
12418. https://doi.org/10.1021/ic301773h.
(68) Varala, R.; Babu, B. H. A Click Chemistry Approach to Tetrazoles: Recent
Advances. Mol. Docking 2018, 51–75.
https://doi.org/10.5772/intechopen.75720.
(69) Bhandari, S.; Mahon, M. F.; Molloy, K. C.; Palmer, J. S.; Sayers, S. F.
Thallium(i)- and Organothallium(in)-Substituted Mono-, Bis- and TrisTetrazoles: Synthesis and Supramolecular Structures. J. Chem. Soc. Dalt.
Trans. 2000, No. 7, 1053–1060. https://doi.org/10.1039/a910235n.
(70) Poturovic, S.; Lu, D.; Heeg, M. J.; Winter, C. H. Synthesis and Structural
142

(71)

(72)
(73)

(74)
(75)
(76)
(77)
(78)
(79)
(80)
(81)
(82)
(83)
(84)
(85)
(86)

Characterization of Heavier Group 1 Methyl Tetrazolate Complexes: New
Bridging Coordination Modes of the Tetrazolate Ligand. Polyhedron 2008, 27
(15), 3280–3286. https://doi.org/10.1016/j.poly.2008.07.010.
Yu, J. H.; Mereiter, K.; Hassan, N.; Feldgitscher, C.; Linert, W. Designed
Assemblies of Metal Halo and Pseudohalo Coordination Polymers with
Bridging 1-Substituted Ditetrazoles. Cryst. Growth Des. 2008, 8 (5), 1535–
1540. https://doi.org/10.1021/cg700778b.
Popova, E. A.; Trifonov, R. E.; Ostrovskii, V. A. Advances in the Synthesis of
Tetrazoles Coordinated to Metal Ions. Arkivoc 2012, 2012 (1), 45–65.
https://doi.org/10.3998/ark.5550190.0013.102.
Gaponik, P. N.; Degtyarik, M. M.; Lyakhov, A. S.; Matulis, V. E.;
Ivashkevich, O. A.; Quesada, M.; Reedijk, J. Bis(2Methyltetrazole)Dichlorocopper(II) Is a Layered Coordination Polymer Built
from Dinuclear Chloro-Bridged Cu Units Linked by Bridging Tetrazoles. the
First Structurally and Magnetically Characterized Complex of 2Monosubstituted Tetrazoles. Inorganica Chim. Acta 2005, 358 (13), 3949–
3957. https://doi.org/10.1016/j.ica.2005.06.029.
Joule, J. A.; Mills, K. Heterocyclic Chemistry; Blackwell Science, 2000.
Runge, F. F. Ueber Einige Produkte Der Steinkohlendestillation. Ann. der
Phys. und Chemie 1834, 107 (5), 65–78.
https://doi.org/10.1002/andp.18341070502.
A.L. Harreus. Ullmann’s Encyclopedia of Industrial Chemistry; Wiley, 2000.
https://doi.org/10.1002/14356007.
Jusélius, J.; Sundholm, D. The Aromatic Pathways of Porphins, Chlorins and
Bacteriochlorins. Phys. Chem. Chem. Phys. 2000, 2 (10), 2145–2151.
https://doi.org/10.1039/b000260g.
NELSON, D. L. . M. M. C. Lehninger: Principles of Biochemistry. Cell
Biochem. Funct. 2005, 23 (4), 293–294. https://doi.org/10.1002/cbf.1216.
NELSON, D. L. . M. M. C. Lehninger Principles of Biochemistry; New York:
Worth Publishers, 2000.
Fowles, J.; Bates, M.; Noiton, D. The Chemical Constituents in Cigarettes
and Cigarette Smoke: Priorities for Harm Reduction. New Zeal. Minist. Heal.
2000, 20. https://doi.org/10.13140/RG.2.1.4977.0488.
Loudon, M. G. Chemistry of Naphthalene and the Aromatic Heterocycles., 4th
ed.; New York: Oxford Unicersity Press, 2002.
Lawrence, S. A. Amines: Synthesis, Properties and Applications By S. A.
Lawrence. Cambridge University Press: Cambridge. 2004. 371. Org. Process
Res. Dev. 2005, 9 (6), 1016–1016. https://doi.org/10.1021/op0501390.
Harreus, A. L. Pyrrole. In Ullmann’s Encyclopedia of Industrial Chemistry;
Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2013; Vol.
30, pp 615–618. https://doi.org/10.1002/14356007.a22_453.
Amarnath, V.; Anthony, D. C.; Amarnath, K.; Valentine, W. M.; Wetterau, L.
A.; Graham, D. G. Intermediates in the Paal-Knorr Synthesis of Pyrroles. J.
Org. Chem. 1991, 56 (24), 6924–6931. https://doi.org/10.1021/jo00024a040.
Dar, A. M.; Mir, S. Simple and Multi-Component Synthesis of Pyrrole
Heterocycles. Synth. Catal. Open Access 2017, 02 (03).
https://doi.org/10.4172/2574-0431.100018.
Banik, B. K.; Banik, I.; Renteria, M.; Dasgupta, S. K. A Straightforward
Highly Efficient Paal-Knorr Synthesis of Pyrroles. Tetrahedron Lett. 2005, 46
(15), 2643–2645. https://doi.org/10.1016/j.tetlet.2005.02.103.
143

(87) Gao, L.; Bing, L.; Zhang, Z.; Kecheng, H.; Xiaoyun, H.; Deng, K. Efficient
Synthesis of N-Substituted Pyrroles Catalyzed by a Novel an OrganicInorganic Hybrid Solid Acid Catalyst. J. Organomet. Chem. 2013, 735, 26–
31. https://doi.org/10.1016/j.jorganchem.2013.03.018.
(88) Marvi, O.; Nahzomi, H. T. Grinding Solvent-Free Paal-Knorr Pyrrole
Synthesis on Smectites as Recyclable and Green Catalysts. Bull. Chem. Soc.
Ethiop. 2018, 32 (1), 139–147. https://doi.org/10.4314/bcse.v32i1.13.
(89) Rahmatpour, A. Polystyrene-Supported GaCl 3 as a Highly Efficient and
Recyclable Heterogeneous Lewis Acid Catalyst for One-Pot Synthesis of NSubstituted Pyrroles. J. Organomet. Chem. 2012, 712, 15–19.
https://doi.org/10.1016/j.jorganchem.2012.03.025.
(90) Wang, B.; Gu, Y.; Luo, C.; Yang, T.; Yang, L.; Suo, J. Pyrrole Synthesis in
Ionic Liquids by Paal-Knorr Condensation under Mild Conditions.
Tetrahedron Lett. 2004, 45 (17), 3417–3419.
https://doi.org/10.1016/j.tetlet.2004.03.012.
(91) Akbaşlar, D.; Demirkol, O.; Giray, S. Paal-Knorr Pyrrole Synthesis in Water.
Synth. Commun. 2014, 44 (9), 1323–1332.
https://doi.org/10.1080/00397911.2013.857691.
(92) Handy, S.; Lavender, K. Organic Synthesis in Deep Eutectic Solvents: PaalKnorr Reactions. Tetrahedron Lett. 2013, 54 (33), 4377–4379.
https://doi.org/10.1016/j.tetlet.2013.05.122.
(93) Zhang, X.; Weng, G.; Zhang, Y.; Li, P. Unique Chemoselective Paal-Knorr
Reaction Catalyzed by MgI2 Etherate under Solvent-Free Conditions.
Tetrahedron. Elsevier Ltd May 6, 2015, pp 2595–2602.
https://doi.org/10.1016/j.tet.2015.03.035.
(94) Tzankova, D.; Vladimirova, S.; Peikova, L. SYNTHESIS OF PYRROLE AND
SUBSTITUTED PYRROLES (REVIEW); 2018; Vol. 53.
(95) Bhardwaj, V.; Gumber, D.; Abbot, V.; Dhiman, S.; Sharma, P. Pyrrole: A
Resourceful Small Molecule in Key Medicinal Hetero-Aromatics. RSC
Advances. Royal Society of Chemistry January 30, 2015, pp 15233–15266.
https://doi.org/10.1039/c4ra15710a.
(96) Kozikowski, A. P.; Cheng, X. M. A Synthesis of 3-Substituted Pyrroles
through the Halogen-Metal Exchange Reaction of 3-Bromo-1(Triisopropylsilyl) Pyrrole. J. Org. Chem. 1984, 49 (17), 3239–3240.
https://doi.org/10.1021/jo00191a047.
(97) Moad, G.; Solomon, D. H. (David H.; Moad, G. The Chemistry of Radical
Polymerization; Elsevier, 2006.
(98) Quirk, R. P.; Zhuo, Q.; Jang, S. H.; Lee, Y.; Lizarraga, G.; Morton, M.
Principles of Anionic Polymerization: An Introduction.
(99) Szwarc, M.; Levy, M.; Milkovich, R. Polymerization Initiated by Electron
Transfer to Monomer. A New Method of Formation of Block Polymers.
Journal of the American Chemical Society. American Chemical Society June
1, 1956, pp 2656–2657. https://doi.org/10.1021/ja01592a101.
(100) Szwarc, M. “Living” Polymers. Nature 1956, 178 (4543), 1168–1169.
https://doi.org/10.1038/1781168a0.
(101) Aoshima, S.; Kanaoka, S. A Renaissance in Living Cationic Polymerization.
Chem. Rev. 2009, 109 (11), 5245–5287. https://doi.org/10.1021/cr900225g.
(102) Campbell, J. D.; Teymour, F.; Morbidelli, M. Production of Hyperbranched
Polystyrene by High-Temperature Polymerization. Macromolecules 2005, 38
(3), 752–760. https://doi.org/10.1021/ma0485639.
144

(103) Braun, D. Origins and Development of Initiation of Free Radical
Polymerization Processes. Int. J. Polym. Sci. 2009, 893234.
https://doi.org/10.1155/2009/893234.
(104) Braunecker, W. A.; Matyjaszewski, K. Controlled/Living Radical
Polymerization: Features, Developments, and Perspectives. Progress in
Polymer Science (Oxford). Pergamon January 1, 2007, pp 93–146.
https://doi.org/10.1016/j.progpolymsci.2006.11.002.
(105) Zetterlund, P. B.; Aldabbagh, F.; Okubo, M. Controlled/Living
Heterogeneous Radical Polymerization in Supercritical Carbon Dioxide. J.
Polym. Sci. Part A Polym. Chem. 2009, 47 (15), 3711–3728.
https://doi.org/10.1002/pola.23432.
(106) Magee, C.; Sugihara, Y.; Zetterlund, P. B.; Aldabbagh, F. Chain Transfer to
Solvent in the Radical Polymerization of Structurally Diverse Acrylamide
Monomers Using Straight-Chain and Branched Alcohols as Solvents. Polym.
Chem. 2014, 5 (7), 2259–2265. https://doi.org/10.1039/c3py01441j.
(107) Gody, G.; Maschmeyer, T.; Zetterlund, P. B.; Perrier, S. Pushing the Limit of
the RAFT Process: Multiblock Copolymers by One-Pot Rapid Multiple Chain
Extensions at Full Monomer Conversion. Macromolecules 2014, 47 (10),
3451–3460. https://doi.org/10.1021/ma402435n.
(108) Willard, H. H.; Merritt, L. L. J.; Dean, J. A.; Settle, F. A. J. Instrumental
Methods of Analysis, 7th Edition, 7th ed.; Wadsworth Publishing Company:
California, 1988.
(109) Evans, D. H.; O’Connell, K. M.; Petersen, R. A.; Kelly, M. J. Cyclic
Voltammetry. J. Chem. Educ. 1983, 60 (4), 290–293.
https://doi.org/10.1021/ed060p290.
(110) Nnamchi, P. S.; Obayi, C. S. Electrochemical Characterization of
Nanomaterials. In Characterization of Nanomaterials: Advances and Key
Technologies; Elsevier, 2018; pp 103–127. https://doi.org/10.1016/B978-008-101973-3.00004-3.
(111) Feninat, F. El; Laroche, G.; Fiset, M.; Mantovani, D. Shape Memory
Materials for Biomedical Applications. Adv. Eng. Mater. 2002, 4 (3), 91–104.
https://doi.org/10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2B.
(112) Park, J.; Lakes, R. S. Biomaterials: An Introduction. In Biomaterials; Springer
New York, 2007; pp 1–16. https://doi.org/10.1007/978-0-387-37880-0_1.
(113) Rupp, F.; Geis-Gerstorfer, J.; Geckeler, K. E. Dental Implant Materials:
Surface Modification and Interface Phenomena. Adv. Mater. 1996, 8 (3), 254–
257. https://doi.org/10.1002/adma.19960080316.
(114) Grainger, D. W. The Williams Dictionary of Biomaterials. Mater. Today
1999, 2 (3), 29. https://doi.org/10.1016/s1369-7021(99)80066-2.
(115) Barrère, F.; Mahmood, T. A.; de Groot, K.; van Blitterswijk, C. A. Advanced
Biomaterials for Skeletal Tissue Regeneration: Instructive and Smart
Functions. Materials Science and Engineering R: Reports. Elsevier February
29, 2008, pp 38–71. https://doi.org/10.1016/j.mser.2007.12.001.
(116) O’Brien, F. J. Biomaterials & Scaffolds for Tissue Engineering. Materials
Today. Elsevier B.V. March 1, 2011, pp 88–95.
https://doi.org/10.1016/S1369-7021(11)70058-X.
(117) Williams, D. F. On the Nature of Biomaterials. Biomaterials 2009, 30 (30),
5897–5909. https://doi.org/10.1016/j.biomaterials.2009.07.027.
(118) Dorozhkin, S. V. Bioceramics of Calcium Orthophosphates. Biomaterials.
145

(119)
(120)

(121)
(122)
(123)
(124)

(125)

(126)

(127)
(128)

(129)
(130)

(131)
(132)

Elsevier March 1, 2010, pp 1465–1485.
https://doi.org/10.1016/j.biomaterials.2009.11.050.
Chen, Q.; Thouas, G. A. Metallic Implant Biomaterials. Materials Science
and Engineering R: Reports. Elsevier Ltd January 1, 2015, pp 1–57.
https://doi.org/10.1016/j.mser.2014.10.001.
Geetha, M.; Singh, A. K.; Asokamani, R.; Gogia, A. K. Ti Based
Biomaterials, the Ultimate Choice for Orthopaedic Implants - A Review.
Progress in Materials Science. Pergamon May 1, 2009, pp 397–425.
https://doi.org/10.1016/j.pmatsci.2008.06.004.
Eliaz, N. Corrosion of Metallic Biomaterials: A Review. Materials. MDPI AG
January 28, 2019. https://doi.org/10.3390/ma12030407.
Driver, M. Coatings for Cardiovascular Devices: Coronary Stents. In Coatings
for Biomedical Applications; Elsevier, 2012; pp 223–250.
https://doi.org/10.1533/9780857093677.2.223.
Guildford, A.; Santin, M.; Phillips, G. J. Cardiovascular Stents. In
Biomaterials and Devices for the Circulatory System; Elsevier, 2010; pp 173–
216. https://doi.org/10.1533/9780857090553.2.173.
Grüntzig, A. Transluminal Dilatation of Coronary Artery Stenosis —
Experimental Report. In Percutaneous Vascular Recanalization; Springer
Berlin Heidelberg, 1978; pp 57–65. https://doi.org/10.1007/978-3-642-463815_9.
Sigwart, U.; Puel, J.; Mirkovitch, V.; Joffre, F.; Kappenberger, L.
Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal
Angioplasty. N. Engl. J. Med. 1987, 316 (12), 701–706.
https://doi.org/10.1056/NEJM198703193161201.
Palmaz, J. C.; Kopp, D. T.; Hayashi, H.; Schatz, R. A.; Hunter, G.; Tio, F. O.;
Garcia, O.; Alvarado, R.; Rees, C.; Thomas, S. C. Normal and Stenotic Renal
Arteries: Experimental Balloon-Expandable Intraluminal Stenting. Radiology
1987, 164 (3), 705–708. https://doi.org/10.1148/radiology.164.3.2956628.
Nuhn, H.; Blanco, C. E.; Desai, T. A. Nanoengineered Stent Surface to
Reduce In-Stent Restenosis in Vivo. ACS Appl. Mater. Interfaces 2017, 9
(23), 19677–19686. https://doi.org/10.1021/acsami.7b04626.
Fischman, D. L.; Leon, M. B.; Baim, D. S.; Schatz, R. A.; Savage, M. P.;
Penn, I.; Detre, K.; Veltri, L.; Ricci, D.; Nobuyoshi, M.; et al. A Randomized
Comparison of Coronary-Stent Placement and Balloon Angioplasty in the
Treatment of Coronary Artery Disease. N. Engl. J. Med. 1994, 331 (8), 496–
501. https://doi.org/10.1056/NEJM199408253310802.
Borhani, S.; Hassanajili, S.; Ahmadi Tafti, S. H.; Rabbani, S. Cardiovascular
Stents: Overview, Evolution, and next Generation. Prog. Biomater. 2018, 7
(3), 175–205. https://doi.org/10.1007/s40204-018-0097-y.
Bolland, B. J. R. F.; Culliford, D. J.; Langton, D. J.; Millington, J. P. S.;
Arden, N. K.; Latham, J. M. High Failure Rates with a Large-Diameter
Hybrid Metal-on-Metal Total Hip Replacement: Clinical, Radiological and
Retrieval Analysis. J. Bone Jt. Surg. - Ser. B 2011, 93 B (5), 608–615.
https://doi.org/10.1302/0301-620X.93B5.26309.
Fricka, K. B.; Ho, H.; Peace, W. J.; Engh, C. A. Metal-on-Metal Local Tissue
Reaction Is Associated with Corrosion of the Head Taper Junction. J.
Arthroplasty 2012, 27 (8 SUPPL.). https://doi.org/10.1016/j.arth.2012.03.019.
Goldberg, J. R.; Gilbert, J. L.; Jacobs, J. J.; Bauer, T. W.; Paprosky, W.;
Leurgans, S. A Multicenter Retrieval Study of the Taper Interfaces of
146

(133)

(134)

(135)

(136)

(137)

(138)
(139)

(140)

(141)
(142)
(143)

(144)

(145)

Modular Hip Prostheses. Clin. Orthop. Relat. Res. 2002, No. 401, 149–161.
https://doi.org/10.1097/00003086-200208000-00018.
Gilbert, J. L.; Buckley, C. A.; Jacobs, J. J. In Vivo Corrosion of Modular Hip
Prosthesis Components in Mixed and Similar Metal Combinations. The Effect
of Crevice, Stress, Motion, and Alloy Coupling. J. Biomed. Mater. Res. 1993,
27 (12), 1533–1544. https://doi.org/10.1002/jbm.820271210.
Kurtz, S. M.; Kocagöz, S. B.; Hanzlik, J. A.; Underwood, R. J.; Gilbert, J. L.;
MacDonald, D. W.; Lee, G. C.; Mont, M. A.; Kraay, M. J.; Klein, G. R.; et al.
Do Ceramic Femoral Heads Reduce Taper Fretting Corrosion in Hip
Arthroplasty? A Retrieval Study. Clin. Orthop. Relat. Res. 2013, 471 (10),
3270–3282. https://doi.org/10.1007/s11999-013-3096-2.
Toyofuku, M.; Inaba, T.; Kiyokawa, T.; Obana, N.; Yawata, Y.; Nomura, N.
Environmental Factors That Shape Biofilm Formation. Biosci. Biotechnol.
Biochem. 2016, 80 (1), 7–12.
https://doi.org/10.1080/09168451.2015.1058701.
Dell’orto, S.; Cattò, C.; Villa, F.; Forlani, F.; Vassallo, E.; Morra, M.;
Cappitelli, F.; Villa, S.; Gelain, A. Low Density Polyethylene Functionalized
with Antibiofilm Compounds Inhibits Escherichia Coli Cell Adhesion. J.
Biomed. Mater. Res. - Part A 2017, 105 (12), 3251–3261.
https://doi.org/10.1002/jbm.a.36183.
Ahmadi Lakalayeh, G.; Rahvar, M.; Haririan, E.; Karimi, R.; Ghanbari, H.
Comparative Study of Different Polymeric Coatings for the Next-Generation
Magnesium-Based Biodegradable Stents. Artif. Cells, Nanomedicine,
Biotechnol. 2018, 46 (7), 1380–1389.
https://doi.org/10.1080/21691401.2017.1369424.
Woods, T. C.; Marks, A. R. Drug-Eluting Stents. Annu. Rev. Med. 2004, 55
(1), 169–178. https://doi.org/10.1146/annurev.med.55.091902.105243.
Simard, T.; Hibbert, B.; Ramirez, F. D.; Froeschl, M.; Chen, Y. X.; O’Brien,
E. R. The Evolution of Coronary Stents: A Brief Review. Canadian Journal
of Cardiology. Elsevier January 1, 2014, pp 35–45.
https://doi.org/10.1016/j.cjca.2013.09.012.
Chen, W.; Habraken, T. C. J.; Hennink, W. E.; Kok, R. J. Polymer-Free DrugEluting Stents: An Overview of Coating Strategies and Comparison with
Polymer-Coated Drug-Eluting Stents. Bioconjug. Chem. 2015, 26 (7), 1277–
1288. https://doi.org/10.1021/acs.bioconjchem.5b00192.
Ong, A. T. L.; Serruys, P. W. Technology Insight: An Overview of Research
in Drug-Eluting Stents. Nature Clinical Practice Cardiovascular Medicine.
December 2005, pp 647–658. https://doi.org/10.1038/ncpcardio0378.
Francolini, I.; Vuotto, C.; Piozzi, A.; Donelli, G. Antifouling and
Antimicrobial Biomaterials: An Overview. APMIS. Blackwell Munksgaard
April 1, 2017, pp 392–417. https://doi.org/10.1111/apm.12675.
Kluin, O. S.; Van Der Mei, H. C.; Busscher, H. J.; Neut, D. Biodegradable vs
Non-Biodegradable Antibiotic Delivery Devices in the Treatment of
Osteomyelitis. Expert Opinion on Drug Delivery. Taylor & Francis March
2013, pp 341–351. https://doi.org/10.1517/17425247.2013.751371.
Owens, G. J.; Singh, R. K.; Foroutan, F.; Alqaysi, M.; Han, C. M.; Mahapatra,
C.; Kim, H. W.; Knowles, J. C. Sol-Gel Based Materials for Biomedical
Applications. Progress in Materials Science. Elsevier Ltd April 1, 2016, pp
1–79. https://doi.org/10.1016/j.pmatsci.2015.12.001.
Neut, D.; Dijkstra, R. J. B.; Thompson, J. I.; Kavanagh, C.; van der Mei, H.
147

(146)
(147)

(148)

(149)

(150)
(151)

(152)

(153)
(154)

(155)
(156)

(157)
(158)

C.; Busscher, H. J. A Biodegradable Gentamicin-Hydroxyapatite-Coating for
Infection Prophylaxis in Cementless Hip Prostheses. Eur. Cells Mater. 2015,
29, 42–56. https://doi.org/10.22203/eCM.v029a04.
A. Chowdhury, M. The Controlled Release of Drugs and Bioactive
Compounds from Mesoporous Silica Nanoparticles. Curr. Drug Deliv. 2016,
13 (6), 839–856. https://doi.org/10.2174/1567201813666151202195104.
Jennings, J. A.; Wells, C. M.; McGraw, G. S.; Velasquez Pulgarin, D. A.;
Whitaker, M. D.; Pruitt, R. L.; Bumgardner, J. D. Chitosan Coatings to
Control Release and Target Tissues for Therapeutic Delivery. Therapeutic
Delivery. Future Science Ltd July 1, 2015, pp 855–871.
https://doi.org/10.4155/tde.15.31.
Francolini, I.; Norris, P.; Piozzi, A.; Donelli, G.; Stoodley, P. Usnic Acid, a
Natural Antimicrobial Agent Able to Inhibit Bacterial Biofilm Formation on
Polymer Surfaces. Antimicrob. Agents Chemother. 2004, 48 (11), 4360–4365.
https://doi.org/10.1128/AAC.48.11.4360-4365.2004.
Francolini, I.; D’Ilario, L.; Guaglianone, E.; Donelli, G.; Martinelli, A.;
Piozzi, A. Polyurethane Anionomers Containing Metal Ions with
Antimicrobial Properties: Thermal, Mechanical and Biological
Characterization. Acta Biomater. 2010, 6 (9), 3482–3490.
https://doi.org/10.1016/j.actbio.2010.03.042.
Xu, W.; Yagoshi, K.; Asakura, T.; Sasaki, M.; Niidome, T. Silk Fibroin as a
Coating Polymer for Sirolimus-Eluting Magnesium Alloy Stents. ACS Appl.
Bio Mater. 2020, 3 (1), 531–538. https://doi.org/10.1021/acsabm.9b00957.
Wang, P.; Xiong, P.; Liu, J.; Gao, S.; Xi, T.; Cheng, Y. A Silk-Based Coating
Containing GREDVY Peptide and Heparin on Mg-Zn-Y-Nd Alloy: Improved
Corrosion Resistance, Hemocompatibility and Endothelialization. J. Mater.
Chem. B 2018, 6 (6), 966–978. https://doi.org/10.1039/c7tb02784b.
Yamaguchi, S.; Spriano, S.; Cazzola, M. Fast and Effective Osseointegration
of Dental, Spinal, and Orthopedic Implants through Tailored Chemistry of
Inorganic Surfaces. In Nanostructured Biomaterials for Regenerative
Medicine; Elsevier, 2019; pp 337–377. https://doi.org/10.1016/B978-0-08102594-9.00013-9.
Scarcello, E.; Lison, D. Are Fe-Based Stenting Materials Biocompatible? A
Critical Review of In Vitro and In Vivo Studies. J. Funct. Biomater. 2019, 11
(1). https://doi.org/10.3390/JFB11010002.
Gastaldi, D.; Sassi, V.; Petrini, L.; Vedani, M.; Trasatti, S.; Migliavacca, F.
Continuum Damage Model for Bioresorbable Magnesium Alloy Devices Application to Coronary Stents. J. Mech. Behav. Biomed. Mater. 2011, 4 (3),
352–365. https://doi.org/10.1016/j.jmbbm.2010.11.003.
Grogan, J. A.; O’Brien, B. J.; Leen, S. B.; McHugh, P. E. A Corrosion Model
for Bioabsorbable Metallic Stents. Acta Biomater. 2011, 7 (9), 3523–3533.
https://doi.org/10.1016/j.actbio.2011.05.032.
Wang, J.; Giridharan, V.; Shanov, V.; Xu, Z.; Collins, B.; White, L.; Jang, Y.;
Sankar, J.; Huang, N.; Yun, Y. Flow-Induced Corrosion Behavior of
Absorbable Magnesium-Based Stents. Acta Biomater. 2014, 10 (12), 5213–
5223. https://doi.org/10.1016/j.actbio.2014.08.034.
Bowen, P. K.; Drelich, J.; Goldman, J. Zinc Exhibits Ideal Physiological
Corrosion Behavior for Bioabsorbable Stents. Adv. Mater. 2013, 25 (18),
2577–2582. https://doi.org/10.1002/adma.201300226.
Drelich, A. J.; Zhao, S.; Guillory, R. J.; Drelich, J. W.; Goldman, J. Long148

(159)
(160)

(161)

(162)

(163)
(164)

(165)
(166)

(167)
(168)

(169)

(170)
(171)

Term Surveillance of Zinc Implant in Murine Artery: Surprisingly Steady
Biocorrosion Rate. Acta Biomater. 2017, 58, 539–549.
https://doi.org/10.1016/j.actbio.2017.05.045.
Food & Drug Administration, U. Biological Responses to Metal Implants;
2019.
Heintz, C.; Riepe, G.; Birken, L.; Kaiser, E.; Chakfé, N.; Morlock, M.;
Delling, G.; Imig, H. Corroded Nitinol Wires in Explanted Aortic Endografts:
An Important Mechanism of Failure? J. Endovasc. Ther. 2001, 8 (3), 248–
253. https://doi.org/10.1177/152660280100800303.
Riepe, G.; Heintz, C.; Kaiser, E.; Chakfé, N.; Morlock, M.; Delling, M.; Imig,
H. What Can We Learn from Explanted Endovascular Devices? Eur. J. Vasc.
Endovasc. Surg. 2002, 24 (2), 117–122.
https://doi.org/10.1053/ejvs.2002.1677.
Halwani, D. O.; Anderson, P. G.; Lemons, J. E.; Jordan, W. D.; Anayiotos, A.
S.; Brott, B. C. In-Vivo Corrosion and Local Release of Metallic Ions from
Vascular Stents into Surrounding Tissue. J. Invasive Cardiol. 2010, 22 (11),
528–535.
Arnholt, C.; Kraay, M. Mechanically Assisted Taper Corrosion in Modular
TKA. J. Arthroplasty 2014, 29 (9), 205–208.
https://doi.org/10.1016/j.arth.2013.12.034.
Higgs, G. B.; Hanzlik, J. A.; MacDonald, D. W.; Gilbert, J. L.; Rimnac, C.
M.; Kurtz, S. M. Is Increased Modularity Associated with Increased Fretting
and Corrosion Damage in Metal-on-Metal Total Hip Arthroplasty Devices? A
Retrieval Study. J. Arthroplasty 2013, 28 (8 SUPPL), 2–6.
https://doi.org/10.1016/j.arth.2013.05.040.
Anderson, J. M.; Rodriguez, A.; Chang, D. T. Foreign Body Reaction to
Biomaterials. Seminars in Immunology. NIH Public Access April 2008, pp
86–100. https://doi.org/10.1016/j.smim.2007.11.004.
Colombo, M.; Mangano, C.; Mijiritsky, E.; Krebs, M.; Hauschild, U.; Fortin,
T. Clinical Applications and Effectiveness of Guided Implant Surgery: A
Critical Review Based on Randomized Controlled Trials. BMC Oral Health
2017, 17 (1). https://doi.org/10.1186/s12903-017-0441-y.
Wang, G.; Wan, Y.; Wang, T.; Liu, Z. Corrosion Behavior of Titanium
Implant with Different Surface Morphologies. Procedia Manuf. 2017, 10,
363–370. https://doi.org/10.1016/j.promfg.2017.07.006.
Fabbri, N.; Rustemi, E.; Masetti, C.; Kreshak, J.; Gambarotti, M.; Vanel, D.;
Toni, A.; Mercuri, M. Severe Osteolysis and Soft Tissue Mass around Total
Hip Arthroplasty: Description of Four Cases and Review of the Literature
with Respect to Clinico-Radiographic and Pathologic Differential Diagnosis.
Eur. J. Radiol. 2010, 77, 43–50. https://doi.org/10.1016/j.ejrad.2010.08.015.
Apostu, D.; Lucaciu, O.; Berce, C.; Lucaciu, D.; Cosma, D. Current Methods
of Preventing Aseptic Loosening and Improving Osseointegration of Titanium
Implants in Cementless Total Hip Arthroplasty: A Review. Journal of
International Medical Research. SAGE Publications Ltd June 1, 2018, pp
2104–2119. https://doi.org/10.1177/0300060517732697.
Lemons, J. E. Introduction: Biomaterials and Implant Surgery. In Advances in
Materials Science and Implant Orthopedic Surgery; Springer Netherlands,
1995; pp 1–12. https://doi.org/10.1007/978-94-011-0157-8_1.
Festas, A. J.; Ramos, A.; Davim, J. P. Medical Devices Biomaterials – A
Review. Proceedings of the Institution of Mechanical Engineers, Part L:
149

(172)
(173)
(174)
(175)

(176)

(177)

(178)

(179)
(180)

(181)
(182)

(183)

(184)
(185)

Journal of Materials: Design and Applications. SAGE Publications Ltd
January 1, 2020, pp 218–228. https://doi.org/10.1177/1464420719882458.
Witte, F.; Eliezer, A. Biodegradable Metals. In Degradation of Implant
Materials; Springer New York, 2012; Vol. 9781461439424, pp 93–109.
https://doi.org/10.1007/978-1-4614-3942-4_5.
Hallab, N. J. Hypersensitivity to Implant Debris. In Degradation of Implant
Materials; Springer New York, 2012; Vol. 9781461439424, pp 329–345.
https://doi.org/10.1007/978-1-4614-3942-4_12.
Hanawa, T. Degradation of Dental Implants. In Degradation of Implant
Materials; Springer New York, 2012; Vol. 9781461439424, pp 57–78.
https://doi.org/10.1007/978-1-4614-3942-4_3.
Gondran, C.; Orio, M.; Rigal, D.; Galland, B.; Bouffier, L.; Gulon, T.;
Cosnier, S. Electropolymerized Biotinylated Poly (Pyrrole-Viologen) Film as
Platform for the Development of Reagentless Impedimetric Immunosensors.
Electrochem. commun. 2010, 12 (2), 311–314.
https://doi.org/10.1016/j.elecom.2009.12.026.
Liéby-Muller, F.; Constantieux, T.; Rodriguez, J. Highly Efficient Access to
Original Polycyclic Pyrrolopiperazine Scaffolds by a Three-Component
Reaction with 1,3-Dicarbonyls. Synlett 2007, 2007 (8), 1323–1325.
https://doi.org/10.1055/s-2007-973906.
Gracia, S.; Cazorla, C.; Métay, E.; Pellet-Rostaing, S.; Lemaire, M. Synthesis
of 3-Aryl-8-Oxo-5,6,7,8- Tetrahydroindolizines via a Palladium-Catalyzed
Arylation and Heteroarylation. J. Org. Chem. 2009, 74 (8), 3160–3163.
https://doi.org/10.1021/jo802768n.
He, Y.; Lin, M.; Li, Z.; Liang, X.; Li, G.; Antilla, J. C. Direct Synthesis of
Chiral 1,2,3,4-Tetrahydropyrrolo[1,2-a]Pyrazines via a Catalytic Asymmetric
Intramolecular Aza-Friedel-Crafts Reaction. Org. Lett. 2011, 13 (17), 4490–
4493. https://doi.org/10.1021/ol2018328.
Hu, X. L.; Lu, G. N.; Chen, L.; Yang, R. D. Synthesis and Characterisation of
a Series of New Aza-Crown Ethers. J. Chem. Res. 2003, 2003 (6), 356–357.
https://doi.org/10.3184/030823403103174100.
Sheridan, U.; McGinley, J.; Gallagher, J. F.; Fleming, A.; Kelleher, F.
Coordination Studies of Copper(II), Nickel(II), Cobalt(II) and Zinc(II) Salts
with Pyridyl-Tetrazole Ligands Containing Alkyl or Alkyl Halide Pendant
Arms. Polyhedron 2013, 59, 8–16. https://doi.org/10.1016/j.poly.2013.04.025.
Özel, A. D.; Dikici, E.; Bachas, L. G. Selectivity Properties of Corrin-Doped
Polypyrrole Film. Monatshefte fur Chemie 2013, 144 (6), 781–791.
https://doi.org/10.1007/s00706-013-0946-2.
Cometa, S.; Bonifacio, M. A.; Mattioli-Belmonte, M.; Sabbatini, L.; Giglio,
E. De. Electrochemical Strategies for Titanium Implant Polymeric Coatings:
The Why and How. Coatings 2019, Vol. 9, Page 268 2019, 9 (4), 268.
https://doi.org/10.3390/COATINGS9040268.
Daire, F.; Bedioui, F.; Devynck, J.; Bied-Charreton, C. Electropolymerisation
and Redox Properties of Bipyridyl-Polypyrrole and Cu(II) BipyridylPolypyrrole Film Electrodes. J. Electroanal. Chem. 1986, 205 (1–2), 309–
318. https://doi.org/10.1016/0022-0728(86)90242-1.
Dehghanghadikolaei, A.; Ansary, J.; Ghoreishi, R. Sol-Gel Process
Applications: A Mini-Review. Proc. Nat. Res. Soc. 2018, 2.
https://doi.org/10.11605/j.pnrs.201802008.
Fotovvati, B.; Namdari, N.; Dehghanghadikolaei, A. On Coating Techniques
150

(186)
(187)

(188)

(189)

(190)

(191)

(192)

(193)

(194)
(195)

(196)
(197)

(198)

for Surface Protection: A Review. J. Manuf. Mater. Process. 2019, 3 (1), 28.
https://doi.org/10.3390/jmmp3010028.
Pillai, R. S.; Frasnelli, M.; Sglavo, V. M. HA/β-TCP Plasma Sprayed
Coatings on Ti Substrate for Biomedical Applications. Ceram. Int. 2018, 44
(2), 1328–1333. https://doi.org/10.1016/j.ceramint.2017.08.113.
Jemat, A.; Ghazali, M. J.; Razali, M.; Otsuka, Y.; Rajabi, A. Effects of TiO2
on Microstructural, Mechanical Properties and in-Vitro Bioactivity of Plasma
Sprayed Yttria Stabilised Zirconia Coatings for Dental Application. Ceram.
Int. 2018, 44 (4), 4271–4281. https://doi.org/10.1016/j.ceramint.2017.12.008.
Levingstone, T. J.; Ardhaoui, M.; Benyounis, K.; Looney, L.; Stokes, J. T.
Plasma Sprayed Hydroxyapatite Coatings: Understanding Process
Relationships Using Design of Experiment Analysis. Surf. Coatings Technol.
2015, 283, 29–36. https://doi.org/10.1016/j.surfcoat.2015.10.044.
Melero, H. C.; Sakai, R. T.; Vignatti, C. A.; Benedetti, A. V.; Fernández, J.;
Guilemany, J. M.; Suegama, P. H. Corrosion Resistance Evaluation of HVOF
Produced Hydroxyapatite and TiO2-Hydroxyapatite Coatings in Hanks’
Solution. Mater. Res. 2018, 21 (2), 20170210. https://doi.org/10.1590/19805373-MR-2017-0210.
Bolelli, G.; Rauch, J.; Cannillo, V.; Killinger, A.; Lusvarghi, L.; Gadow, R.
Microstructural and Tribological Investigation of High-Velocity Suspension
Flame Sprayed (HVSFS) Al 2O 3 Coatings. J. Therm. Spray Technol. 2009,
18 (1), 35–49. https://doi.org/10.1007/s11666-008-9279-9.
Zhang, S. L.; Li, C. X.; Li, C. J.; Yang, G. J.; Liu, M. Application of High
Velocity Oxygen Fuel Flame (HVOF) Spraying to Fabrication of
La0.8Sr0.2Ga0.8Mg0.2O3 Electrolyte for Solid Oxide Fuel Cells. J. Power
Sources 2016, 301, 62–71. https://doi.org/10.1016/j.jpowsour.2015.09.050.
Gadow, R.; Killinger, A.; Rauch, J. Introduction to High-Velocity Suspension
Flame Spraying (HVSFS). In Journal of Thermal Spray Technology;
Springer, 2008; Vol. 17, pp 655–661. https://doi.org/10.1007/s11666-0089264-3.
Costa, D. O.; Dixon, S. J.; Rizkalla, A. S. One- and Three-Dimensional
Growth of Hydroxyapatite Nanowires during Sol-Gel-Hydrothermal
Synthesis. ACS Appl. Mater. Interfaces 2012, 4 (3), 1490–1499.
https://doi.org/10.1021/am201735k.
Pehkonen, S. O.; Yuan, S. Superhydrophobic Film Coatings for Corrosion
Inhibition. In Interface Science and Technology; Elsevier B.V., 2018; Vol. 23,
pp 133–184. https://doi.org/10.1016/B978-0-12-813584-6.00006-5.
Motealleh, A.; Eqtesadi, S.; Perera, F. H.; Pajares, A.; Guiberteau, F.;
Miranda, P. Understanding the Role of Dip-Coating Process Parameters in the
Mechanical Performance of Polymer-Coated Bioglass Robocast Scaffolds. J.
Mech. Behav. Biomed. Mater. 2016, 64, 253–261.
https://doi.org/10.1016/j.jmbbm.2016.08.004.
Dehghanghadikolaei, A.; Fotovvati, B. Coating Techniques for Functional
Enhancement of Metal Implants for Bone Replacement: A Review. Materials.
MDPI AG June 1, 2019. https://doi.org/10.3390/ma12111795.
Bakin, B.; Koc Delice, T.; Tiric, U.; Birlik, I.; Ak Azem, F. Bioactivity and
Corrosion Properties of Magnesium-Substituted CaP Coatings Produced via
Electrochemical Deposition. Surf. Coatings Technol. 2016, 301, 29–35.
https://doi.org/10.1016/j.surfcoat.2015.12.078.
He, D. H.; Wang, P.; Liu, P.; Liu, X. K.; Ma, F. C.; Zhao, J. HA Coating
151

(199)

(200)

(201)

(202)

(203)

(204)
(205)
(206)
(207)

(208)

(209)
(210)
(211)
(212)

Fabricated by Electrochemical Deposition on Modified Ti6Al4V Alloy. Surf.
Coatings Technol. 2016, 301, 6–12.
https://doi.org/10.1016/j.surfcoat.2016.07.005.
Shalom, H.; Feldman, Y.; Rosentsveig, R.; Pinkas, I.; Kaplan-Ashiri, I.;
Moshkovich, A.; Perfilyev, V.; Rapoport, L.; Tenne, R. Electrophoretic
Deposition of Hydroxyapatite Film Containing Re-Doped MoS2
Nanoparticles. Int. J. Mol. Sci. 2018, 19 (3), 657.
https://doi.org/10.3390/ijms19030657.
Yan, L.; Xiang, Y.; Yu, J.; Wang, Y.; Cui, W. Fabrication of Antibacterial and
Antiwear Hydroxyapatite Coatings via in Situ Chitosan-Mediated Pulse
Electrochemical Deposition. ACS Appl. Mater. Interfaces 2017, 9 (5), 5023–
5030. https://doi.org/10.1021/acsami.6b15979.
Yadav, S.; Yadav, B. S.; Chaudhary, S.; Pandya, D. K. Deposition Potential
Controlled Structural and Thermoelectric Behavior of Electrodeposited CoSb3
Thin Films. RSC Adv. 2017, 7 (33), 20336–20344.
https://doi.org/10.1039/c7ra01740e.
Raj, V.; Mumjitha, M. S. Fabrication of Biopolymers Reinforced TNT/HA
Coatings on Ti: Evaluation of Its Corrosion Resistance and Biocompatibility.
Electrochim. Acta 2015, 153, 1–11.
https://doi.org/10.1016/j.electacta.2014.10.055.
He, Q.; Liu, J.; Liang, J.; Liu, X.; Li, W.; Liu, Z.; Ding, Z.; Tuo, D. Towards
Improvements for Penetrating the Blood–Brain Barrier—Recent Progress
from a Material and Pharmaceutical Perspective. Cells 2018, 7 (4), 24.
https://doi.org/10.3390/cells7040024.
Bonhoeffer, K. F.; Jena, W. The Electrolytic and Chemical Passication and
Activation of Iron. J. Elektrochem 1951, 59, 151.
Kakaei, K.; Esrafili, M. D.; Ehsani, A. Graphene and Anticorrosive
Properties. In Interface Science and Technology; Elsevier B.V., 2019; Vol. 27,
pp 303–337. https://doi.org/10.1016/B978-0-12-814523-4.00008-3.
Piontek, M. C.; Roos, W. H. Atomic Force Microscopy: An Introduction. In
Methods in Molecular Biology; Humana Press Inc., 2018; Vol. 1665, pp 243–
258. https://doi.org/10.1007/978-1-4939-7271-5_13.
Schmitz, I.; Schreiner, M.; Friedbacher, G.; Grasserbauer, M. Tapping-Mode
AFM in Comparison to Contact-Mode AFM as a Tool for in Situ
Investigations of Surface Reactions with Reference to Glass Corrosion. Anal.
Chem. 1997, 69 (6), 1012–1018. https://doi.org/10.1021/ac9607020.
Aliano, A.; Cicero, G.; Nili, H.; Green, N. G.; García-Sánchez, P.; Ramos, A.;
Lenshof, A.; Laurell, T.; Qi, A.; Chan, P.; et al. AFM, Tapping Mode. In
Encyclopedia of Nanotechnology; Springer Netherlands, 2012; pp 99–99.
https://doi.org/10.1007/978-90-481-9751-4_33.
J. Roa, J.; Oncins, G.; Diaz, J.; Sanz, F.; Segarra, M. Calculation of Young’s
Modulus Value by Means of AFM. Recent Pat. Nanotechnol. 2011, 5 (1), 27–
36. https://doi.org/10.2174/187221011794474985.
Hopcroft, M. A.; Nix, W. D.; Kenny, T. W. What Is the Young’s Modulus of
Silicon? J. MICROELECTROMECHANICAL Syst. 2010, 19 (2), 229.
https://doi.org/10.1109/JMEMS.2009.2039697.
Ma, Y. X-Ray Absorption, Emission, and Resonant Inelastic Scattering in
Solids. Phys. Rev. B 1994, 49 (9), 5799–5805.
https://doi.org/10.1103/PhysRevB.49.5799.
Hernandez, C. L. Scanning Electron Microscopy and X-Ray Microanalysis152

(213)
(214)
(215)

(216)

(217)
(218)
(219)
(220)

(221)

(222)

(223)

(224)

(225)

(226)
(227)

Goldstein,Newbury.Pdf.
Zhou, W.; Apkarian, R. P.; Lin Wang, Z.; Joy, D. Fundamentals of Scanning
Electron Microscopy.
Masui, M.; Sayo, H. Anodic Oxidation of Amines. Part II. Electrochemical
Dealkylation of Aliphatic Tertiary Amines. J. Chem. Soc. B Phys. Org. 1971,
No. 0, 1593–1596. https://doi.org/10.1039/J29710001593.
Pittenger, B.; Yablon, D. G. Improving the Accuracy of Nanomechanical
Measurements with Force-Curve-Based AFM Techniques. Bruker Application
Note AN149. Bruker 2017, pp 1–7.
https://doi.org/10.13140/RG.2.2.15272.67844.
Miyake, K.; Satomi, N.; Sasaki, S. Elastic Modulus of Polystyrene Film from
near Surface to Bulk Measured by Nanoindentation Using Atomic Force
Microscopy. Appl. Phys. Lett. 2006, 89 (3).
https://doi.org/10.1063/1.2234648.
Nečas, D.; Klapetek, P. Gwyddion: An Open-Source Software for SPM Data
Analysis. Central European Journal of Physics. De Gruyter February 1, 2012,
pp 181–188. https://doi.org/10.2478/s11534-011-0096-2.
Hermanowicz, P.; Sarna, M.; Burda, K.; Gabryś, H. AtomicJ: An Open
Source Software for Analysis of Force Curves. Rev. Sci. Instrum. 2014, 85
(6), 063703. https://doi.org/10.1063/1.4881683.
Nanomechanical Measurements with Force-Curve-Based AFM Techniques
https://www.azonano.com/article.aspx?ArticleID=4749 .
Frutos, E.; Karlík, M.; Jiménez, J. A.; Langhansová, H.; Lieskovská, J.;
Polcar, T. Development of New β/Α″-Ti-Nb-Zr Biocompatible Coating with
Low Young’s Modulus and High Toughness for Medical Applications. Mater.
Des. 2018, 142, 44–55. https://doi.org/10.1016/J.MATDES.2018.01.014.
Zhou, C.; Feng, X.; Shi, Z.; Song, C.; Cui, X.; Zhang, J.; Li, T.; Toft, E. S.;
GE, J.; Wang, L.; et al. Research on Elastic Recoil and Restoration of Vessel
Pulsatility of Zn-Cu Biodegradable Coronary Stents. Biomed. Eng. / Biomed.
Tech. 2020, 65 (2), 219–227. https://doi.org/10.1515/BMT-2019-0025.
Ordikhani, F.; Tamjid, E.; Simchi, A. Characterization and Antibacterial
Performance of Electrodeposited Chitosan-Vancomycin Composite Coatings
for Prevention of Implant-Associated Infections. Mater. Sci. Eng. C 2014, 41,
240–248. https://doi.org/10.1016/j.msec.2014.04.036.
Ordikhani, F.; Farani, M. R.; Dehghani, M.; Tamjid, E.; Simchi, A.
Physicochemical and Biological Properties of Electrodeposited Graphene
Oxide/Chitosan Films with Drug-Eluting Capacity. Carbon N. Y. 2015, 84
(C), 91–102. https://doi.org/10.1016/j.carbon.2014.11.052.
GhavamiNejad, A.; Aguilar, L. E.; Ambade, R. B.; Lee, S. H.; Park, C. H.;
Kim, C. S. Immobilization of Silver Nanoparticles on Electropolymerized
Polydopamine Films for Metal Implant Applications. Colloids Interface Sci.
Commun. 2015, 6, 5–8. https://doi.org/10.1016/j.colcom.2015.08.001.
Ion, R.; Drob, S. I.; Ijaz, M. F.; Vasilescu, C.; Osiceanu, P.; Gordin, D. M.;
Cimpean, A.; Gloriant, T. Surface Characterization, Corrosion Resistance and
in Vitro Biocompatibility of a New Ti-Hf-Mo-Sn Alloy. Materials (Basel).
2016, 9 (10). https://doi.org/10.3390/ma9100818.
Amais, R. S.; Donati, G. L.; Zezzi Arruda, M. A. ICP-MS and Trace Element
Analysis as Tools for Better Understanding Medical Conditions. TrAC Trends Anal. Chem. 2020, 133. https://doi.org/10.1016/J.TRAC.2020.116094.
Sajnóg, A.; Hanć, A.; Koczorowski, R.; Makuch, K.; Barałkiewicz, D.
153

Usefulness of Laser Ablation ICP-MS for Analysis of Metallic Particles
Released to Oral Mucosa after Insertion of Dental Implants. J. Trace Elem.
Med. Biol. 2018, 46, 46–54. https://doi.org/10.1016/J.JTEMB.2017.11.007.

154

